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SUMMARY 
 
 
Crustacean shell waste contains 20 – 30 % chitin which can be extracted to produce more 
valuable products such as chitosan, glucosamine and their derivatives. Due to their natural 
source, they are non-toxic, biodegradable and biocompatible. They have been applied in a 
wide range of industries, especially in the production of functional foods, pharmaceutics and 
cosmetics due to their binding, film-forming and antimicrobial properties. Although the safety 
of these products is highly regarded, some residual proteins from shrimp shell such as 
tropomyosin and arginine kinase could remain in these products and cause allergic reactions 
among consumers. Therefore, chitin and chitosan properties must be characterized in detail 
before applying them, especially in the food and drug industry. 
 
At present, chitosan-based edible films are already used as a new material for food packaging. 
However, there is still very limited research in the application of chitosan film for instant food 
products due to its poor solubility in water. Therefore, it is necessary to mix chitosan with 
other water-soluble materials to apply it to instant food casing. 
 
This study is aimed at investigating the allergenicity of residual shrimp proteins in chitin and 
chitosan samples. Antimicrobial property of normal chitosan was examined and compared 
with purified chitosan. The film-forming property of chitosan and some biopolymers was also 
characterized to formulate an edible film which is soluble and sealable to make spice sachets 
for instant noodles. 
 
At the beginning, the study focuses on the production of rabbit polyclonal antibodies. These 
antibodies were raised by injecting antigens into rabbits to generate specific antibody 
containing sera. Two types of antigens were prepared. The first antigen was the purified 
tropomyosin from four different shrimp species. The second antigen was the mixed protein 
extracted from three crustacean species. The injection of antigens and collection of rabbit sera 
was conducted by a specialised company in Australia and not conducted at the University. 
These sera were analysed for titre and immunoreaction with different immunogens. The 
generated sera were used to investigate the immunoreactions of different shrimp extracts as 
well as residual shrimp proteins and allergens in chitin and chitosan preparations. 
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Next, the study focuses on the identification of the allergenic protein tropomyosin in different 
protein extracts of the two most common shrimp species sold in the Australian market: Black 
Tiger shrimp and Banana shrimp. Six different protein extractions from each shrimp species 
were prepared by different methods: raw extraction, heat-treated extraction and whole-cooked 
extraction. These protein extracts were then compared according to their SDS-PAGE profiles, 
immunoblotting reactions by Western blotting as well as cross-reaction through inhibition 
ELISA. The result demonstrated that the allergenic tropomyosin protein not only presents in 
the tail meat but also in the shell extracts of shrimp. The tropomyosin seemed to be more 
stable to heat processing in whole-cooked extracts. The IC50 values of rabbit sera 
demonstrate strong cross-reactivity of both sera to most extracts with the highest 
concentration of tropomyosin in cooked shrimp. 
 
The allergenic protein tropomyosin in the shrimp shell may be present in the residual proteins 
in chitin and chitosan samples. Therefore the characterisation of possible allergenic residual 
proteins in chitin and chitosan has been conducted. Numerous methods were used in an 
attempt to pull the proteins out of the chitin and chitosan samples. However, due to the small 
amount of protein residue and the resistant property of tropomyosin, it is difficult to isolate 
the protein residue from chitin and chitosan using SDS-PAGE and Western blot. However, 
the Dot blot results demonstrated that there is a certain amount of the tropomyosin remaining 
in the chitin and chitosan samples. The inhibition ELISA also confirmed the 
immunoreactivity of the protein residue in chitin and chitosan samples to rabbit sera which 
are specific to crustacean protein and shrimp tropomyosin. This result could somewhat 
explain the reason that some people may get adverse reactions when dealing with products 
containing chitin and chitosan. 
 
The next section of the study focuses on the antimicrobial properties of chitosan. Firstly, the 
biochemical properties of some chitin and chitosan products were characterized based on their 
moisture content, ash content, heavy metal content, and protein content. The results indicated 
that these chitin and chitosan samples have acceptable biochemical properties that are suitable 
for application in the food industry. The protein content of normal chitosan samples was less 
than 1 %, while it cannot be detected in the purified sample. Some variability in the results 
indicated that chitin and chitosan need to be characterized and standardized for their properties 
before application in the food industry. Secondly, the antimicrobial property of normal chitosan 
at different chitosan concentrations against Gram-negative Escherichia coli and Gram-positive 
Staphylococcus aureus was examined. The results showed that chitosan at 0.05 % and 0.1 % 
concentration can inhibit the growth of both E. coli and S. aureus after 4 hours of incubation. 
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After that, the antimicrobial properties between normal chitosan and purified chitosan were 
compared to each other by MIC, MBC and disc diffusion methods. The results demonstrated 
that purified chitosan still retains its antimicrobial property comparable to the normal chitosan. 
Finally, the application of the normal and purified chitosan in the preservation of shrimp was 
a confirmation of the antimicrobial property of chitosan. Both normal and purified chitosan 
can inhibit the outgrowth of bacteria on shrimps during 15 days of storage at 0 – 4 oC while 
limiting weight loss and maintaining hardness better than in the non-treated shrimps. 
 
In the following work, the film forming capacity of chitosan has been investigated to find 
appropriate methods for making chitosan film. In addition, the film forming ability of some 
other biopolymers were also examined to find out which polymer is best to combine with chitosan 
to make films with desired properties. The composite edible film was investigated for its 
formulation as well as antimicrobial properties. The use of this edible film in spice casing for 
instant noodles is an attempt to apply chitosan-based films in the instant food industry. This 
study found that the neutralization process, the degree of deacetylation of chitosan and the 
chitosan concentration affected significantly the solubility of chitosan film. Among the tested 
biopolymers, gelatin showed the best appropriate properties to blend with chitosan in forming 
soluble and sealable edible film. The composition of 0.5 % chitosan and 5 % gelatin has been 
shown as the most appropriate formulation to make the desired edible film. This edible film 
showed excellent antimicrobial property to both Gram-negative and Gram-positive bacteria. 
Therefore, it could be used in the preservation of food products. This composite chitosan / 
gelatin edible film was applied in making seasoning and oil sachets for instant noodles to 
examine the feasibility of this film. The spice stored in these edible film sachets can still 
maintain quality after 6 months of storage. These sachets should be kept in another container 
to prevent the exposure to humidity, but overall, this edible film is suitable for application in 
spice casings for instant noodles. 
 
The current study confirmed the presence of shrimp protein residue in chitin and chitosan 
samples and associated strong immunoreactivity with specific antibodies against the shellfish 
allergen tropomyosin, as well as with crustacean - sensitized patient sera. This indicated the 
presence of the major allergen tropomyosin and the potential risk of allergic reactions in 
sensitized consumers of contaminated chitosan products. The purification did not affect the 
antimicrobial property of chitosan. So, commercial chitosan should be purified before 
applying in the food industry to protect consumers from allergic reactions. In addition, a 
combination of chitosan and gelatine formed a water-soluble and sealable edible film which 
can be applied to instant food casing. 
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Chapter 1 
INTRODUCTION 
 
 
1.1 OVERVIEW OF CHITIN AND CHITOSAN 
1.1.1 Source and structure of chitin and chitosan 
Chitin, which was first identified in 1884 (Rinaudo, 2006), is among the most abundant 
natural polymers in the world, just after cellulose. It is a linear polysaccharide consisting of 
(1-4)-linked 2-acetamido-2-deoxy-β-D-glucopyranose (Hudson and Jenkins, 2002; Ravi 
Kumar, 1999) (Figure 1.1). It functions as a structural polysaccharide in animals. Chitin is a 
white, hard, inelastic, nitrogenous polysaccharide and the major source of surface pollution in 
coastal areas (Nair and Madhavan, 1992) 
 
 
Figure 1.1: Structure of chitin 
 
Chitin can be found in a wide variety of sources such as in the cell walls of fungi of 
Zygomycetes, in the green algae Chlorella, yeast and protozoa as well as insect cuticles and 
especially in the exoskeletons of crustaceans (Alishahi and Aïder, 2011; Rinaudo, 2006). 
Shells of crustaceans such as crab, shrimp, and crawfish contain approximately 15-40 % 
chitin (Kurita, 2006) (Table 1.1). It is produced to an amount of a hundred billion tons each 
year by these natural sources (Rege and Block, 1999). 
 
Chitin is extracted from crustacean shell through two major steps. Deproteination is taken 
place at diluted alkaline conditions while demineralization occurs at diluted acidic conditions. 
Chitin is then converted into chitosan through the deacetylation at very strong alkaline 
conditions with high temperature (Stevens, 2000). The conversion of chitin  to chitosan can be 
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carried out effectively at milder condition by enzymatic method (Stevens, 2005) to remove 
the acetyl groups from chitin structure. However, because chitin exits as a naturally partially 
deacetylated form depending on the source (Rinaudo, 2006), it is very difficult to clearly 
distinguish between chitin and chitosan. Therefore, the term chitin and chitosan can be used 
interchangeably. Usually, the term chitosan is used when there is more than a 50% degree of 
deacetylation.  
 
Table 1.1: Contents of chitin and calcium carbonate (Kurita, 2006) 
Source Chitin (%) CaCO3 (%) 
Crab cuticle 15–30 40–50 
Shrimp cuticle 30–40 20–30 
Krill cuticle 20–30 20–25 
Squid pen 20–40 Negligible 
Clam/oyster shell 3–6 85–90 
Insect cuticle 5–25 Negligible 
Fungi cell wall 10–25 Negligible 
 
 
Chitosan, obtained from chitin by deacetylation, is a linear polysaccharide consisting of (1-4)-
linked 2-amino-2-deoxy-β-D-glucopyranose (Figure 1.2). In the solution, the –NH2 groups at 
C-2 position of chitosan structure are protonated to form the NH3
+
 cations. Due to its 
relatively higher polyelectrolyte nature, chitosan has more active properties than chitin such 
as adsorption, film-forming and antimicrobial properties which brings chitosan to wide 
applicability (Stevens, 1996).  
 
 
Figure 1.2: Structure of chitosan 
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Chitosan is a reactive polymer susceptible to many chemical modifications (Muzzarelli, 
1983). Many derivatives from chitosan have been investigated for their properties and 
application (Table 1.2). 
 
Table1.2: Chitosan Derivatives and Proposed Uses  (Muzzarelli, 1983) 
Chitosan Derivatives Proposed Uses 
N-Acyl chitosans acetyl, propionyl, butyryl, hexanoyl, octanoyl, decanoyl, 
dodecanoyl, tetradecanoyl, lauroyl, myristoyl, palmitoyl, 
stearoyl, benzoyl, dichloroacetyl, carbamoyl (textiles, 
membranes)  
 
N-Carboxyalkyl chitosans N-carboxymethyl (metal ion collection) 
N-Carboxyacyl chitosans from anhydrides such as: maleic, itaconic, (acetylthio)-
succinic, glutaric, cyclohexane-l,2-dicarboxylic, phthalic, 
cis-tetrahydrophthalic,5-norbornene-2,3-dicarboxylic, 
diphenic, salicyl 
O-Carboxyalkyl chitosans O-carboxymethyl, epichlorohydrin-cross-linked 
Ocarboxymethyl (membranes, molecular sieves) 
Deoxyglycit-l-yl chitosans 1-deoxygalactit-l-yl, 1-deoxyglucit-l-yl, 1-deoxymelibiit- 
1-yl, 14actit-l-yl (gels, drilling muds) 
Metal ions - chitosan chelates palladium, copper, silver, iodine (catalysis, photography, 
health products, insecticides) 
Semi-synthetic resins of chitosan methyl methacrylate, poly(urea-urethane) poly(amide-
ester), acrylamide-maleic anhydride-ehitosan copolymer) 
Natural polysaccharide complex chitosan-glucan (flocculation, metal ion chelation) 
Miscellaneous alkali chitin (intermediate), benzyl chitin (serine protease 
purification), hydroxybutyl chitosan (desalting), 
cyanoethyl chitosan (filtration, dialysis, insulating papers), 
glycol chitosan (dialysis, special papers), glutaraldehyde 
chitosan (enzyme immobilisation), linoleic acid--chitosan 
complex (food additive, anticholesterolaemic), uracyl 
chitosan, theophylline chitosan, adenine chitosan, 
chitosan salts of acidic polysaccharides. 
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1.1.2 Properties of chitin and chitosan 
Chitin and chitosan have higher nitrogen content (6.89 %) than synthetically substituted 
cellulose (1.25  %), thus make them more attractive for many industrial applications (Rathke 
and Hudson, 1994). Due to their natural sources, chitin and chitosan are considered 
biocompatible, biodegradable and non-toxic (Muzzarelli and Muzzarelli, 2005).  
 
Table 1.3: Specification of chitin and chitosan (technical grade) in the world market 
(Changrkrachang, 1996) 
Parameter 
Commercial chitin Commercial chitosan 
England Norway India England Norway India 
Source - Shrimp shells - - - - 
Form - Flakes - Ground - - 
Color - 
White to 
yellow 
- White - - 
Moisture content 
(%) 
≤ 8 ≤ 10 < 10 ≤ 10 < 10 - 
Ash content (%) ≤ 2 ≤ 1 < 2 ≤ 1 < 1.5 < 1 
Heavy metal content 
(ppm) 
- ≤ 10  - - - 
Deacetylation 
degree (%DD) 
≥ 15 - - 80 - 90 > 70 - 
Protein content (%) ≤ 3-4 - - - - - 
Viscosity (cps) - - - 
a) 20 
b) 50-150 
c) 200-400 
d) 400-1000 
e) >1000 
> 200 
a) 200-800 
b) 800-2000 
c) >2000  
Insoluble    < 0.5 < 2 < 0.5 
Note:  - = Data is not available      
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While most of the naturally occurring polysaccharides such as cellulose, dextran, pectin, 
alginic acid, agar, agarose, carragenans are neutral or acidic in nature, chitosan is a highly 
basic polysaccharide (Rinaudo, 2006). 
 
The properties of chitin and chitosan depend largely on their molecular weight and the degree 
of deacetylation (DD). Chitosan is characterized by either the degree of acetylation (DA), 
which corresponds to N-acetylamine groups or the degree of deacetylation (DD) (DD=100-
DA), D-glucosamine groups. The degree of deacetylation has an influence on the 
physicochemical properties of chitosan (viscosity, solubility, swelling index, etc.) (Stevens, 
1996). 
 
1.1.2.1 Solubility 
Due to its rigid structure, chitin is a highly insoluble material with low chemical reactivity. 
This is the major reason that limits the development of processing and uses of chitin. Chitin 
can dissolve in strong inorganic salts such as LiCNS, Ca(CNS)2, CaI2, CaBr2, or strong acid 
and polar solvents such as trichloroacetic acid  (TCA), dichloroacetic acid (DCA), lithium 
chloride – tertiary amide solvent systems, calcium chloride – dihydrate-saturated methanol 
solvent system (Pillai et al., 2009). 
 
While chitin is insoluble in water, alkaline solution and most organic solvents, chitosan is 
readily soluble in aqueous inorganic acids with pH below 6.0. There are some critical factors 
that contribute to chitosan solubility such as temperature and time of deacetylation, alkali 
concentration, prior treatments applied to chitin isolation, ratio of chitin to alkali solution, 
particle size, etc. (Pillai et al., 2009). Acetic acid is a common solvent to dissolve chitosan. 
 
1.1.2.2 Viscosity 
When dissolving in aqueous organic acid, chitosan forms a very viscous solution. This is due 
to its high molecular weight and linear unbranched structure. Thus, chitosan can be used as a 
thickening agent in an acidic environment. In some acids the concentration ratio between 
chitosan and acid affects the viscosity of the solution (Kristl et al., 1993).  
 
1.1.2.3 Adsorption property 
Chitosan acts as a cationic substance in acidic solution. Therefore it can bind to other anionic 
substances. Chitosan with molecular weight of 0.7  106 has high dye binding capacity (No et 
al., 2007). However, in low pH conditions (pH less than 5), chitosan gradually dissolves and 
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therefore loses its function as an absorbent.  Due to its porous polymer structure, affinity for 
water and ionic properties, chitosan can bind to water, protein, fat, and metal (Knorr, 1983; 
Shafaei et al., 2007; Trung et al., 2003).  
 
1.1.2.4 Film-forming property 
Chitin and chitosan belong to very interesting family of -(1-4) linked polysaccharides. This 
kind of glycosidic linkage leads to relatively extended and rigid structures in the solid state, 
particularly in the dry state. As a consequence, these polymers, as cellulose, have a good film 
and fiber forming capability (Muzzarelli, 1983). The positively charged groups on chitosan 
interact with opposite charged groups of the solvent yield three-dimensional networks 
(Khoshgozaran-Abras et al., 2012). Chitosan films are tough, long-lasting, flexible and very 
difficult to tear (Shahidi et al., 1999). Chitosan films have moderate water vapour 
permeability values and could be used to increase the storage life of fresh produce and 
foodstuffs with higher water activity values (Shahidi and Abuzaytoun, 2005; Shahidi et al., 
1999). It exhibits an excellent barrier to oxygen permeation (Butler et al., 1996). 
 
The properties of the chitosan films depend on intrinsic characteristics of chitosan (source, 
molecular weight, degree of deacetylation), type and amount of solvents, plasticizers, 
copolymers, dispersants, and method for film preparation and storage condition (Caner et al., 
1998; Khoshgozaran-Abras et al., 2012). The mechanical strength of the film increases with 
an increase in the molecular weight and the degree of deacetylation of chitosan (Chen et al., 
2011; Chen et al., 1996; Wan et al., 2003).. 
 
1.1.2.5 Antimicrobial property 
The antimicrobial property of chitosan is often examined based on its bacteriostatic and 
bactericidal properties (Tayel et al., 2010). The antimicrobial property of chitosan is 
interesting for the food industry due to its natural, biocompatible and non-toxic attributes 
(Dutta et al., 2009). Chitosan is often used in the form of a solution or coating film for food 
preservation. Many studies showed that chitosan can express a high inhibition rate to a wide 
range of microorganisms (Gram positive and Gram negative bacteria, fungi and yeast) at a 
low concentration, and thus assist in maintaining food safety (Kanatt et al., 2008a, 2008b; 
Sagoo et al., 2002; Zheng and Zhu, 2003). Chitosan is known as more effective against fungi 
and yeast compared to Gram positive and Gram negative bacteria (Rhoades and Rastall, 
2003).  Chitosan can also suppress viral infection (Chirkov, 2002). 
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Chitosan can inactivate different pathogenic bacteria including Escherichia coli, Bacillus 
cereus, Staphylococcus aureus and Pseudomonas spp at low concentration (MIC = 0.05 %) in 
four hours (Kanatt et al., 2008b). In the case of Gram-negative Salmonella typhimurium, the 
growth of the bacterium was inhibited for 4 hours in the presence of 0.1 % chitosan but not 
for 24 hours of incubation. 
 
In recent studies, it was discovered that chitosan extracted from fungi such as Mucor, 
Zygomyces, Rhizomucor has better antimicrobial properties than chitosan extracted from 
crustaceans (Tajdini et al., 2010; Tayel et al., 2010).  
 
1.1.2.5.1 Mode of antimicrobial action of chitosan 
The exact antibacterial mechanism of chitosan is unclear but there are many suppositions. The 
most supportive hypothesis is related to the solubility of chitosan in acid condition. It is 
presumed that positively charged NH3
+
 in glucosamine inhibit the growth of bacteria by 
binding to the negatively charged cell wall. Some reports demonstrated that chitosan-treated 
cell walls of bacteria were weakened and frayed, which may lead to leakage of intracellular 
materials such as electrolytes, proteins, nucleic acids, through changes in the membrane 
permeability (Fernández-Saiz and Lagaron, 2011; Tang et al., 2010; Tayel et al., 2010). The 
antimicrobial activity can be due to the metal binding capacity of chitosan which can inhibit 
various enzymes in the cell that lead to the death of the microorganism (Darmadji and 
Izumimoto, 1994; Dutta et al., 2009; Tayel et al., 2010). Chitosan also has the capacity to 
absorb nutrients and thereby inhibit the growth of microorganisms (Knorr, 1983; Tayel et al., 
2010) 
 
Helander et al. (2001) studied about the effect of chitosan on Gram-negative bacteria by 
measuring the uptake of the hydrophobic probe 1-N-phenylnaphthylamine (NPN). The 
increase of NPN uptake is equivalent to the decrease of barrier function of the outer 
membrane. The study demonstrated that chitosan binds to the outer membrane and destroys 
its barrier function (Helander et al., 2001). 
 
Chitosan has different actions towards Gram-negative and Gram-positive bacteria. Chitosan 
prevents the transfer of nutrients into Gram-positive cells by covering its outer membrane; 
however, chitosan with low molecular weight can enter the cell and inhibit DNA synthesis 
(Dutta et al., 2009). In another study, the greater effect of chitosan on Gram-positive 
compared to Gram-negative bacteria was explained by the difference in the cell wall structure 
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of these bacteria (Fernández-Saiz and Lagaron, 2011). The main components of Gram-
positive cell walls, peptidoglycan (50 – 90 %) and the anionic teichoic acid, bind with the 
NH3
+
 group of chitosan.  
 
The antifungal property of chitosan was also confirmed by rupturing of the outer membrane 
of the fungus and was not related to the sequestration of microbial nutrients (Tajdini et al., 
2010).  
 
1.1.2.5.2 Factors affected the antimicrobial of chitosan 
The antimicrobial activity of chitosan is affected by its intrinsic characteristics (degree of 
deacetylation, molecular weight, concentration, viscosity), by the environment (pH, 
temperature), microbial species, status of the microorganism or the nutrient composition. The 
type of acid used in the preparation of chitosan solution influences antimicrobial activity. 
Chitosan prepared with acetic acid exhibits more immediate antifungal effects as compared 
with chitosan prepared with lactic acid (Cuero et al., 1990; 1991). 
 
1.1.2.5.2.1 Degree of deacetylation (DD) 
The DD index affects not only the physical and mechanical properties of chitosan film but 
also its antimicrobial properties. A higher DD will increase the number of NH3
+ 
groups, thus 
raising the solubility of chitosan in acid environments and the binding with negative 
components on the cell wall (Aider, 2010). 
 
The study of Tayel (2010) on the antimicrobial activity of fungal chitosan with different DD 
against eleven bacterial strains showed that chitosan with the highest DD (95 %) had the 
lowest minimal inhibitory concentration indicating the highest antimicrobial effect (Table 
1.4).  
 
1.1.2.5.2.2 Molecular weight (MW) 
The molecular weight of chitosan has different effects on Gram-negative and Gram-positive 
chitosan. The study of Zheng and Zhu (2003) showed that chitosan with lower MW has 
greater effects on Gram-negative E. coli (Chitosan with MW < 5 kDa can inhibit 100 % E. 
coli at 0.25 % concentration) (Table 1.5). In contrast, the antimicrobial activity of chitosan 
against Gram-positive S. aureus increases as MW increases (Table 1.6). 
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Table 1.4: Minimal inhibitory concentrations (MIC) (mg/ml) of different chitosan types 
against determined bacterial strains (means of triplicates)  (Tayel et al., 2010) 
Bacterial strains 
MIC (mg/ml) 
CTS1  
(84.9 % DD)                      
CTS2  
(83 % DD)  
CTS3   
(95 % DD)                      
CTS4  
(84.9 % DD) 
Escherichia coli1 
Staphylococcus aureus 1 
Samonella typhimurium 
Pseudomonas fluorescens 
Psedomonas aeruginosa 
Bacillus subtilis 
Escherichia coli O157:H7 
Sarcina lutea 
Sarratia marcescens 
Staphylococcus aureus 2 
Escherichia coli 2 
2.0 
0.75 
2.5 
2.25 
2.0 
1.5 
2.25 
1.0 
1.75 
1.75 
2.5 
2.0 
1.0 
2.0 
3.25 
2.0 
1.25 
1.75 
1.75 
1.75 
1.5 
1.75 
1.25 
0.75 
2.0 
1.75 
1.5 
0.75 
1.75 
1.0 
1.25 
1.0 
1.5 
1.75 
0.5 
2.0 
2.25 
1.75 
1.0 
1.5 
0.75 
2.0 
1.25 
2.25 
 
 
 
Table 1.5: The antimicrobial effect of chitosan on E. coli (Zheng and Zhu, 2003) 
 
  
MW (kDa) 
Inhibition rate η (%) 
Chitosan concentration 
0.25 % 0.5 % 0.75 % 1.0 % 
< 5 
48.5 
72.4 
129 
166 
305 
50 
30 
5 
0 
0 
0 
60 
80 
10 
5 
40 
40 
90 
90 
50 
90 
80 
50 
100 
100 
100 
100 
100 
100 
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Table 1.6: The antimicrobial effect of chitosan on S. aureus (Zheng and Zhu, 2003) 
 
 
Chitosan only has its antimicrobial activity within a certain MW range. Chitosan with MW 
below 1.4 kDa or above 400 kDa showed very weak antimicrobial effect (Zheng and Zhu, 
2003).  
 
Similarly, chitosan oligomers cannot inhibit the growth of bacteria in sausages (Jo et al., 
2001) while N-acetylated chitosan cannot inhibit E. coli, S. aureus and Candida albicans (Qin 
et al., 2006). 
 
1.1.2.5.2.3 pH 
Many studies showed that the antimicrobial activity of chitosan increases in low pH 
conditions. This is because more cationic NH3
+ 
groups are formed (Tang et al., 2010) and also 
the effect of acidic solutions in preventing the growth of bacteria.  
 
Chitosan inhibited Salmonella typhimurium and Serratia marcescens more at pH 4 than pH 
4.5 (Tayel et al., 2010). A higher number of S. aureus were killed at pH 6.2 (3 log cfu/ml) 
than at pH 7.4 (1.5 log cfu/ml) (Fernández-Saiz and Lagaron, 2011). Chitosan with 0.005 % 
concentration at pH 4 exhibited 100 % inhibition rate to Candidan lambica while lengthened 
the lag phase and had no inhibition at pH 6. 
 
  
MW (kDa) 
Inhibition rate η (%) 
Chitosan concentration 
0.25 % 0.5 % 0.75 % 1.0 % 
< 5 
48.5 
72.4 
129 
166 
305 
0 
0 
0 
40 
95 
99 
0 
95 
96 
100 
100 
100 
0 
99 
99 
99 
100 
100 
0 
100 
100 
100 
100 
100 
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1.1.2.5.2.4 Other factors 
The incubation temperature when testing the microorganism or when testing the preservation 
of food also affects the antimicrobial of chitosan (Tayel et al., 2010).  
 
The age of bacteria also has an effect on the antimicrobial properties of chitosan. 
Staphylococcus aureus is more sensitive to chitosan at its mid log phase (Fernández-Saiz and 
Lagaron, 2011). 
 
The ingredients of food such as starch, whey protein, sodium chloride and essential oil were 
recognised to enhance the antimicrobial activity of chitosan. 
 
1.1.2.6 Health and safety factors 
Chitin and chitosan have very low toxicity. Therefore, they can be used as a dietary fiber for 
osteoarthrosis treatment, body weight control and lowering of blood plasma cholesterol level 
(Hudson and Jenkins, 2002).  
 
The toxicity of chitosan examined by Knorr (1984) indicated that only concentrations above 
18 g of free chitosan /kg of body weight/day were harmful to mice. 
 
Chitosan was also confirmed for its non-toxicity for use in excipients (Paul, 2010).  
 
1.1.3 Application of chitin and chitosan in food industry 
Due to its excellent properties such as adsorption, film-forming and antimicrobial properties, 
chitosan has a wide range of application in many industrial fields such as food, biotechnology, 
paper manufacture, cosmetics, agriculture, environment and medical fields (Fernández-Saiz 
and Lagaron, 2011; Knorr, 1983; Kristl et al., 1993; Muzzarelli and Muzzarelli, 2005; 
Muzzarelli, 1983; Nair and Madhavan, 1992; Ravi Kumar, 1999; Stevens, 2005; Synowiecki 
and Al-Khateeb, 2003; Trung et al., 2003)  
 
In the food industry, chitosan is used in edible films, immobilization of enzymes, antimicrobial 
activity, additives (color stabilization agent, emulsifying agents, antioxidant agents, and gelling 
agents), dietary fiber (fat entrapment, glucose dialysis, and water holding capacity) (Agulló et 
al., 2003; Aider, 2010; Alishahi and Aïder, 2011; Kanatt et al., 2008b; No et al., 2007). Some 
important applications of chitosan in the food industry are presented in Table 1.7. 
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Table 1.7: Food applications of chitin, chitosan and their derivatives in the food industry 
(Shahidi et al., 1999) 
Area of application Examples 
Antimicrobial agent Bactericidal 
Fungicidal 
Measure of mould contamination in agricultural 
commodities 
Edible film industry Controlled moisture transfer between food and 
surrounding environment 
Controlled release of antimicrobial substances 
Controlled release of antioxidants 
Controlled release of nutrients, flavours and drugs 
Reduction of oxygen partial pressure 
Controlled rate of respiration 
Temperature control 
Controlled enzymatic browning in fruits 
Reverse osmosis membranes 
Additive Clarification and deacidification of fruits and beverages 
Natural flavour extender 
Texture controlling agent 
Emulsifying agent 
Food mimetic 
Thickening and stabilizing agent 
Colour stabilization 
Nutritional quality Dietary fibre 
Hypocholesterolemic effect 
Livestock and fish feed additive 
Reduction of lipid absorption 
Production of single cell protein 
Antigastritis agent 
Infant feed ingredient 
Recovery of solid materials 
from food processing wastes 
Affinity flocculation  
Fractionation of agar 
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Purification of water Recovery of metal ions, pesticides, phenols and PCB's 
Removal of dyes 
Other applications Enzyme immobilization 
Encapsulation of nutraceuticals 
Chromatography 
Analytical reagents 
 
 
Chitosan in solution was applied to preserve many types of food such as meat balls and 
sausages to increase their shelf-life (Sagoo et al., 2002).  Chitosan solution can inhibit some 
pathogenic food bacteria in the preservation of fresh pork as well as retaining their sensory 
value during storage (Darmadji and Izumimoto, 1994). In the preservation of fruits, chitosan 
has been used as a coating and antifungal agent, resulting in increased quality and storability. 
Chitosan markedly reduced the growth of Botrytis cinerea and Rhizopus stolonifer on 
strawberries with a greater effect at higher concentrations (Shahidi et al., 1999).  
 
Chitosan was also combined with other natural substances to enhance its antimicrobial 
activity. The blending of chitosan – glucose can increase the shelf-life of lamb by two weeks 
(Kanatt et al., 2008b). The mixture of chitosan and mint also has good effect on the inhibition 
of Escherichia coli, Bacillus cereus, Staphylococcus aureus and Pseudomonas spp. (Kanatt et 
al., 2008a).  
 
Chitosan film was used to preserve nutrient-rich and perishable food such as raw meat, fish, 
egg, fruit and vegetables, and green tea (Devlieghere et al., 2004; Park and Chinnan, 1995; 
Siripatrawan and Harte, 2010) 
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1.2 OVERVIEW OF EDIBLE FILM FOR FOOD PACKAGING 
1.2.1 Introduction to edible film 
Edible film is defined as a thin layer of edible materials formed on food as a coating or a self-
supporting thin layer placed on or in between the food components, and in both cases 
consumed along with the food (Gontard et al., 2011). Edible films have recently become one 
of the most effective methods in maintaining the quality of food. Its functions are to extend 
the shelf life of food and maintain its quality by inhibiting migration of moisture, oxygen, 
carbon dioxide, aromas, lipid, and solute as well as to solve environment waste problems.  
 
Edible films have potential in a number of different areas. They can coat food surfaces, 
separate different compounds, act as casings, pouches or wraps. They also can preserve 
product quality by forming oxygen, aroma, oil or moisture barriers, carrying functional 
ingredients, such as antioxidants, antimicrobials, and improving appearance, structure and 
handling. Recent have shown that edible films and edible coatings also are able to reduce oil 
uptake of some fried food products (Butler et al., 1996). 
 
1.2.2 Materials for edible film 
The material for making films should meet Food and Drug Administration (FDA) 
requirements, since they are applied to foods. The material must be generally regarded as safe 
(GRAS), hence will be accepted in the wide market. The commercial production of edible 
films has been already undertaken by some companies. They sell specific edible films with 
explanation of usage including their properties. 
 
Many researches now focus intensively on biomaterials from natural sources such as gelatine, 
casein, pectin, starch, carageenan, agar and carboxymethyl cellulose. Those biomaterials can 
form homogenous films or be mixed together to support and enhance their film properties. 
The combination of two or more biomaterials will form a blended film or a composite film.  
 
1.2.3 Roles of edible film in food application 
1.2.3.1 Barrier 
The properties of films act as a barrier to either gas, oil, or more often water. Moisture levels 
in food are critical for maintaining freshness, controlling microbial growth, and providing 
mouth-feel and texture. Edible films can control water activity preventing either moisture loss 
or uptake (Pérez-Gago and Krochta, 2005).   
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1.2.3.2 Binding 
Edible coating is applied to the surface of snack food and crackers to serve as a foundation or 
adhesive for seasoning (Bravin et al., 2006). 
 
1.2.3.3 Glaze 
Edible film can also act as glazes to enhance the appearance of baked good (Petersen et al., 
1999). For instance, a wheat-gluten replaces the traditional eggs-based coating. In the food 
industry, zein is commonly used as a confectioner’s glaze to provide a shine of product such 
as jellybeans. The alginate coating gives a glossy appearance to the product coated.  
 
1.2.3.4 Encapsulating agent 
It is used for various applications in the food industry and also the pharmaceutical industry. 
For example zein is common used as a tablet coating and in sustained release applications. 
(Gontard et al., 2011) 
 
1.2.3.5 Secondary packaging 
Edible film helps maintain the quality of foods after the packaging is opened by protecting 
against moisture change, oxygen uptake, and aroma loss. Edible films formed or placed 
between food components can also improve the quality of multicomponent food.(Gómez-
Guillén et al., 2011; Gontard et al., 2011; Kołodziejska and Piotrowska, 2007; Miller and 
Krochta, 1997) 
 
1.2.3.6 Protecting from mechanical damage 
Edible films with adequate mechanical properties conceivably serve as edible packaging for 
select foods (e.g., pouches for dried soup which would become part of the prepared soup). 
The sanitary condition of the edible package would need to be maintained during storage, 
transportation, and marketing. (Debeaufort et al., 1998; Janjarasskul and Krochta, 2010; Phan 
et al., 2005) 
 
1.2.3.7 Protection from mechanical disintegration 
Application of whey protein in freeze-dried chicken dice is one example. Application of 
carragenan-based coating in frozen fish is also to protect mechanical disintegration.(Petersen 
et al., 1999) 
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1.2.3.8 Bioactive carrier agents 
Active ingredient and seasoning can be incorporated into edible films and coatings. They may 
carry antioxidants, antimicrobial agents, colorants, flavours, fortified nutrients, and spices. 
(Langer and Peppas, 1983) 
 
1.2.4 Current studies on chitosan-based film 
Chitosan can make homogenous films as well as composite film when mixing with other 
substances such as polymer Low density polyethylene (LDPE), metal zinc, hydroxypropyl 
methylcellulose, pectin laminate, whey, pectin, methylcellulose (Aider, 2010; Li et al., 2011). 
The aim of blending chitosan with other substances is to enhance its biochemical, physical, 
mechanical as well as antimicrobial properties.  
 
Numerous studies on chitosan-based films have been conducted. Among those, the 
combination of chitosan with other biopolymers to make composite edible film is of interest 
to achieve attributes of biodegradability and biocompatibility with the environment. 
 
Composite film made of chitosan (90 % DD) and corn starch (25 % amylose) has higher 
tensile strength when the ratio of chitosan and corn starch increases to 1:1. However, when 
the ratio rises up to 1:2, the tensile strength of the composite film decreases. The increase of 
the tensile strength was explained by the increase of binding between -NH3
+
 groups of 
chitosan to –OH- groups of corn starch. However, when all the -NH3
+
 groups are already 
bound, the excess –OH- groups will dissociate, resulting in separation between chitosan and 
starch and decreasing the tensile strength. The deformation value of the mixed film also 
increases proportionally to the ratio of corn starch while its water vapour permeation 
decreases (Xu et al., 2005). 
 
The blending of chitosan film with active substances, in addition to increasing the 
antimicrobial properties of the film, is to slowly release these substances, therefore lengthen 
the action of these active substances to food. Ouattara et al. (2000) examined the release of 
acids (acetic, propionic, lauric) and cinnamaldehyde on several types of meat such as bologna, 
cooked ham, and pastrami. After a period of time, those foods were tested for the residual 
amount of acid or cinnamaldehyde on chitosan film. It was found that propionic acid was 
released totally after 48 hours; acetic acid remained 2-22 % after 168 hours. The addition of 
lauric acid lengthened the retention of acetic acid significantly.   
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In another study, Pranoto blended active substances such as garlic oil, potassium sorbate and 
nisin into chitosan film to increase its antimicrobial properties. This type of film has good 
appearance, physical, mechanical properties and has antimicrobial properties against Bacillus 
cereus, Staphylococcus aureus, Salmonella typhimurium (Pranoto et al., 2005). 
 
One of the unfavourable properties of natural polymer films, especially protein films is the 
fragility of the material. For this reason, such films have to be plasticized. Hydrophilic 
plasticizers are most often used to improve flexibility of the films (Arvanitoyannis et al., 
1997; Arvanitoyannis et al., 1998; Butler et al., 1996; Caner et al., 1998). Incorporation of 
plasticizers into natural polymer films eliminates the fragility of the films and improves their 
elongation.  
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1.3 OVERVIEW OF FOOD ALLERGY  
1.3.1 Introduction to food allergy  
Food allergy is an immunological reaction to a component (the allergen) of a food. The 
resultant symptoms may affect the gastrointestinal tract, respiratory tract, skin, a combination 
of any of these, or the whole body (Carins, 2010).  
 
In recent times, people have more concerns about allergic reaction because food allergy 
affects up to 4% of adults and 8% of children. About 90% of allergic reactions is due to the 
contact within eight allergenic food groups including fish and crustaceans (Lopata, 2007). 
 
To protect the customers from the exposure to allergens, food producers are required by law 
to declare the major food allergens present in their products, or even to remove unnecessary 
major allergens from their products. (Carins, 2010) 
 
Food allergy reaction is related to the binding between the antigen and the IgE antibody, a 
class of serum immunoglobulins (Eaton et al., 1998). This type of reaction is usually named 
“Type I – IgE mediated hypersensitive reaction” to distinguish with other adverse reactions to 
food (Lehrer et al., 2002). The mechanism of food allergic reactions is presented in Figure 
1.3. 
 
 
 
Figure 1.3: Induction and provocation of an allergic reaction 
(Lehrer et al., 2003) 
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When an antigen passes through the mucosal membrane, it is processed by macrophages and 
presented to T and B lymphocytes, resulting in the production of antigen-specific IgE 
antibodies. These antibodies can bind to the surfaces of mast cells and basophils. These cells 
are therefore sensitized to the allergen and the first exposure of the allergen to the body is 
called the sensitizing dose. When the antigens enter the cell the second time, the reaction 
between IgE and antigen can cross-link two or more cell-membrane-bound IgE antibodies, 
which release the preformed mediators and synthesis and release newly formed mediators. 
These mediators cause significant changes in cell migration, mobility, and dilation of blood 
vessels as well as smooth muscle contraction, which result in the typical symptoms of an 
allergic reaction. 
 
1.3.2 Seafood allergy 
Seafood allergy often develops in adulthood. The prevalence of seafood allergy in adults has 
been estimated to be between 1.3 % and 2.8 % (Sicherer and Sampson, 2006). It occurs more 
frequently in areas which have more fish in the diet (Lopata and Lehrer, 2009) (Table 1.8).  
 
Table 1.8: Prevalence of sensitization to shelfish in various countries among individuals 
(adults and children) with food allergy (Lopata and Lehrer, 2010) 
Country Number of individuals investigated Prevalence (%) 
Philippines 38 58 
South Africa 105 55 
Singapore 227 39 
France 580 34 
Indonesia 600 24 
Thailand 202 22 
Taiwan 392 21 
Singapore 334 15 
Spain 355 6.8 
United States* 14,948 2.0 
Note:  A survey among the general population is indicated by an asterisk*. 
 Sensitization established by SPT and/or quantification of specific IgE antibody. 
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Table 1.9: Classification of seafood groups causing allergies (Lopata, 2007) 
Phylum Class Common Name Allergens 
Molluscs Gaastropods Abalone, snail 
Tropomyosin 
? 
 Bivalves Clams, oyster, mussel 
Tropomyosin 
? 
 Cephalopods Quid (cuttlefish), octopus 
Tropomyosin 
? 
Arthropods Crustacean 
Crab, rock lobster, prawn, 
shrimp 
Tropomyosin 
Arginine kinase 
Chordates 
Osteichtyes 
(bony fish) 
Salmon, hake, tuna, herring, 
sardine , mackerel, carp 
Parvalbumin 
Skin collagen? 
Roe? 
Note: ? = indicates allergens not well characterised. 
 
Among the allergens listed in Table, tropomyosin is considered the major allergenic protein in 
seafood (Lopata and Lehrer, 2010; Reese et al., 1999).   
 
 
Figure 1.4: Structure of tropomyosin 
(Lehrer et al., 2002) 
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Tropomyosin is a heat – stable muscle protein which has a very conserved structure (Figure 
1.4) (Lehrer et al., 2002). It is a coiled-coil dimer consist of two parallel alpha-helical 
tropomyosin molecules wound around each other (Lehrer et al., 2003; Reese et al., 1999). Its 
average molecular weight is approximately 34 – 38 kDa with pI at 4.5 (Reese et al., 1999).  
 
Tropomyosin has also been identified as an important allergen in other invertebrates including 
house dust mites and cockroaches. This molecular and clinical cross-reactivity of tropomyosin 
between crustaceans, molluscs, house dust mites and insects has proposed it to be an 
invertebrate pan allergen (Lehrer et al., 2003; Lopata et al., 2010; Reese et al., 1999). Five 
different major IgE-binding regions in shrimp tropomyosin have been identified as containing 
8 epitopes (Lehrer et al., 2003). Mutations of these shrimp allergenic epitopes can reduce 
seafood allergenicity; methods utilizing such mutations will provide safer vaccines for more 
effective treatment of seafood-allergic patients, and in the future less-allergenic seafood 
products for consumption (Lehrer et al., 2003). 
 
Recently, other cross-reactive allergens have also been identified and characterized. The 
allergen Pen m 2, identified in the Black tiger shrimp (Penaeus mondon) has high similarity to 
the enzyme arginine kinase. This 40 kDa protein may represent a new class of crustacean pan 
allergen (García-Orozco et al., 2007; Yu et al., 2003). Also in the Black tiger shrimp, a 20 
kDa protein, which  has been identified as Sarcoplasmic calcium binding protein (SCP), has 
been found to be a cross-reactive allergen to lobsters but not to crabs (Shiomi et al., 2008). 
Another new major shrimp allergen, Lit v 3.0101, a 20-kDa myosin light chain protein 
extracted from the white leg Pacific shrimp (L. vannamei) has been successfully characterized 
and cloned (Ayuso et al., 2008). Other IgE binding proteins which have molecular size 
ranging from 8-166 kDa have also been found but not completely characterized. 
 
1.3.3 Current studies on the allergenicity of chitin and chitosan  
Although chitin and chitosan is considered safe and non-toxic, there are still some reports 
related to the hypersensitivity to the products which contain chitin and chitosan.  
 
The first case related to a moisturizing cream which is an oil / water emulsion containing 
chitin derivative 0.3 %, glucosamine, gluconic acid, pyrrolidone carboxylic acid, specific 
reconstituted sebum 3%, preservative, aroma composition, and purified water. Chitosan 
gluconate is the active ingredient of this product.  The patient was tested with crustacean by 
cutaneous contact and eating but there were no symptoms of Type I allergy. However, 
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chitosan is still an unknown allergen, so this case is only a reference for the dermatologist to 
find the reason for skin allergy (Cleenewerck et al., 1994). 
 
The second case was an immediate-type allergy for a chitosan – containing health food. The 
patient had systemic urticaria and difficulty in breathing after oral ingestion of chitosan. The 
skin test with another commercial chitosan was positive. After avoiding using that product, 
the patient no longer had the condition. Therefore chitosan was assumed to have function as a 
food allergen due to its molecular weight and general properties (Kato Y, 2005). 
 
The third case related to a cream containing chitin and a Carbitol. The patient was sensitized 
not only to chitosan gluconate / chlorhydrate glucosamine but also to ethyl diglycol Carbitol 
(Pereira et al., 1998). 
 
Overall, there has been no detailed research to confirm the allergenicity of chitin and chitosan. 
Therefore, it is necessary to undertake these studies to have the appropriate recommendations 
for the safety of the consumers.  
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1.4 AIMS AND OBJECTIVES OF CURRENT STUDY 
1.4.1 Aims 
This study aimed at investigating the presence of the allergenic protein tropomyosin in 
residual proteins of chitin and chitosan samples. After that, the antimicrobial properties of 
normal chitosan and purified chitosan were compared to examine if the purification process 
changed the properties of chitin and chitosan. The purified chitosan was then applied in food 
technology by the formulation of a chitosan-based edible film which is sealable and soluble in 
hot water and feasibility for application in instant food casing was investigated. 
 
1.4.2 Objectives 
There were five objectives for this study: 
 
Objective 1: Production of polyclonal antibodies against shrimp tropomyosin and crustacean 
proteins 
The aim of this objective was to produce two polyclonal antibodies from rabbits to investigate 
the presence of the shellfish allergen tropomyosin and/or other crustacean proteins in the 
shrimp tissues as well as chitin and chitosan preparations. 
 
Objective 2: Investigation of the allergenicity of shrimp proteins  
The aim of this objective was to examine the immunoreactivity of the allergenic tropomyosin 
protein in shrimp products due to variations in the shrimp species, parts of shrimp and the 
processing methods.  
 
Objective 3: Investigation of the allergenicity of residual proteins in chitin and chitosan 
The aim of this objective was to examine the presence of tropomyosin in residual proteins of 
chitin and chitosan samples. 
 
Objective 4: Investigation of the biochemical and antimicrobial properties of chitin and chitosan 
The aim of this objective was to characterize some biochemical properties of chitin and 
chitosan samples and to compare the antimicrobial property between normal and purified 
chitosan. 
 
Objective 5: Formulation of chitosan-based edible film for application in instant food casing 
The aim of this objective was to formulate a chitosan-based edible film which is sealable and 
soluble in hot water and then to examine its potential application in instant food casing.  
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Chapter 2 
GENERAL MATERIALS AND METHODS 
 
 
This chapter describes the general methods used in this project. Specific methods are 
described in each chapter. All materials, chemicals, and equipments used in this project are 
listed in this chapter. 
 
2.1 GENERAL PROCEDURES 
All chemicals used were of analytical, chromatography and electrophoresis reagent grade. 
Solutions were prepared in deionised water (dH2O) delivered from a Millipore Milli-Q® 
water system, unless otherwise specified. Solutions were dispensed using Finnpipette 
micropipettes (Pathtech Pty Ltd., Australia) with the following volume ranges: 1 mL to 5 mL, 
200 μL to 1 mL, 20 μL to 200 μL, 5 μL to 50 μL, 0.5 μL to 10 μL and 0.1 μL to 2 μL. 
 
Glassware was washed using Pyroneg detergent, rinsed in tap water, with a final rinse in 
dH2O. All glassware, micropipette tips, plastic ware, media and solutions used for bacterial 
work was sterilised by autoclaving at 121°C for 20 min, unless stated otherwise. 
 
2.2 MATERIALS  
2.2.1 General equipment  
Equipment   Supplier 
Amicon ultrafilter 
Balance: 
     Analytical balance (0.0001 – 220 g) 
     Balance (0.01 – 500 g) 
Cellulose acetate membrane 
Centrifuge: 
     Eppendorf centrifuge 
     Bench top centrifuge 
     Bench top centrifuge 
 
Millipore, USA 
 
Sartorius Gottingen, Germany  
U-Lab, Australia 
Sartorius Gottingen, Germany 
 
Eppendorf Geratebau, Germany 
Thermal Scientific, Australia   
Beckman Allegra, USA 
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Centrifuge tubes: 
     1.5 mL centrifuge tubes 
     10 mL centrifuge tubes 
     50 mL centrifuge tubes 
Chromatography (Biologic LP system) 
Colony counter 
Desiccator  
Dry block heater 
ECL Hyperfilm 
Electrophoresis Units 
Filter 
Gel Doc image system 
Homogeniser 
Micropipette plastic tips (Blue and Yellow) 
Micropipette plastic tips (5 mL and 10 mL) 
Microplate reader 
Panme ruler 
Petri dish 
pH meter 
PVDF membrane 
Shaker 
Sonicator 
Spectrophotometer-Dynatek MR7000 
Syringe (1 mL, 5 mL, 10 mL, 20 mL, 50 mL) 
Texture machine 
Vortex mixer  
Water bath 
Whatman paper 
 
 
Sarstedt, Germany 
Greiner Labortechnik, Germany 
Greiner Labortechnik, Germany 
Bio-Rad, USA 
Stuart Scientific, United Kingdom 
 
Ratek, Australia 
GE Healthcare, USA 
BioRad, USA 
Sartorius Gottingen, Germany 
Bio-Rad, USA 
ART, Germany 
Greiner Bio-One, Germany 
Pathtech Pty Ltd., Australia 
Thermal Scientific, Australia 
Mitutoyo, Japan  
Nunc, Denmark 
Metrohm, Germany 
Bio-Rad, USA 
Ratek Instruments, Australia 
Branson Sonic Power Co., USA 
Baxter Dagnostics, Australia 
Terumo Pty, Ltd., Australia 
Zwick/Roell, Germany 
Ratek Instruments, Australia 
Ratek, U-lab, Australia 
Whatman, England 
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2.2.2. General chemicals 
Reagents Supplier 
10X PBS Buffer 
Acetic Acid, glacial 
Acetone 
Acrylamide (electrophoresis grade) 
Bis-Acrylamide  
Ammonium acetate 
Ammonium persulfate  
Ammonium sulfate 
Ampicillin disc 
Bacteriological agar (No. 1) 
Bacteriological peptone  
Bovine serum albumin (BSA) 
Bromophenol blue  
Chloramphenicol disc 
Calcium chloride 
Chloroform  
Coomassie blue R -250 
Dithiothreitol (DTT) 
Dimethylsulfoxide (DMSO) 
Ethylenediamine tetra acetic acid (EDTA) 
Ethanol 
D-Glucose 
Glycerol 
Glycine 
Hydrochloric acid (32%)  
Mercaptoethanol 
Methanol  
NBT/BCIP substrate solution 
Potassium acetate 
Potassium chloride 
Potassium dihydrogen orthophosphate  
Precision Plus Dual stain protein marker  
Oxoid, England 
BDH Chemicals, Australia 
BDH Chemicals, Australia 
Sigma-Aldrich, USA 
Sigma-Aldrich, USA 
Ajax Chemicals Ltd, Australia 
Sigma-Aldrich, USA 
Ajax Chemicals Ltd, Australia 
Oxoid, England 
Oxoid, Australia 
Oxoid, Australia 
Promega, USA 
Sigma-Aldrich, USA 
Oxoid, England 
Merck, USA 
Merck, USA 
Sigma-Aldrich, USA  
Bio-Rad, USA 
BDH Chemicals, Australia 
BDH Chemicals, Australia 
BDH Chemicals, Australia 
BDH Chemicals, Australia 
BDH Chemicals, Australia 
BDH Chemicals, Australia  
Ajax Chemicals Ltd., Australia 
Sigma-Aldrich, USA 
Merck, USA  
Roche Diagnostics, Germany 
BDH Chemicals, Australia 
BDH Chemicals, Australia 
BDH Chemicals, Australia 
Bio-Rad, USA  
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Skim milk  
Sodium acetate 
Sodium chloride 
Sodium dodecyl sulphate (SDS) 
Sodium hydroxide (pellets) 
Sodium phosphate 
Sorbitol 
Sulfuric acid 
TEMED (N, N, N', N'-tetramethylene-
ethylenediamine) 
Tris-Base 
Tris-HCl 
Tween 20 
Yeast Extract 
 
Diploma. Australia 
Amresco, USA 
BDH Chemicals, Australia 
BDH Chemicals, Australia 
BDH Chemicals, Australia 
Mallinckrodt Inc., USA 
BDH Chemicals, Australia 
BDH Chemicals, Australia 
Sigma-Aldrich, USA 
 
Roche Diagnostics, Germany 
Roche Diagnostics, Germany 
Sigma-Aldrich, USA 
Oxoid, Australia 
 
2.2.3. General media  
Luria Bertani agar (LB agar): 1% (w/v) tryptone, 0.5% (w/v) yeast extract, 0.5% (w/v) 
sodium chloride (NaCl), 1% (w/v) bacteriological agar 
Luria Bertani broth (LB broth): 1% (w/v) tryptone, 0.5% (w/v) yeast extract, 0.5% (w/v) 
sodium chloride (NaCl) 
Mueller Hinton Agar (Oxoid): 3.8% medium mix. Autoclave. 
Mueller Hinton Broth (Oxoid): 2.1% medium mix. Autoclave. 
Plate count agar (Merck): 2.25 % medium mix. Autoclave. 
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2.3 METHODS  
2.3.1 Methods of analysing basic properties of samples 
2.3.1.1 Moisture content:  drying method to stable weight 
The crucible was dried at 105 
o
C for 3 hours and let cool in the desiccator before being 
recorded its weight (W0). One gram of sample was added into each crucible. The initial 
weight of both crucible and sample was recorded (Wi). The crucible and sample was weighed 
(W1) after drying at 105 
o
C for 8 hours. Then it was dried and weighed for each 2 hours until 
the difference between two weights was not bigger than 5 %. The last weight was recorded as 
Wd.  
The moisture content of sample (%) = (Wi – Wd) / (Wi – W0) x 100 
 
2.3.1.2 Ash content: standard AOAC method (AOAC, 2000) 
The crucible was heated at 550 
o
C overnight and let cool in desiccators before being recorded 
its weight (W0). About 1 g of sample was put into each crucible. The initial weight of crucible 
with sample was recorded (Wi). The crucible with sample was heated at 550 
o
C overnight and 
weighed (Wd) after cooling down in the dessicator.   
The ash content of sample (%) = (Wi – Wd) / (Wi – W0) x 100 
 
2.3.1.3 Heavy metal content 
Atomic absorption spectroscopy (AAS) method was used to test the heavy metal content in 
chitin and chitosan samples following procedure of ACIAR (Australian Centre for 
International Agricultural Research, 2007). 
 
This test was conducted by the Institute of Biotechnology and Environment, Nong Lam 
University, Ho Chi Minh City, Vietnam. 
 
2.3.1.4 Protein concentration quantification  
The Quick Start Bradford Protein Assay Kit (Bio-Rad, USA) which followed the Bradford 
method (Bradford, 1976) was used in this study. This technique was based on the binding 
between the protein in the sample solution and the Coomassie Brilliant blue G-250 dye in the 
Bradford reagent. The protonated cationic dye which predominantly exhibited a dark red 
colour in acidic conditions converted to a stable unprotonated blue form which exhibits a 
maximum absorbance at 595 nm when binding to a protein. 
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In this research, the microplate assay technique was used for the protein concentration 
measurement using the Thermo Scientifics’ Multiskan Ascent microplate reader. A standard 
curve of the absorbance reading at 595 nm against bovine serum albumin (BSA) in the 
concentration range of 0.01 - 2 mg/mL was generated, and the protein concentration of the 
extracts were estimated based on this standard curve. The blank, standard and the protein 
extract readings were performed in duplicate to increase the accuracy of the assay. 
 
2.3.2 Sodium dodecyl sulphate- polyacrylamide gel electrophoresis (SDS-PAGE) of 
protein  
The method, described by Bollag, Rozycki and Edelste (Bollag et al., 1996), was used to 
create protein profiles of protein extracts. This technique could help to separate proteins from 
a mixture based on its molecular size under the influence of an electrical charge (Walker, 
2002).  
 
In this study, the Mini Protean III gel electrophoresis system (Bio-Rad, USA) was used for 
SDS-PAGE. The gels, which had the thickness of 0.75 mm, had two parts: the stacking gel (5 
% polyacrylamide) and the separating gel (12 % polyacrylamide). This kind of gel had the 
separating resolution range between 15 and 60 kDa (Hames and Rickwood, 1990). The 
purpose of the stacking gel was to concentrate proteins before passing through the separating 
gel, therefore resulting in shaper protein bands.  
 
2.3.2.1 Preparing the working solutions 
- Solution A (Acrylamide stock solution), 100 mL: 29.2 g acrylamide, 0.8 g bis-
acrylamide, and water to make 100 mL total volume 
- Solution B (4 x Separating gel buffer), 100 mL: 75 mL 2M Tris-HCl (pH 8.8), 4 mL 
10 % SDS, and 21ml water 
- Solution C (4 x Stacking Gel Buffer), 100mL: 50 mL 1M Tris-HCl (pH 6.8), 4 mL 10 
% SDS, and 46 mL water 
- 10% ammonium persulfate, 5 mL: 0.5 g ammonium persulfate, and water to make 5 
mL total volume 
- Electrophoresis Buffer, 1000 mL: 3g Tris, 14.4g glycine, 1g SDS, and water to make 
1liter total volume 
- 5x Sample Buffer, 10mL: 0.6 mL 1M Tris-HCl (pH 6.8), 5 mL 50 % glycerol, 2 mL 
10 % SDS, 0.5 mL 2-mercaptoethanol, 1 mL 1 % bromophenol blue, and 0.9 mL water 
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- Stain solution, 100 mL: 0.1 g coomassie blue, 45 mL methanol, 10 mL glacial acetic 
acid, and 45 mL water 
- Destain solution, 100 mL: 10 mL methanol, 10 mL glacial acetic acid and 80 mL water 
 
2.3.2.2 Preparing the gel 
The formulation of gels used in this study was described in Table 2.1.  
 
Table 2.1: Amounts of reagents for making 2 gels 
Gels 
Reagents 
12 % separating gel 5 % stacking gel 
Solution A 4 mL 2.3 mL 
Solution B 2.5 mL 0.67 mL 
Solution C - 1 mL 
Milli-Q water 3.5 mL 4.8 mL 
10% ammonium persulfate 50 µL 30 µL 
TEMED 5 µL 5 µL 
 
Mixed separating gel solution was degassed and poured into the glass plate assembly.  Then, 
they were overlaid with water saturated butanol to remove any bubbles and linearise the level. 
The gels were allowed to polymerize for 1 hour. After that, water saturated butanol was 
poured off before pouring staking gel. Mixed stacking gel solution was also degassed and 
poured into the glass plate assembly. 10 or 15-well combs were then immediately inserted and 
the gels were allowed to polymerize for 20 minutes.  
 
Both gels were fit to electrode assembly before being inserted into electrophoresis chamber. 
Electrophoresis buffer was added to inner and outer reservoir to make the gels immersed in 
buffer. The combs were then carefully removed from the stacking gels. 
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2.3.2.3 Preparing samples and operation of SDS-PAGE  
The prepared protein extracts were diluted to make a final concentration of 1 mg/mL, and 
then mixed with the loading dye. This solution was then heated at 100˚C for 10 minutes in a 
water bath. After cooling down to room temperature, the mixtures were centrifuged at 13,000 
rpm for 30 seconds to settle any precipitated particles prior being loaded into the wells.  
 
An amount of 15 or 20 µg of each protein mixture was introduced into the wells. The 
Precision plus dual stain protein marker 10 – 250 kDa (Bio-Rad, USA) was also added to one 
of the wells as a reference to estimate the molecular weight of the separated protein bands.  
 
The apparatus was run into two stages: stage 1 with 80 voltages in 20 minutes to have the 
proteins settled in the stacking gel, and stage 2 with 180 voltages in 50 minutes to separating 
the protein solution.  
 
After the run was completed, the gels were removed from the glass plate assembly and put in 
the Coomassie blue stain solution for 10 minutes with shaking and then washed in the destain 
solution for 3 hours till the protein bands were visible as dark blue bands against a transparent 
background. The gels were then scanned their images and saved in computer for later 
analysis. 
 
2.3.3 Immunoblotting techniques  
2.3.3.1 Western Blotting 
This method was used to detect possible allergenic protein in our samples. This study 
followed semi-dry blot technique, where the gel and membrane are fitted between buffer-
wetted filter papers that are in direct contact with two closely spaced solid-plate electrodes 
(Gravel, 2002).  
 
The proteins separated in the SDS-PAGE were transferred onto polyvinylidene diflouride 
(PVDF) membrane, which have a strong affinity to proteins. The membrane was then probed 
with a primary antibody which specifically bound to target protein. Next, a secondary 
antibody which was conjugated with an enzyme was added to bind with the primary antibody. 
Finally, a substrate which reacts with the enzyme was added to the membrane to form a 
colour reaction or a chemiluminescent reaction. This method can detect as little as 10 pg 
protein (Gershoni and Palade, 1982).  
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2.3.3.1.1Equipment 
- Trans-Blot Semi Dry transfer cell (Bio-Rad, USA) 
- Power supply (capacity 200V, 500mA) 
- Polyvinylidene diflouride (PVDF) membrane (Bio-Rad, USA) 
- Extra thick filter pads (Whatman) 
- X-ray film (Amersham hyperfilm ECL film, GE healthcare, UK) 
- Micro-pipettes 
- Rotary shaker (Ratek) 
- Other glassware (beakers, cylinders, flasks,...) 
 
2.3.3.1.2 Reagents 
Primary antibodies:  
- Monoclonal antibody (mAbαTM): Commercial rat anti-tropomyosin IgG antibody, 
MAC-141 (Abcam). This antibody was raised against troponin-tropomyosin complex 
extracted from an insect muscle (Lethocerus indicus). 
- Polyclonal antibodies against tropomyosin (pAbαTM): This is rabbit serum containing 
antibodies which was raised against the shrimp tropomyosin. 
- Polyclonal antibodies against crustacean protein (pAbαCR): This is rabbit serum 
containing antibodies which was raised against the whole-cooked crustacean protein.  
 
Secondary antibody:  
- Rabbit anti-rat-IgG, alkaline phosphatase conjugated (Sigma-Aldrich) 
- Goat anti-mouse IgG (H+L), horse radish peroxidase conjugated (Promega) 
 
Substrate:  
- NBT-BCIP substrate: solution of 18.8 mg/ml nitro-blue tetrazolium chloride; 9.4 
mg/ml 5-bromo-4-chloro-3-indolylphosphate toluidine salt in 67% Dimethyl 
sulfoxide. (Sigma-Aldrich, USA) 
- Novex® ECL Chemiluminescent Substrate Reagent Kit (Life Technologies): a two-
part reagent consisting of Reagent A (luminol) and Reagent B (an enhancer) used in 
equal volumes to attain the most intense light emission. 
 
Other reagents: 
- Tris-HCl (Roche Diagnostics, Germany) 
- Glycine (BDH Chemicals, Australia) 
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- Methanol (Merck, USA) 
- NaCl (BDH Chemicals, Australia) 
- Skim milk (Diploma, Australia) 
- Tween 20 (Sigma-Aldrich, USA) 
- Transfer buffer: 25mM Tris, 192 mM Glycine, 20% methanol 
- Tris Buffered Saline (TBS): 20 mM Tris-HCl, 150 mM NaCl (pH 7.5) 
- Blocking solution: 5 % skim milk in TBS 
- TBS-T: 0.05 % Tween 20 in TBS 
 
2.3.3.1.3 Operation of Western blotting system 
The gel sandwich was setup to facilitate the transfer of the separated proteins from the 
polyacrylamide gel to the PVDF membrane, without mixing of any protein lanes. An extra 
thick blot paper was soaked in freshly prepared transfer buffer and placed on the positive-
electrode base plate. Then a PVDF membrane was placed on the blot paper after being 
activated in 100 % methanol for 10 seconds and soaked in transfer buffer until it was 
completely submerged. Next, the gel, after being equilibrated in transfer buffer for 2 minutes, 
was placed carefully on the membrane. Finally, another extra thick blot paper pre-soaked in 
transfer buffer was placed on the top. The negative-electrode upper lid was placed on top of 
the sandwich and locked in its position.  
 
The transfer was conducted at 12 volts for 25 minutes. During the transfer, the negative 
charged proteins in the gel went towards the base positive electrode and binding to the PVDF 
membrane. After the transfer was completed, the membrane was placed in blocking solution 
to cover up the rest of the exposed membrane apart from the bound proteins region. After that, 
the membrane was incubated in the primary antibody solution with the dilution of 1:3000 in 1 
% skim milk in TBS for 1 hour at room temperature or overnight at 4 ˚C. Then it was 
incubated for 30 minutes in the secondary antibody solution with the dilution of 1:5000. Next, 
it was also incubated for 30 minutes in the conjugate solution with the dilution of 1:5000. 
Between each step, the membrane was washed with TBS or TBS-T to get rid of unbound 
antibodies. The final step was to develop the blot using the substrate solutions.  
 
If the alkaline phosphatase conjugate was used, the blot would be incubated in NBT-BCIP 
substrate solution for 10 minutes in the dark until visible bands appeared, and it was washed 
with distilled water to stop the reaction. The blot was dried and scanned its image for further 
analysis. 
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If the horse radish peroxidase conjugate was used, this step must be done in the dark room. 
First, the blot would be incubated in the Novex® ECL Chemiluminescent substrate for five 
minutes. The membrane was then covered between two transparent plastic sheets, and an X-
ray film was placed over it. This setup was closed tightly in a photographic cassette for about 
1 second to 1 minute to receive the clearest bands. The X-ray film was then removed from the 
cassette and immediately dipped into the developer solution for a minute, then rinsed with 
water. Next, the film was placed in the fixer solution for one minute and finally washed with 
water. The film was allowed to air dry before being scanned. 
 
2.3.3.2 Dot Blot  
This method was used for chitin / chitosan samples to detect possible allergenic proteins as 
they cannot be separated by conventional SDS-PAGE due to their high molecular weight and 
viscosity.  
 
The principal and reagents of this method were similar to the Western Blot. This study used 
nitrocellulose membrane (Bio-Rad, USA) instead of PVDF membrane and followed the 
protocol from Abcam company (www.abcam.com/technical). 
 
The nitrocellulose membrane was cut into 8 x 10 cm dimension and drawn grid by pencil to 
mark the blotting region. Then 2 μl of each sample was spotting slowly onto the membrane at 
the centre of the grid so that the spot diameter was limited in 3 - 4 mm. A serial concentration 
of purified tropomyosin was also added as reference.  
 
After drying, the membrane was blocked non-specific sites by soaking in blocking solution 
for 1 hour at room temperature. Then it was incubated with primary antibody for 1 hour at 
room temperature and washed 3 times with TBS-T for 5 minutes. Next, the membrane was 
incubated with secondary antibody conjugated with HRP for 30 minutes at room temperature, 
then washed 2 times with TBS-T for 5 minutes and once with TBS for 5 minutes. Finally, it 
was incubated with ECL reagent for 5 minute and expose X-ray film in the dark room.  
 
The signals from the samples were compared to that of standards and the concentration of 
tropomyosin in each sample was estimated. 
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2.3.3.3 Immunoblotting with human sera from shellfish allergic patients 
This work was conducted at Monash Medical Centre, Melbourne to investigate the reaction 
between human serum IgE and the allergenic protein(s). Tropomyosin IgE-positive results has 
been shown to be a good predictor of shrimp allergy (Gámez et al., 2011). 
 
The human sera were collected from patients who showed a strong reactivity to ingested 
shellfish by the Alfred hospital, Melbourne and were stored at -20 ˚C at the Monash Medical 
Centre. The total IgE and specific IgE concentration to lobster, crab and shrimp were tested 
using UniCAP system (Phadia, Sweden). The patient’s clinical histories were summarized in 
Table 2.2. Patient JB21 had a slightly higher specific IgE concentration then patient AN01. 
Atopy refers to the status of the patients making also specific IgE antibody to inhalant 
allergens such as house dust-mites and pollen. 
 
Table 2.2: Clinical characteristics of shellfish allergic patients 
Patient 
Code 
IgE 
Total 
(kU/l) 
Specific IgE (kU/l) 
Atopic 
Allergic 
reaction after 
ingestion 
Lobster 
(Homarus 
gammarus)  
Crab (Cancer 
pagurus)  
Shrimp 
(Penaeus 
monodon)  
ANO1 242 1.65 1.17 1.32 Yes Yes 
JB21 100 Not Done 2.04 2.11 Yes Yes 
(Source: Alfred Hospital, Melbourne, 2008) 
 
For the immunoblotting, the membrane with proteins transferred from the SDS-PAGE was 
incubated in the human serum which was diluted 10 times in PBS (4.7 mM Na2HPO4, 1.25 
mM NaH2PO4, 150 mM NaCl, dH2O) containing 1% skim milk overnight at 4˚C. The next 
day, it was shaken on a shaker for 20 minutes before being washed three times with PBS-T 
for five minutes each. The membrane was then incubated for 1 hour in 5 mL of rabbit 
antihuman IgE antibody (Sigma-Aldrich) diluted 1000 times in PBS-T containing 1% skim 
milk. 
 
After being washed with PBS-T thrice for five minutes each, it was incubated for 30 minutes 
in 5 mL of goat anti-rabbit polyclonal antibody - HRP conjugated (Dako, USA) diluted 1000 
times in PBS-T containing 1% skim milk. It was then washed with PBS thrice for five 
minutes each before being developed using the enhanced chemiluminescence technique. 
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2.3.4 Enzyme-linked immunosorbent assay (ELISA) methods 
The indirect ELISA and inhibition ELISA have been used in this study depending on the aim 
of each experiment. 
 
2.3.4.1 Indirect ELISA  
Indirect ELISA was used to measure the optimal antigen concentration to coat wells and to 
check the titre of our home-made antibodies (Crowther, 1995). In this assay, a constant 
amount of antigen was absorbed to wells, and then a serial dilution of rabbit serum was added 
to react with the antigen. The second antibody, Goat anti-rabbit IgG conjugated with HRP 
(Dako, Denmark), was added to bind with the serum. TMB One-Step Substrate System 
(TMB) containing 3,3'-5,5' tetramethylbenzidine and hydrogen peroxide was then used to 
create color reaction which can be detected by microplate reader with the optical density at 
450 nm.  
 
In this study 200 µL of immunizing antigen diluted in PBS pH7 (4.7 mM Na2HPO4, 1.25 mM 
NaH2PO4, 150 mM NaCl, dH2O) was first coated onto each well. The plate was sealed with 
cling wrap to avoid evaporation and incubate overnight at 4
o
C. Then it was washed 3 times 
wih PBS-Tween before being added with 250 µL of blocking buffer (PBS containing 5% 
skim milk) to each well. The plate was washed again 3 times wih PBS-Tween. Then 200 µL 
of rabbit serum (serially diluted in PBS with 0.5% skim milk) was added to each well and 
incubated for 1 hour at 37
o
C, following by shaking 30 minutes at room temperature. After 
being washed 3 times with PBS-Tween, 200 µL of diluted goat-anti rabbit antibody 
conjugated with HRP (1:10,000 in PBS with 0.5% skim milk; Dako, Denmark) was added 
and incubated 30 minutes at 37
o
C, following by shaking 30 minutes at room temperature. The 
plate was then washed 6 times with PBS-Tween, then added with 100 µL of TMB substrate 
solution (Dako, Denmark) to each well and incubated for 20-30 min at 25
o
C (wait until the 
first well at the second row turn very dark). Finally, 100 µL of 2 N HCl or H2SO4 was added 
to each well to stop the reaction. The absorbance at 450 nm wavelength was determined using 
a Multiskan plate reader (Labsystems).  
 
2.3.4.2 Inhibition ELISA 
Inhibition ELISA was used to examine the immunoreactivity of tropomyosin in different 
protein extracts and to estimate the quantity of tropomyosin in shrimp extracts as well as 
chitin and chitosan samples. This method was followed the protocol of Lopata (2005) with 
modifications described below (Lopata et al., 2005).   
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The wells were first coated with 200µL antigen (0.01 µg/mL of purified tropomyosin or 0.1 
µg/mL of mix crustacean protein) in PBS then incubated for 1 hour at 37 
o
C and for 3 hours at 
room temperature. After being washed 3 times with PBS-Tween, the wells were blocked with 
250 µL of 5 % Skim milk in PBS and incubated for 1 hour at 37 
o
C, then washed again 3 
times with PBS-Tween. A double strength dilution of antibody and inhibitor were prepared in 
0.5 % skim milk in PBS, and then mixed together with the ratio 1:1. The wells were then 
coated with 200 µL of “antibody-inhibitor” mixture and incubated for 1 hour at 37 oC 
following by washing 3 times with PBS-Tween. After that, 200 µL of the secondary antibody 
(goat anti- rabbit polyclonal HRP labelled) diluted 1:10,000 in 0.5 % skim milk in PBS were 
added and incubated for 30 minutes at 37 
o
C. The wells were then washed 5 times with PBS-
Tween and 1 time with PBS before adding 100 µL of TMB substrate solution (Dako, 
Denmark) and incubating for 20-30 minutes (or longer) at room temperature. The reaction 
was stopped by adding 100 µL of 2 N HCL and the absorbance of the solution in the well was 
read at 450nm wavelength by using a Multiskan plate reader (Labsystems).  
 
Calculating percentage inhibition in inhibition ELISA: 
The Y values were calculated by substract the absorbance of each sample to the absorbance of 
the blank (only TMB and HCl). The Ymax value is the absorbance of the well containing no 
inhibitor. The percentage inhibition (PI) was calculated as . 
 
2.3.5 Ion-Exchange chromatography (IEC) 
The ion-exchange chromatography was used for the purification of tropomyosin from the 
whole-cooked prawn extracts. This technique can separate proteins based on the intrinsic 
protein charge. An ion exchange column is basically a resin containing charged moieties 
which are capable of binding to the opposite-charged proteins through electrostatic binding. 
The unbound proteins are washed out of the column. The bound proteins are then eluted by 
increasing the salt concentration in the mobile phase which mainly contains the counter ion of 
the column. 
 
2.3.5.1 The equipment and the buffer system 
In this study, the Biologic LP system (Bio-Rad) was used. It has an integrated system with a 
buffer mixing system, sample loader, low pressure pump, UV absorbance detector, 
conductivity detector and a separate fraction collector. A strong anion exchange column, Bio-
100 ( ) /max maxY Y Y
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Scale mini Macro-prep, High Q prepacked column (1 mL volume) was used for the 
purification. 
 
The starting buffer was 30 mM Acetate buffer with a pH of 5.5. The eluting buffer was 1000 
mM Sodium chloride with pH 5.5. All buffers were filtered through 0.45 μm membrane and 
sterilized by autoclaving before each run. 
 
2.3.5.2 Sample preparation 
A protein extract containing approximately 3 mg of protein was pipetted into a falcon tube 
and the volume was made up to 6 mL with the starting buffer. The tube was centrifuged at 
4000 g for 10 minutes to separate any precipitated proteins due to the pH change. The 
supernatant was filtered through a 0.45 μm membrane, then concentrated in an Amikon tube 
(Millipore, USA) with a 3 kDa cut-off value by spinning at 4000 g until the volume came 
down to 1 mL. This retentate was added to 9 mL of the starting buffer to a final volume of 10 mL. 
 
2.3.5.3 Purification procedure 
Before starting the purification run, the column was regenerated by purging with 2 M NaCl 
solution for 5 column volumes, then with the eluting buffer until the conductivity reading 
stabilized to a certain value. It was then equilibrated with the starting buffer until the 
conductivity reading dropped down and stabilized at a lower value. After this step, the system 
was ready for a purification run.  
 
The run was started with the starting buffer passing through the column at 2.5 mL/min. Then 
the prepared sample solution was injected into the system. After the initial solvent peak was 
visible, the starting buffer was passed through the column until the absorbance reading went 
down to baseline. The gradient salt concentration was then added, with the concentration of 
sodium chloride increased from 0 mM to 500 mM over 25 minutes, and from 500 mM to 
1000 mM over 10 minutes. Finally the 100 % eluting buffer was passed through the column to 
remove any bound proteins, and then again equilibrated with the starting buffer for the next run. 
 
During the run, the fractions which corresponded to the peaks containing the eluted proteins 
were collected and concentrated in Amikon filter tubes with a 3 kDa cut-off to a final 
concentration of 1 mg/mL. The fractions were stored at -80 ˚C for further analysis. After the 
purification runs, the column was purged with 70 % ethanol as a column sanitizer. Finally it 
was purged with 20 % ethanol before storage.  
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2.3.6 Antimicrobial susceptibility tests 
The antimicrobial susceptibility tests of chitosan samples were performed employing the 
micro-dilution method and disc diffusion method described by the Clinical and Laboratory 
Standards Institute (CLSI, 2006 (a), 2006 (b)). The tests were run in triplicate. 
 
Quality control strains E. coli ATCC 25922 and S. aureus ATCC 29213 were used in this 
experiment. A well-isolated colony was inoculated into LB-broth and incubated overnight at 
37
o
C. The bacterial suspensions were prepared by adjusting the turbidity of the 16-hour-old 
test micro-organisms to an equivalent 0.5 McFarland standard which equals to 1x10
8
 
CFU/mL with Mueller-Hinton broth. This suspension was used for the MIC test. 
 
100 μl of the above suspension was further diluted into 2 ml of Mueller-Hinton broth, which 
was used as the final inoculums (approximately 5 × 10
6
 CFU/mL) for the minimum inhibition 
concentration and disc diffusion test.  
 
Chitosan stock solutions were prepared in 0.2 N acetate buffer pH 4.3 at a concentration of 
0.1% (equivalent to 1000 mg/L).  
 
2.3.6.1 Minimum inhibition concentration (MIC) test  
A 150 µL aliquot of each prepared bacterial suspension (approximately 5 × 10
6
 CFU/mL) was 
mixed with 150 µL of sterilised chitosan solutions, which were twofold serially diluted in 
advance with 0.85 % sterile NaCl to the designated concentration. The chitosan solutions have 
the concentration ranging from 3.77 to 500 mg/L. A corresponding mixture containing no test 
strain was used as a control. The mixture was then applied to each well of a 96-well 
microplate and incubated at 37 
o
C for each micro-organism for 48 hours. Growth of the test 
micro-organism was monitored by determining OD590 every 12 hours for 48 hours using the 
Thermo Scientifics’ Multiskan Ascent microplate reader. All treatments were conducted three 
times. MIC was ultimately defined as the lowest concentration of sample required to inhibit 
bacterial growth for over 48 h beyond that of the control sample. 
 
2.3.6.2 Minimum Bactericidal Concentration (MBC) test 
The MBC was measured by inoculating the broths used for MIC determinations onto drug-
free medium. The MBCs were determined by transferring 0.1 mL from each well without 
visible growth of the MIC microdilution plate to a petri dish containing Mueller-Hinton agar 
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(MHA). The plates were incubated at 37°C for 48 hours. The MBC was read as the lowest 
concentration of drug at which no growth was observed (Du et al., 2009). 
 
2.3.6.3 The disc diffusion test 
The Muller Hinton agar medium was prepared according to the manufacturer’s instructions. It 
was cooled and poured into Petri dishes of approximate 4 mm depth. The plates were used 
within seven days after preparation.  
 
Chitosan samples were dissolved in 0.2 N acetate buffer pH 4.3 to obtain the concentration of 
10 µg/µL (1 %). The prepared bacterial suspension was inoculated onto the entire surface of a 
Mueller-Hinton agar plate with a sterile cotton-tipped swab to form an even lawn. Sterile 
paper discs (6 mm in diameter, Whatman paper) were placed on the surface of each MHA 
plate using a sterile pair of forceps. 20 μL of diluted chitosan solutions were carefully pipetted 
onto the discs. The plates were then incubated aerobically at 37 
o
C for 24 hours. The diameter 
(mm) of the growth-inhibition zone including the disc diameter was measured after 24 h 
incubation using a ruler (CLSI, 2006 (a); Mayachiew et al., 2010). 
 
2.3.7 Total aerobic plate count method 
Conventional plate count was performed for all samples as described in the FDA 
Bacteriological Analytical Manual (Maturin and Peeler, 2001). Standard plate count agar 
(AES CHEMUNEX, France) has been used. One millilitre of sample homogenate in each 
decimal dilution was plated in duplicate on plate count agar and incubated at 37 °C for 24-48 h. 
 
The plates which had 25 – 250 colonies were used to calculate the number of viable cell.  
The number of viable cell N = Σ C / [ (1 * n1) + (0.1 * n2) ] * (d) 
Where: N = Number of colonies per mL (CFU/mL)  
Σ C = Sum of all colonies on all plates counted 
n1 = Number of plates in first dilution counted  
n2 = Number of plates in second dilution counted  
d = Dilution from which the first counts were obtained 
 
If all plates from both dilutions yield fewer than 25 CFU each, the number of viable cell was 
recorded as less than 25 x 1/d when d is the dilution factor for the dilution from which the 
first counts were obtained. 
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2.3.8 Methods of analysing basic properties of edible films 
2.3.8.1 Film thickness 
The thickness of the film was measured using a panme ruler (Mitutoyo, Japan) with the 
smallest unit 0.001 mm. The data recorded was the average of 10 measurements. 
 
2.3.8.2 Solubility in hot water  
Approximately 0.5 g of edible film was soaked in 50 mL of distilled water and stirred well at 
70 
o
C. The soluble part and insoluble part were then separated by filtering through filter paper 
(Whatman). The insoluble part was dried at 105 
o
C for 6 hours and recorded its weight.  
 
The solubility (%) of the edible film was estimated as following equation: 
Solubility (%)  =  (M1 –M2)  /  M1  x  100    
Where:  M1: initial weight of edible film (g) 
M2: weight of insoluble part of film 
 
2.3.8.3 Mechanic properties 
Mechanic properties of edible films were measured by the texture measurement machine 
(Zwich/Roell, Germany). Edible film was cut into each small pieces with the dimension of 12 
x 2 cm (Figure 4.3). 
 
The film was affected by stretching force at both ends at an instant speed 100 mm/min to 
evaluate the tensile strength (N) and the deformation (%). The data recorded was the average 
of 10 measurements. 
 
12 cm   
   
  
2
 c
m
 
Figure 2.1: Film sample to measure mechanic properties 
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2.3.8.4 Seal ability  
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Figure 2.2: Process of sealing film 
 
Edible film sample with the size of 2 × 12 cm is cut into 2 identical parts. They were then 
sealed together to make a film that have the size of 2 x 10 cm with the sealed part at the 
middle of the film (Figure 2.2). The film was stored in dessicators at room temperature.  
 
The strength of the seal was measured by force that break the film seal using texture 
measurement machine (Zwick/Roell, Germany). The data recorded was the average of 10 
measurement. 
Seal  1
0
 c
m
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2.3.8.5 Water vapor permeation (WVP) 
Water vapor permeation of edible films was estimated based on the increase of the film 
weight at a relative humidity differential of 84 – 22 % using a modified French standard 
method AFNOR NF H00-030 and ASTM Method E96-80 (Phan-The et al., 2002).  
 
Prior to measurement of the water vapour permeation, all films were stored at 25 
o
C in 
desiccators containing saturated potassium chloride which has a water activity (aw) of 0.84 for 
48 hours. Then the film was fixed between two Teflon rings on the top of a glass cell 
containing saturated potassium acetate which has a water activity of 0.22 at 25 
o
C. Finally, the 
test cells were put in desiccators containing saturated potassium chloride (aw = 0.84) at 25 
o
C 
and periodically weighed until a constant weight variation rate was attained (Figure 2.3).  
 
 
 
Figure 2.3: Principle outline of water vapour permeation measurement  
 
The water vapour permeation was calculated using the equation: 
 
 
Where: 
∆m: the weight gained by the permeation cell (g)  
x: the film thickness (m) 
S: the exposed area of edible film during water vapour transfer (S = 8.04 x 10
-4
 m
2
) 
 
S ∆t ∆p 
 
 
 ∆m x 
 × e = WVP 
(g.m
-1
. s
-1
.Pa
-1
) 
 
 
Relative humidity in the test 
cell was fixed by saturated 
CH3COOK (1 < 2) 
 
Saturated CH3COOK 
(aw = 0.22) 
Desiccator 
Teflon rings 
     Edible film 
Test cell 
d = 3.4 cm 
 
Relative humidity in the 
desiccator was fixed by 
saturated KCl (2) 
 
 
 Saturated KCl (aw = 0.84) 
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∆t: duration of water vapour transfer (s) 
∆p: partial water vapor pressure differential (Pa) 
∆p  =  aw  x  po  =  ∆aw  ×  23,756  ×    (Pa)  
 
 
 
2.4 DATA ANALYSIS 
Most of the experiments in this project were carried out in triplicate. The obtained data were 
calculated using Microsoft Excel 2007. The average values with standard deviation were 
reported. The analysis of variance was performed to determine the significance of the 
differences using SPSS (Statistical Package for Social Sciences, SPSS Inc., Chicago, Ill, 
USA) software package version 17.0. 
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Chapter 3 
PRODUCTION OF RABBIT ANTI-CRUSTACEAN 
PROTEIN AND ANTI-SHRIMP TROPOMYOSIN 
POLYCLONAL ANTIBODIES 
 
 
3.1 INTRODUCTION 
Tropomyosin is a protein which is present widely in all species of vertebrates and 
invertebrates. However, only invertebrate tropomyosin such as crustacean, arachnids, insects, 
and molluscs can cause allergic reactions (Lehrer et al., 2003; Lopata and Lehrer, 2009; 
Lopata et al., 2010; Reese et al., 1999). In nature, it exists in multiple isoforms which are 
coiled-coil dimers consisting of two parallel alpha-helical tropomosin molecules that are 
wound around each other (Reese et al., 1999).  
 
The antibody can bind with the antigen at one or more regions which are defined as epitopes. 
The monoclonal antibody is an antibody which can react with the antigen at only one epitope 
while the polyclonal antibody can react at two or more epitopes on the antigen structure. The 
cross-reactivity of tropomyosin among crustaceans (Ayuso R et al., 2002; Lehrer, 1986; 
Lopata et al., 2010; Reese et al., 1999; Taylor and Steve, 2008) indicates that a monoclonal 
antibody can recognise the tropomyosin of different species at the same epitope (Lehrer and 
McCants, 1987).  Therefore, the monoclonal antibody to a specific species can be used to 
investigate the presence of that antigen in other species. However, because different B cells 
can be stimulated by the tropomyosin, the blood will contain a variety of anti-tropomosin 
antibodies which can have different immune-reactivity (ABcam, 2012). Therefore, there is a 
need to use polyclonal antibodies in analysis under different experimental conditions 
(Newcombe and Newcombe, 2007; Seiki et al., 2007; Yeung et al., 1997). In the other hand, 
no polyclonal antibodies to crustacean proteins or crustacean tropomyosin are currently 
commercially available. Hence these antibodies have been made and they were described in 
this chapter. Without these antibodies no further analysis of chitin or chitosan products would 
have been possible. 
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The polyclonal antibodies are made by immunizing with the same antigen at intervals of 
several weeks to stimulate specific B cells to produce antibodies in the blood (ABcam, 2012; 
Stills, 2012; Yeung et al., 1997). The methodologies are varied depending on the immunogen, 
the adjuvant and the intended purpose in producing the antibodies (Stills, 2012). The immune-
sera can be used in its crude form or antibodies isolated from the immune-sera. Among 
laboratory animals, rabbits are used most commonly in the production of polyclonal 
antibodies due to their many advantages such as the adequate body size, the ready 
assessibility and the excellent responsiveness to a wide variety of antigens (Duranthon et al., 
2012; Seiki et al., 2007; Stills, 2012).  
 
The generated polyclonal antibodies are examined for immunological characteristics by 
immunoreacting with the antigen by Western blot and ELISA method (Crowther, 1995; Seiki 
et al., 2007; Werner et al., 2007).   
 
The aim of this chapter is to produce two polyclonal antibodies from rabbits to investigate the 
presence of the shellfish allergen tropomyosin and/or other crustacean proteins in the shrimp 
tissues as well as chitin and chitosan preparations. 
 
The rationale for choosing these protein preparations for antibody production is based on the 
knowledge that tropomyosin is the major allergen found in most crustaceans. Therefore the 
presence and concentration of this protein in food preparations derived from chitosan is 
central to manage the risk of the sensitised consumer to allergic reactions. 
 
In addition antibodies to total protein extracts of crustacean, which in addition to 
tropomyosin, contain other crustacean derived proteins was also generated. One 
representative species from each crustacean group of shrimp, lobster and crab was chosen. It 
was expected that these antibodies should be able to identify if any residual crustacean 
proteins were present in chitosan containing products.  
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Summary of Chapter 3:  
 
This chapter focuses on the production of rabbit polyclonal antibodies. These antibodies were 
raised by injecting antigens into rabbits to generate specific antibody containing sera. Two 
types of antigens were prepared. The first group of antigens were the mixed protein extracted 
from three crustacean species. The second group of antigens were the purified tropomyosin 
from four different shrimp species. The injection of antigens and collection of rabbit sera was 
conducted by a specialised company of the Institute of Medical and Veterinary Science 
(IMVS), Australia and not conducted at the University. These sera were analysed for their 
titters and immune reactions with the different antigens. The generated sera were used to 
investigate the immune reactions of different shrimp extracts as well as with residual shrimp 
proteins and allergens in chitin and chitosan preparation in following chapters. 
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3.2 MATERIALS AND METHODS 
Throughtout this study, a commercial monoclonal anti-tropomyosin antibody was used for testing 
the immunoblotting with the samples investigated. However, this antibody was raised against 
the troponin – tropomyosin complex extracted from an insect. Therefore, polyclonal antibodies 
were generated to the total crustacean proteins and major shrimp allergen tropomyosin for use 
in experimental trials in comparison with the monoclonal antitropomyosin preparation.  
  
Two types of rabbit sera were generated: 
A) Rabbit serum containing polyclonal IgG antibodies against mixed crustacean protein 
extracted from Mud crab, Slipper lobster, and Black Tiger shrimp, referred to as 
“Rabbit serum pAbαCR”. 
B) Rabbit serum containing polyclonal IgG antibodies against purified tropomyosin 
extracted from four shrimp species (Black Tiger, Banana, Vannamei, and School 
shrimp), referred to as “Rabbit serum pAbαTM”. 
 
3.2.1 Preparation of the antigens 
The two antigens used for the production of polyclonal antibodies were extracted from 
different crustacean species: 
A) The first antigen was the total protein seperatedly extracted from each of three 
crustacean species: Mud crab, Slipper lobster, and Black Tiger shrimp.  
B) The second antigen was the protein tropomyosin purified seperatedly from the total 
protein of Black Tiger, Banana, Vannamei, and School shrimp. 
 
All crustacean samples were collected fresh or frozen from the local market and transported to 
the laboratory on ice. The list of these samples is described in Table 3.1.  
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Table 3.1: Common and scientific names of the crustacean samples 
No. Common name Scientific name Specimens’ picture 
1 Banana Shrimp 
Fenneropenaeus 
merguiensis 
 
2 
Black Tiger 
Shrimp 
Penaeus monodon 
 
3 
Vannamei 
Shrimp 
Litopenaeus 
vannamei 
 
4 School Shrimp 
Metapenaeus 
macleayi 
 
5 King Shrimp 
Melicertus 
latisulcatus 
 
(http:// www.austfish.com.au/king.html) 
6 Mud Crab Scylla serrata 
 
7 
Slipper lobster 
(Moreton Bay 
Bugs) 
Thenus orientalis 
 
(http://www.oceanexports.com.au/ 
crustaceans.htm) 
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3.2.1.1 Preparation of the total protein extracts from crustacean 
Protein extract from Mud crab, Slipper lobster, and Black Tiger shrimp were prepared 
separately by boiling whole fresh crustacean at 100 
o
C for 5 min in Milli-Q water. After that 
they were peeled to remove the shell. The tail meat part of the crustacean was cut into thin 
shreds using a pair of scissors. Approximately 20 g of the mass was added to 300 mL of PBS, 
homogenized for 10 min and then tumbled (shaker, Ratek Instruments, Australia) overnight 
(approximately 16 h) at 4
o
C.  
 
The next day, the mixture was decanted into 50 mL conical Falcon tubes (Sarstedt, Germany) 
and centrifuged at 4000 g for 30 minutes. The supernatant was passed through a glass fibre 
pre-filter (Sartorius, Germany), and then through a 0.45 µm cellulose acetate filter membrane 
(Sartorius, Germany).  
 
The protein concentration of the resultant filtrate was measured by the Bradford method using 
Quick Start Bradford Protein Assay (Bio-Rad, USA) and adjusted to the 1 mg/mL 
concentration by dilution with PBS.  
 
3.2.1.2 Preparation of purified tropomyosin from shrimp 
The proteins from four shrimp species: Black Tiger, Banana, Vannamei, and School shrimp 
were extracted using the same procedure as described in Section 3.2.1.1.  
 
These protein extracts were then separated by the ion-exchange chromatography (Biologic LP 
system, Bio-Rad) to collect the tropomyosin fractions. A strong anion exchange column, Bio-
Scale mini Macro-prep, High Q prepacked column (1 mL volume) was used for the purification. 
The starting buffer was 30 mM Acetate buffer, pH 5.5. The eluting buffer was 1 M Sodium 
chloride, pH 5.5. All buffers were filtered through 0.45 μm membrane to remove all insoluble 
articles and sterilized by autoclaving for long storage. 
 
Purified tropomyosin fractions were tested for their purity by SDS-PAGE. The protein 
concentration of each purified tropomyosin samples were measured by the Bradford method, 
concentrated to a level of 1 mg/mL by centrifugation at 3000 g through an Amicon Ultracel 
membrane (3 kDa cut-off, Millipore, USA) and then mixed together in equal volumes. 
Aliquots (0.5 mL) were also stored at the -80 
o
C freezer for use in an antibody production. 
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3.2.2 Procedure of antibody production 
The antigens used in the production of polyclonal antibodies were 1) total crustacean protein 
and 2) purified tropomyosin prepared following the procedure described in Sections 3.2.1.1 
and Section 3.2.1.2.  
 
The production was conducted at a specialised company, the Polyclonal Antibody Production, 
Institute of Medical and Veterinary Science (IMVS), Veterinary Services Division, South 
Australia. Their address is at 101 Blacks Road, Gilles Plains SA 5086. Their website is 
www.imvs.sa.gov.au/vet. The protocol used in this production has been approved by the 
IMVS Animal Ethics Committee. 
 
Three rabbits were used for the antibody production: 
 Rabbit 1 and rabbit 2 were injected with the mixed purified tropomyosin to obtain the 
sera pAbαTM. 
 Rabbit 3 were injected with the mixed crustacean protein to get the serum pAbαCR. 
 
Four doses of antigen were injected to each rabbit using Freunds adjuvant at specific time as 
scheduled in Table 3.2. Each dose contained 0.5mL solution of 500µg antigen in Phosphate 
buffer saline pH 7.4. The first dose (primary immunisation) was emulsified in Freunds 
complete adjuvant and the other boost doses were emulsified in Freunds incomplete adjuvant. 
 
Table 3.2: Immunization schedule 
 Dose No Bleed type  
Week 0 1 Prebleed  
Week 3 2  
Week 4  Test bleed 1 
Week 5 3  
Week 6  Test bleed 2 
Week 7 4  
Week 9  Bleed out 
 
The sera were taken four times to examine their response by methods described in Section 
3.2.3. The pre-bleed sera were stored frozen before injecting the immunogen and the bleed-
out sera were collected under anaesthesia after which the rabbits were euthanased.  
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The blood was collected at 37
o
C in sterile containers to accelerate clotting. After clots were 
formed, the blood was centrifuged and the serum was transferred to a sterile container and 
filtered (sterile 0.2 µm membrane) prior to storage at -80
o
C. 
 
3.2.3 Analytical methods 
The rabbit immune sera were assessed for their characteristics using different methods. 
 
The confirmation of antibody specificity was conducted by SDS-PAGE and Western Blot. 
 
The screening of the rabbit immune sera was determined by indirect ELISA, as described in 
Chapter 2 – Section 2.3.4.1.  
 
The immunoreaction of rabbit sera to the immunogens (the mixed purified tropomyosin and 
the mixed total crustacean protein) was investigated by the indirect ELISA method, at three 
dilutions: 1:5,000; 1:20,000; and 1: 30,000. 
 
The immunoreaction of rabbit sera to different separate crustacean extracts (purified 
tropomyosins from different shrimp species and total protein extracts from different 
crustaceans) were investigated by using the indirect ELISA method, at three dilutions: 
1:5,000; 1: 20,000; and 1:30,000. 
 
In indirect ELISA, the goat-anti rabbit antibody conjugated with horse radish peroxidase 
(HRP) was used as the second antibody to react with the tetramethylbenzidine (TMB) 
substrate solution (Dako, Denmark). The absorbance at 450 nm wavelength was determined 
using a Multiskan plate reader (Labsystems). 
 
All tests were conducted in triplicate. The obtained data were processed by using Microsoft 
Excel 2007 and ANOVA statistically analysed by SPSS 17.0 program. 
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3.3 RESULTS AND DISCUSSION 
The production of polyclonal antibody involved two steps. The first step is the preparation of 
antigen and the second step is the immunisation.  
 
3.3.1 Preparation of antigen 
The preparation of antigen is very important because it can affect the quantity and the quality 
of the generated antibody. The optimal immunogen dose depends upon the specific 
immunogen (including factors like immunogenicity, purity, pH, contaminants, the adjuvant 
used, the frequency and number of immunisations, and the route of immunisation (Stills, 
2012). The recommended maximum quantity of each immunogen dose at 500 µL for each 
rabbit was advised by the Polyclonal Antibody Production, IMVS, Veterinary Services 
Division, South Australia,  
 
Two different antigens were prepared to generate immune sera containing:  
- The crustacean protein polyclonal antibody in response to mix crustacean protein. 
- The tropomyosin polyclonal antibody in response to purified shrimp tropomyosin.  
 
Four protein extracts from different shrimp species had similar chromatography (Figure 3.1). 
Three fractions from the protein extract were collected and examined to obtain the exact 
tropomyosin fraction. Fraction 1 was collected from 22 to 30 min; fraction 2 was collected 
from 30 to 35 min; and fraction 3 was collected from 35 to 40 min.  
 
The fractions were investigated with SDS-PAGE and immunoblot with monoclonal shrimp 
antibody to examine specificity (Figure 3.2). The results indicated that fraction 3 contained 
the tropomyosin protein, which was eluted off the ion-exchange column once the salt 
concentration in the elution buffer reached 600 mM level. This fraction was then subjected to 
the ion-exchange chromatography again to collect the most purified tropomyosin sample.  
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(a) Banana shrimp (b) Black Tiger shrimp 
  
(c) School shrimp (d) Vannamei shrimp 
    : running buffer chromatography    : protein chromatography       : fractions which contained the tropomyosin 
Figure 3.1: The ion-exchange chromatography of tropomyosin purification from different shrimp species
AU 
Time (min) 
AU 
Time (min) 
AU 
Time (min) 
AU 
Time (min) 
5
7
 
 
58 
 
 
  A B 
  
 
 
 
 
 
 
 
 
  Marker      (a)          (b)          (c)          (d)       (a)          (b)          (c)        (d) 
Figure 3.2: The SDS-PAGE (A) and immunobloting (B) of purified tropomyosin from  
(a) Banana shrimp; (b) Black Tiger shrimp; (c) School shrimp and (d) Vannamei shrimp. 
 
Figure 3.2 presented the protein profile and immunoblotting of the final purified trpomyosin 
of each shrimp species. They all had highly purified tropomyosin at approximately 35 kD.  
 
 
3.3.2 Immunization of rabbit 
Three rabbits were used to obtain the polyclonal antibodies. The first two rabbits were 
injected with the purified shrimp tropomyosin to generate anti - tropomyosin sera and the 
third rabbit was injected with the mixed crustacean protein to get anti - crustacean protein 
serum. The number of rabbits was prioritised on the importance of the antibody and available 
project resources. Because the purified tropomyosin could cause reaction in the rabbit 
immune system and the important need of the anti - tropomyosin serum, two rabbits were 
used for this type of antibody production.  
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Unfortunately, rabbit 1 reacted too strongly to the antigen and died after the second dose 
injected. However, rabbit 2 and 3 reacted well with the antigens. They were injected with 
totally 4 doses of antigen as scheduled in Table 3.2. Each dose contained 0.5 mL solution of 
500 µg antigen in Phosphate buffer saline pH 7.4. The Phosphate buffer saline is 
recommended by the IMVS Veterinary Services Division for use in the handling of the 
antigen to avoid high concentrations of denaturing or toxic compounds. The sera were taken 
four times to test their immune responses. The aim of injecting several boosts was to give 
time for the rabbits to generate the appropriate antibodies against the injected immunogen. 
  
3.3.3 Confirmation of antibody specificity  
This experiment was carried out to examine the affinity of the rabbit sera to the immunogens. 
The sera of each rabbit were tested for immunological reactivity using a Western blotting 
technique. The pre-bleed, test-bleed and bleed-out sera of each rabbit were immunoblotted 
with the purified tropomyosin and the mixed crustacean protein. The reactions of those sera 
were compared with the reaction of the monoclonal antibody against insect tropomyosin. The 
results were presented in Figures 3.3 – 3.5.  
 
 
 
                                                       
           (a)          (b)                 (a)        (b)                    (a)        (b)                 (a)        (b) 
          SDS-PAGE         Monoclonal antibody      Pre- bleed serum        Bleed-out serum        
Note:  The red box indicates the range of tropomyosin  
Figures 3.3: Immunoblotting of (a) crustacean protein and (b) purified shrimp tropomyosin 
with monoclonal antibody mAbαTM and rabbit 1’s sera pAbαTM.  
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The immunoreactivity of the rabbit 1’s sera is presented in Figure 3.3. Both the crustacean 
protein and the purified shrimp tropomyosin reacted so strongly to the monoclonal antibody 
that they exhibited very thick diffuse dark bands around the 20 - 37 kDa range. The pre-bleed 
serum of rabbit 1 already expressed strong reaction to the purified tropomyosin. However, 
after the second dose was injected with the purified tropomyosin, the antibody titre  in rabbit 
1’s blood increased sharply. The serum recognized a clear dark band of about 35 kDa, the 
same size as the original immunogen. This result indicated that rabbit 1 was very sentitive to 
tropomyosin. 
 
The monoclonal antibody mAbαTM reacted with the crustacean protein and the purified 
shrimp tropomyosin at different bands. This result indicated that the presence of tropomyosin 
in these extracts could exist in different isoforms. 
    
The immunoreactivity of the rabbit 2’s sera is presented in Figure 3.4. The pre-bleed serum of 
rabbit 2 also expressed weak reaction with the mixture of purified tropomyosin. After the 
second dose was injected with the mixture of purified tropomyosin, the antibody titre in rabbit 
2’s blood increased significantly. The serum also recognized a dark band of about 35 kDa, the 
size of the allergic tropomyosin (Lopata et al., 2010). The reaction was still very strong in the 
bleed-out serum.  
 
                                              
       (a)      (b)       (a)     (b)        (a)     (b)       (a)     (b)        (a)     (b)        (a)     (b) 
    SDS-PAGE  Monoclonal     Pre-bleed    Test bleed 1   Test-bleed 2   Bleed-out                      
                            antibody           serum           serum             serum            serum 
Note:  The red box indicates the range of tropomyosin 
Figures 3.4: Immunoblotting of (a) crustacean protein and (b) purified shrimp tropomyosin 
with monoclonal antibody mAbαTM and sera of rabbit 2 pAbαTM. 
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The sera also demonstrated strong binding with tropomyosin in the mixture of crustacean 
protein. However, after being immunised the second time, most of the antibody in rabbit 
serum was produced against the tropomyosin antigen. This result indicated that the rabbit 2’s 
immune system had very good reaction to the purified tropomyosin immunogen.  
 
 
                                            
(a)     (b)        (a)     (b)        (a)    (b)        (a)     (b)       (a)    (b)         (a)    (b) 
   SDS-PAGE Monoclonal    Pre-bleed   Test bleed 1  Test-bleed 2   Bleed-out                      
                         antibody          serum           serum           serum           serum 
Note:  The red box indicates the range of tropomyosin 
Figures 3.5: Immunoblotting of (a) mix crustacean protein and (b) mix purified tropomyosin 
with monoclonal antibody mAbαTM and with sera from rabbit 3 pAbαCR. 
 
The pre-bleed of rabbit 3 expressed strong reaction with tropomyosin in the mixture of 
crustacean protein but weak reaction with the mixture of purified tropomyosin (Figure 3.5). 
The reaction to the crustacean protein seemed stronger after the second dose with a very thick 
dark band in the 37 kDa range. The rabbit antibody could also bind with other proteins in the 
mixture of crustacean protein.  
 
The test-bleed and bleed-out sera of rabbit 3 expressed strong binding with both mixture of 
crustacean protein and mixture of purified tropomyosin. 
 
In general, it could be concluded that the immunization of antigen into rabbits was successful 
in generating the desired antibodies in the rabbit’s sera.  
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3.3.4 Screening of antibody titers in the rabbit sera  
The screening of the rabbit sera is an important step before using them in the research. This 
titration experiment was conducted to find out the optimum titer or dilution which gives the 
best result with minimum non-specific binding by using a series of dilutions of the rabbit sera.  
 
In this experiment, a serial concentration of antigen and a serial dilution of antibody were 
carried out to investigate the appropriate concentration of antigen and the suitable dilution of 
rabbit serum which provided the highest immunoblotting reaction. The examined 
concentration of purified shrimp tropomyosin and crustacean protein varied from 0.001 
µg/mL to 10 µg/mL while the dilution of the rabbit sera increased from 1,000 to 500,000 
times. 
 
The indirect ELISA was carried out in this experiment (Crowther, 1995). Data analysis was 
performed reading absorbance at 450 nm and analyzing with Microsoft Excel 2007. The 
results were presented in Figure 3.6 and Figure 3.7. 
  
3.3.4.1 Checkerboard titration of rabbit serum pAbαCR 
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Figure 3.6: Checkerboard titration  of rabbit serum pAbαCR with different concentrations of 
crustacean protein  
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Figure 3.6 demonstrated that the immunoreations between rabbit serum and crustacean 
protein was varied depending on the crustacean protein concentration and the dilution of the 
serum.  
 
Both crustacean protein concentrations of 0.001 µg/mL and 0.01 µg/mL expressed the lowest 
binding reactions to the rabbit serum. The reaction reduced significantly when the rabbit 
serum was diluted more than 10,000 times.  
 
The higher crustacean protein concentrations, 0.1 µg/mL, 1 µg/mL and 10 µg/mL, expressed 
strong immunoreactions when the rabbit serum was diluted 20,000 times. Therefore, the 
crustacean protein concentration of 0.1 µg/mL was chosen to use in the next experiments to 
get the highest immunoreactions at the lowest antigen concentration. 
 
3.3.4.2 Checkerboard titration of rabbit serum pAbαTM 
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Figure 3.7: Checkerboard titration of rabbit serum pAbαTM with different concentrations of 
tropomyosin  
 
Figure 3.7 also demonstrated that the immunoreations between rabbit serum and tropomyosin 
varied depending on the tropomyosin concentration and the dilution of the serum.  
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The tropomyosin concentration of 0.001 µg/mL expressed the lowest binding reaction to the 
rabbit serum. The reaction reduced sharply when the rabbit serum was diluted more than 
5,000 times.  On the other hand, the tropomyosin concentration of 1 µg/mL and 10 µg/mL 
expressed the highest binding reaction. The reactions were still very strong even when the 
rabbit serum was diluted 20,000 times.  
 
The tropomyosin concentration of 0.01 µg/mL and 0.1 µg/mL still expressed strong 
immunoreactions when the rabbit serum was diluted 20,000 times. Therefore, the 
tropomyosin concentration of 0.01 µg/mL was chosen for use in the next experiments to 
obtain the highest immunoreactions at the lowest antigen concentration. 
 
3.3.5 Immunoreactivity of different rabbit sera to the immunogens 
This study was conducted to investigate immunoreactions of different rabbit sera to the 
purified tropomyosin and the crustacean protein.  
 
In this experiment, the four sera (pre-bleed, test bleed 1, test bleed 2 and bleed-out) of each 
rabbit were incubated with the purified shrimp tropomyosin and crustacean protein to 
examine their immunoreactions. The examined concentration of the purified shrimp 
tropomyosin was 0.01 µg/mL, and the concentration of the crustacean protein was 0.1 µg/mL. 
The rabbit sera were investigated with three dilutions: 1:5,000; 1:20,000; and 1: 30,000. 
 
The indirect ELISA has been conducted in this experiment. Data analysis was performed on 
the A450 readings using Microsoft Excel 2007. The results were presented in Figure 3.8 – 3.10.  
 
3.3.5.1 Sera dilution 1:5,000 
When the sera were diluted 5,000 times, the immunoreactions increased when more antigens 
was injected into the rabbits in the case of test-bleed 1. The reaction of the test-bleed 1, test-
bleed 2, and bleed-out sera of the rabbit 2 were unchanged. The reaction of the test bleed 2 of 
the rabbit 3 continued to increase after the third boost, but the reaction of its bleed-out serum 
slightly decreased. 
 
The rabbit 2’s test-bleed 1 had the highest immunoreactions with both purified tropomyosin 
and crustacean protein. Both test-bleed 2 sera of the rabbit 2 and 3 had high bindings and the 
reactions continued increasing slightly in their bleed-out sera. 
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All sera exhibited higher immunoreactions to the crustacean protein than to the purified 
tropomyosin. This could be because the concentration of the crustacean protein was 10 times 
more than that of the purified tropomyosin.  
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Figure 3.8: The immunoreactions of rabbit sera to purified tropomyosin and crustacean 
protein at sera dilution 1:5,000 
Note:  TROP: Purified tropomyosin;  CRUS: crustacean protein 
  
3.3.5.2 Sera dilution 1:20,000 
The sera of rabbit 1 exhibited very weak reaction with both purified shrimp tropomyosin and 
crustacean protein. Reverselly, the sera of rabbit 2 exhibited very strong reaction with both 
purified shrimp tropomyosin and crustacean protein with the maximum bindings achieved in 
the test-bleed 2 sera.  
 
The sera of rabbit 3 had high reaction with the crustacean protein but low reaction with the 
purified tropomyosin. This is because the rabbit 3 was immunised with the crustacean protein 
to produce anti- crustacean protein sera. 
 
The immunoreactions of the bleed-out sera of both rabbit 2 and 3 were slightly decreased as 
compared to that of the test-bleed 2. 
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Figure 3.9: The immunoreactions of rabbit sera to purified tropomyosin and crustacean 
protein at serum dilution 1:20,000 
Note:  TROP: Purified tropomyosin;  CRUS: crustacean protein 
 
3.3.5.3 Sera dilution 1:30,000 
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Figure 3.10: The immunoreactions of rabbit sera to purified tropomyosin and crustacean 
protein at serum dilution 1:30,000 
Note:  TROP: Purified tropomyosin;  CRUS: crustacean protein 
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The sera might be too diluted in this case. The immunoreactions of rabbit 1 and 3 were very 
low. Only the rabbit 2’s sera can exhibite the high bindings with the antigens. 
 
In general, the immunoreactions of different rabbit sera changed with the change of the serum 
dilution. The 20,000 times diluted sera had the highest reaction, and the 5,000 times diluted 
sera had the lowest reaction. The immunoreactions were also different among different sera in 
the same dilution. 
 
 
3.3.6 Immunoreactivity of rabbit sera to specific crustacean protein extracts 
This experiment was aimed to compare the immunoreactions of rabbit serum pAbαTM and 
rabbit serum pAbαCR to different purified tropomyosin and protein extracts.  
 
In this experiment, the rabbit sera were incubated with purified tropomyosin from different 
shrimp species and with different crustacean protein extracts. The purified tropomyosin was 
used at the 0.01 µg/mL concentration and the crustacean protein was used at the 0.1 µg/mL 
concentration. The immunoreactions were examined with three dilutions of rabbit serum: 
1:5,000; 1: 20,000; and 1:30,000. The results are presented in Figure 3.11.  
 
The immunoreactions of the rabbit sera changed with the change of the serum dilution, in 
which the 5,000 times diluted sera had the lowest reaction. The immunoreactions were also 
different between the two rabbit sera and among different protein extracts in the same 
dilution. 
 
With the dilution 1:5,000, the rabbit serum pAbαTM exhibited stronger reaction to purified 
tropomyosin than crustacean extracts. The immunoreactions of this serum to the purified 
tropomyosin from Black Tiger, Banana, Vannamei and School shrimp were even higher than 
the mixed purified tropomyosin. The reaction of the rabbit serum pAbαCR to the purified 
tropomyosin extracts was similar to the crustacean extracts. 
 
The 20,000 and 30,000 times dilution of rabbit sera exhibited similar immunoreactions. They 
both had high binding to the crustacean protein extracts than the purified tropomyosin. This 
might be due to the appropriate dilution of the sera that expressed the maximum binding 
reactions. 
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Figure 3.11: The immunoreactions of rabbit sera to different protein extracts  
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(1)  Mix purified tropomyosin 
(2)  Black Tiger shrimp – Tropomyosin 
(3)  Banana shrimp – Tropomyosin 
(4)  Vannamei shrimp – Tropomyosin 
(5)  School shrimp – Tropomyosin 
(6)  King shrimp – Tropomyosin 
(7)  Mix crustacean protein 
(8)  Mud crab  protein 
(9)  Slipper lobster protein 
(10)  Black Tiger shrimp protein 
(11)  Banana shrimp protein 
(12)  Vannamei shrimp protein 
(13)  School shrimp protein 
(14)  King shrimp protein 
 
 
 
 
 
Overall, the dilution 1:30,000 of rabbit sera was chosen to use for the next experiments due to 
their high binding immunoreactions to the crustacean protein extracts.  
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3.4 GENERAL DISCUSSION AND CONCLUSION 
 
Two rabbit polyclonal antibodies were successfully generated. These antibodies were raised 
against the total crustacean proteins from Mud crab, Slipper lobster, and Black Tiger shrimp 
and against the purified tropomyosin from four species of shrimp. This research showed that 
rabbit is a suitable laboratory animal for antibody production in this study. Other researchers 
were also successful in using rabbit for antibody production in their studies (Duranthon et al., 
2012; Hashimura et al., 1982; Ridder et al., 1995). 
 
All antigen preparations in this chapter had very compact bands arounds 37 kDa range in 
SDS-PAGE and Western Blot with anti-tropomyosin monoclonal antibody. It indicated the 
presence of tropomyosin there. This result was confirmed by other researchers in various 
shellfish allergens (Ayuso R et al., 2002; Lopata and Lehrer, 2009; Lopata et al., 2010). 
 
Both rabbit sera had very thick dark bands at the 37 kDa range, which indicated that the rabbit 
sera are very sensitive for the detection of the presence of tropomyosin. In addition, the rabbit 
serum against higher molecular weight crustacean proteins which are most likely polymers of 
tropomyosin. The rabbit sera not only recognise the immunogen but also proteins from other 
species such as King shrimp. This strong reaction between the rabbit sera against proteins 
extracted from other species of shrimp as well as other crustacean species can confirm the 
cross reactivity of the allergenic tropomyosin which was discovered by other scientists 
(Hoffman et al., 1981; Lopata and Lehrer, 2010; Lopata et al., 2010; Mills and Breiteneder, 
2005; Patrick et al., 1998; Shanti et al., 1993; Wild and Lehrer, 2005). 
 
The rabbit sera showed high affinity and specificity to their antigen in Western blotting. The 
antibody titration was carried out using the indirect ELISA. The immunoreactivity of the 
rabbit sera were still very strong when the antibody was diluted 30,000 times with very low 
concentrations of the purified tropomyosin and the crustacean protein, with 0.01 µg/mL and 
0.1 µg/mL respectively. These results demonstrated that the obtained polyclonal antibodies 
from rabbits are suitable for the analysis of chitin and chitosan in the next chapters. 
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Chapter 4 
INVESTIGATION OF THE ALLERGENICITY  
OF SHRIMP PROTEIN 
 
 
4.1 INTRODUCTION 
Consumers are getting more and more concerned about their health. Therefore, there is an 
increasing demand for healthy food to support and strengthen the quality of lives (Alishahi 
and Aïder, 2011). Most of the nutritious food products which provide functional substances 
such as eicosapentaenoic acid, docosahexaenoic acid and omega-3 can be found in 
aquacultural products. As a result, the aquaculture industry has become one of the fastest 
developed industries over recent years (Kandra et al., 2012). South East Asia countries such 
as Thailand, Vietnam, Indonesia and Philippins are among the world’s leader producer of 
cultured shrimp (FAO, 2003).   
 
On the other hand, shellfish allergy is one of the most prevalent food allergies, especially in 
adults (Asero et al., 2012; Hill et al., 1997; Lopata and Lehrer, 2010; Mills and Breiteneder, 
2005; Ng et al., 2011; Sicherer et al., 2004; Sicherer and Sampson, 2006; Taylor and Steve, 
2008; Wild and Lehrer, 2005). It is estimated that about 1% of the world population is allergic 
to shrimp (Leung et al., 1998; Lopata and Potter, 2000; Sicherer et al., 2004).  
 
The shrimp muscle protein tropomyosin has been shown to be the major heat-stable allergen 
causing sensitisation in consumers (Ayuso et al., 2002; Hoffman et al., 1981; Leung et al., 
1998; Liu et al., 2010; Lopata, 2010; Nagpal et al., 1989). The molecular weight of 
tropomyosin varies from 34 to 38 kDa (Reese et al., 1999; Shanti et al., 1993). It has a coiled-
coil dimer structure of two paralled alpha-helical tropomyosin molecules (Reese et al., 1999). 
The processing of shrimp may affect the IgE binding properties of tropomyosin (Liu et al., 
2010). Generally, shrimp is exported in frozen form without exoskeleton (Kandra et al., 
2012). About 48 – 56 % by weight of shrimp raw material is discarded as waste depending on 
species (Sachindra et al., 2007).  
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Therefore, this research is aimed at investigating the allergenic tropomyosin protein in shrimp 
products due to variations in the shrimp species, body parts of shrimp and the processing 
methods.  
 
Summary of Chapter 4:  
This chapter focuses on the identification of the allergenic protein tropomyosin in different 
protein extracts of the two most common shrimp species sold in the Australian market: Black 
Tiger shrimp and Banana shrimp.  
 
Six different protein extractions from each shrimp species were prepared by different 
methods: raw extraction, heat-treated extraction and whole shrimp-cooked extraction. These 
protein extracts were then compared together according to their SDS-PAGE profiles, 
immunoblotting reactions by Western blotting as well as their immunological cross-
reactivities through inhibition ELISA.  
 
The result demonstrated that the allergenic tropomyosin protein is not only present in the tail 
meat but also in the extracted shell waste of shrimp. The tropomyosin seemed to be more 
stable to heat processing when extracted after heating the whole shrimp. 
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4.2 MATERIALS AND METHODS 
4.2.1 Preparation of protein extracts  
Two shrimp species were used for this study, the Australian Banana shrimp (Fenneropenaeus 
merguiensis) and the Black Tiger shrimp (Penaeus monodon). A general procedure of the 
three methods of protein extraction from shrimp is shown in Figure 4.1.  
 
Raw specimens were bought from the local market and stored in ice during the transit. They 
were peeled to separate the shell (including shell, head - carapace and rostrum, and legs -
pereopods and pleopods) and the tail meat (which is termed “tail” for the remainder of the 
thesis) of the shrimp to prepare two different protein extracts, the shell protein extract and the 
tail protein extract. Those parts were then cut into thin shreds using a pair of scissors and 
approximately 20 g was added homogenized in PBS as described in Section 3.2.1.1 and 
refererred to as “Mixture A”. 
 
The “raw protein extract” was aliquots from mixture A, filtered and frozen at -80 oC freezer 
(Section 3.2.1.1). 
 
The “heat-treated protein extract” was prepared from mixture A by heating at 70 oC for 5 
min, clarifying by centrifugation, filtered sterilising, aliquoting and storing at -80 
o
C (Section 
3.2.1.1). 
 
The “whole-cooked protein extract” was prepared from whole raw shrimp cooked at 100 oC 
for 5 min in Milli-Q water and then treated as for other preparations as described in Section 
3.2.1.1.  
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Figure 4.1: A general layout of the protein extraction procedure from shrimp 
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4.2.2 Analytical requirements 
4.2.2.1 Protein concentration of shrimp protein 
The protein concentration of each extract was quantified by Bradford method using the Quick 
Start Bradford Protein Assay (Bio-Rad) (Chapter 2 – Section 2.3.1.4). The protein 
concentration of each extract was calculated based on the initial amount of shrimp tissue used 
for extraction and expressed as % (w/w).  
 
4.2.2.2 Protein profile of different shrimp protein extracts 
The 12% SDS polyacrylamide gel electrophoresis was used to separate the proteins of the 
different extracts by molecular weight (Chapter 2 – Section 2.3.2). The protein profiles of 
different protein extracts were discussed and compared together. 
 
4.2.2.3 Immunoblotting of different shrimp protein extracts 
The presence of tropomyosin was examined by Western blotting (Chapter 2 – Section 
2.3.3.1). The immunoblotting was conducted with the monoclonal antibody and sera of two 
patients with clinical symptoms to crustacean: 
- Monoclonal antibody mAbαTM: Commercial rat anti-tropomyosin IgG antibody, 
MAC-141 (Abcam).  
- Human serum AN01: Serum from patient who has allergic symptoms with specific 
IgE against lobster, crab and shrimp. 
- Human serum JB21: Serum from patient who has allergic symptoms with specific IgE 
against crab and shrimp. 
 
4.2.2.4 Immunoreactivity of different shrimp protein extracts 
The immunoreactivity of tropomyosin in shrimp extracts was examined by the indirect ELISA 
as described in Chapter 2 – Section 2.3.4.1. In this assay, two rabbit sera were used to detect 
the presence of tropomyosin: the rabbit serum pAbαTM containing antibodies which was 
raised against the shrimp tropomyosin and the rabbit serum pAbαCR containing antibodies 
which was raised against the whole-cooked crustacean protein. Protein extracts from Black 
Tiger and Banana shrimp was first coated onto the wells. The rabbit sera pAbαTM and 
pAbαCR diluted 30,000 times were then added. The goat-anti rabbit antibody conjugated with 
HRP was used as the second antibody to react with the TMB substrate solution (Dako, 
Denmark). The absorbance at 450 nm wavelength was determined using a Multiskan plate 
reader (Labsystems).  
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Serial concentrations of the purified tropomyosin from 0.0001 µg/mL to 0.1 µg/mL were also 
loaded as antigens to create a standard curve for the estimation of tropomyosin concentration 
in the shrimp protein extracts. 
 
To determine the cross-reactivities of each antibody to different protein extracts, inhibition 
ELISA was performed (Chapter 2 – Section 2.3.4.2). A high percentage of inhibition indicates 
a high degree of cross-reactivity of the antibody to the antigen. In this assay, the wells were 
first coated with antigen (0.01 µg/mL of purified tropomyosin or 0.1 µg/mL of crustacean 
protein). The inhibitors were the different protein extracts from Black Tiger and Banana 
shrimp. The inhibitor was mixed with rabbit serum pAbαTM or pAbαCR (depending on the 
coated antigen) at different concentrations before coating onto the wells. The goat anti-rabbit 
polyclonal antibody labelled with HRP was used as the second antibody. After adding TMB 
One-Step Substrate System, the reaction was stopped by HCl and the OD was read at 450 µm.  
 
The percentage inhibition of each shrimp protein extract was calculated following the below 
formula: 
Percentage inhibition (%) = 100 x (Ymax – Y) / Ymax 
Where  Ymax: the absorbance of the well containing no inhibitor 
  Y: the absorbance of the well containing inhibitior 
 
The 50 % inhibition value of different protein extracts were recorded and compared together. 
 
 
4.2.3 Data analysis 
The experiments were conducted in triplicate. The data were analysed by Microsoft Excel 
2007 program and by SPSS 17.0 programs for the analysis of variances. 
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4.3 RESULTS AND DISCUSSION 
4.3.1 Evaluation of protein concentration in shrimp  
The protein concentration of different extracts from Black Tiger shrimp and Banana shrimp 
were determined by Bradford method (Bradford, 1976) using the Quick Start Bradford 
Protein Assay kit from Bio-Rad (USA) (Figure 4.2). The protein concentrations were different 
significantly at p < 0.05 (Appendix – Chapter 4, Table A.4.2). 
 
 
Figure 4.2: The protein concentration (%) of different shrimp protein extracts 
 
4.3.1. 1 Comparison of the protein concentration of different shrimp species 
The amount of protein extracted from the Black Tiger shrimp was double the amount from the 
Banana shrimp in the raw and cooked extracts. However, the concentrations of the heat-
treated protein extracts were mostly similar between these two species. 
 
4.3.1.2 Comparison of the protein concentration of different extraction methods 
The protein concentration in the heat-treated and cooked extracts had much lower protein 
concentrations as compared to the raw extracts in both Black Tiger shrimp and Banana 
shrimp. This could be because some proteins have been hydrolysed during the heating process 
(An et al., 1988). Some shrimp proteins might be denatured or come out to the solution during 
heating process of the cooked extracts.  
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As for the tail meat, the raw shell extracts had the highest protein concentration amongst 
different extraction methods of raw, heat-treated and cooked. 
 
The protein content in the heat-treated tail extract was double the amount in the cooked tail 
extract in Banana shrimp while it remained the same in the Black Tiger shrimp.  
 
4.3.1.3 Comparison of the protein concentration of different parts of shrimp 
The results also proved that there is a certain amount of protein in the shell extracts. As the 
proteins exist mostly in the muscle of the shrimp, the shell extracts contained smaller amount 
of protein than the tail extract. However, the protein concentration in the raw shell extract 
from Black Tiger was even higher than the protein concentration in the heat-treated tail 
extracts. These proteins may remain in the derived products from the shrimp shell. Therefore, 
it is very important to investigate the protein content in products derived from shrimp shell 
such as chitin and chitosan. 
 
4.3.2 SDS Gel electrophoresis profile of different shrimp protein extracts 
 
Figure 4.3: SDS Gel electrophoresis profile of different shrimp tail and shell protein extracts. 
Note: The red box indicates the position of the major allergen tropomyosin.  
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Equal amounts (20μg) of the protein extract were loaded onto each well to compare SDS-
PAGE profiles. The results were presented in Figure 4.3. Several proteins bands were 
detected after electrophoresis with molecular weight between 15-250 kDa. The most visible 
bands could be observed near the 75, 37 and 20 kDa regions.  
 
4.3.2.1 Comparison of the protein profile of different shrimp species 
The raw tail extract from Banana shrimp seemed to have more types of protein than from 
Black Tiger shrimp. The raw shell, heat-treated tail and cooked tail extracts from these two 
species had similar protein profiles. However, the heat-treated shell extract from Black Tiger 
shrimp had very strong bands at 75 and 37 kDa regions while it could not be seen in this 
extract from Banana shrimp. This could be because most of the proteins that remained in the 
shell of the Banana shrimp were hydrolysed during the heating process. Besides that, the 
cooked shell extract from Black Tiger shrimp had only one strong band at 37 kDa range, 
while there were visible bands at 75 and 20 kDa ranges in the protein profile of cooked shell 
extract from the Banana shrimp. 
 
4.3.2.2 Comparison of the protein profile of different extraction methods 
The raw and the heat-treated tail extracts had more protein bands than the cooked tail extracts. 
The raw and heat-treated shell extracts from the Black Tiger shrimp had similar protein 
profile with 3 major bands at 75 and 37 kDa ranges which could not be detected in the Banana 
shrimp. 
 
4.3.2.3 Comparison of the protein profile of different parts of shrimp  
Most proteins in the raw shell extracts are in at the 75 kDa range compared to the protein 
profile of the raw tail extracts. The shell extracts seemed to have fewer  protein bands than the 
tail extracts, which demonstrated a large variety of proteins. 
 
4.3.3 Immunoblotting of different shrimp protein extracts (Western blotting) 
The mouse monoclonal anti-tropomyosin antibody and the crustacean allergic patient serum 
were used for the detection of the allergen tropomyosin in the shrimp species (Figure 4.4 – 
4.5). Most of the protein extracts expressed clear dark bands at the 37 kDa range, indicating 
the presence of tropomyosin in these extracts. 
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The immunoblotting with the monoclonal antibody (Figure 4.4) demonstrated much stronger 
bands of at around 37 kDa range in the cooked extracts as compared to the others.  
 
The treated tail extracts of these two species expressed two dark bands when reacted with the 
monoclonal antibody, while the raw extracts only had one band. This could be due to the 
changes in the structure of tropomyosin during the heat treatment. 
 
All the shell extracts from the Black Tiger shrimp had the binding reactions with the 
monoclonal antibody at 37 kDa range, while the cooked shell extract and the raw shell extract 
from the Banana shrimp expressed reactions at 37 kDa and at lower band, respectively. 
 
 
Figure 4.4: Immunoblotting of different shrimp tail and shell protein extracts with 
monoclonal antibody  
Note: The red box indicates the position of the major allergen tropomyosin. 
 
The immunoreactions were confirmed when probing protein extracts with the human patient 
sera (Figure 4.5). 
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Figure 4.5: Immunoblotting of different shrimp protein extracts with crustacean allergic 
patient serum AN01 (A) and JB21 (B)  
Note: The red box indicates the position of the major allergen tropomyosin. 
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Most protein extracts expressed visible bands at the 37 kDa range, indicated the IgE bindings 
to the tropomyosin in these extracts. The JB21 serum has more specific IgE to Black Tiger 
shrimp than the AN01 serum. Hence, it can bind to more proteins in the Black Tiger shrimp 
extracts, especially the treated ones. The treated protein extracts of both Black Tiger shrimp 
and Banana shrimp had stronger reactions to both human sera than the raw extracts while 
similar to the monoantibody blots.  The whole-cooked shrimp shell extract shows very dark 
bands after immunoblotting with the patient sera at around 37 kDa. This indicated the 
presence of high amounts of tropomyosin in these extracts as well as possible isoforms at 
about 33 – 37 kDa and dimers at about 65 – 75 kDa.  
 
4.3.4 Immunoreactivity of different shrimp protein extracts to rabbit sera 
In this experiment, the indirect ELISA was designed to examine the binding reaction of 
tropomyosin and shrimp protein extracts to the two in-house produced polyclonal antibodies, 
the pAbαTM and the pAbαCR. The tropomyosin concentrations in these extracts were also 
estimated based on their reaction with the pAbαTM and the standard curve from purified 
tropomyosin.  
 
The inhibition ELISA was conducted to determine the cross-reactivity of rabbit sera pAbαTM 
and pAbαCR to different protein extracts.  
 
4.3.4.1 Immunoreactivity of shrimp protein extracts to rabbit serum pAbαCR 
4.3.4.1.1 The bindings of shrimp protein extracts to rabbit serum pAbαCR 
The bindings of different shrimp protein extracts to rabbit serum pAbαCR were demonstrated 
through the absorbance value obtained from the indirect ELISA (Figure 4.6). The absorbance 
values of different shrimp protein extracts to rabbit serum pAbαCR were different 
significantly at p < 0.05 (Appendix – Chapter 4, Table A.4.4). 
 
Most tail extracts expressed high binding with the rabbit serum pAbαCR, except the heat-
treated tail extract from Black Tiger shrimp. It can be assumed that the heat-treated process 
can break down or denature most of the proteins in Black Tiger shrimp.  
 
Most protein extracts from the shrimp shell had lower immunoreactions which can be compared 
as the reaction of the 0.001 µg/mL crustacean protein concentration. However, the cooked shell 
extract from Black Tiger shrimp showed very high immunoreactions to pAbαCR. 
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Figure 4.6: Absorbance values of the bindings of different shrimp protein extracts to rabbit 
serum pAbαCR 
 
4.3.4.1.2 Percentage inhibition of shrimp protein extracts to rabbit serum pAbαCR 
To compare the similarity of tropomyosin between the different extracts and the concentration 
of antigen, the inhibition ELISA was performed. An amount of 0.01 µg/mL of purified 
tropomyosin was coated onto the wells before adding the inhibitor and rabbit serum mixture. 
The percentage inhibitions of shrimp protein extracts at different concentrations were 
calculated. A high degree of inhibition demonstrates a high concentration of tropomyosin. 
The results were presented in Figure 4.7 and 4.8. 
 
The percentage inhibition of different concentration of protein extracts from both Black Tiger 
shrimp and Banana shrimp to rabbit serum pAbαCR increased with the increasing 
concentration of the inhibitors.  
 
All the tail protein extracts from Black Tiger shrimp as well as Banana shrimp had 
significantly higher percentage inhibition than the shell extracts with p < 0.05 (Appendix – 
Chapter 4, Table A.4.6 and Table A.4.8). The cooked tail extracts from both shrimp had the 
highest percentage inhibition (> 90 % at 10 µg/mL inhibitor concentration). The lowest 
percentage inhibition occurred at the heat-treated shell extracts from both Black Tiger and 
Banana shrimp. 
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Figure 4.7: Percentage inhibition to rabbit serum pAbαCR of different protein extracts from 
Black Tiger shrimp 
 
 
 
Figure 4.8: Percentage inhibition to rabbit serum pAbαCR of different protein extracts from 
Banana shrimp 
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For the Black Tiger shrimp, the cooked shell extract had the highest percentage inhibition 
with the 92 % inhibition at the 10 µg/mL inhibitor concentration. The percentage inhibition of 
heat-treated and raw shell extracts increased slightly when the inhibitor concentration 
increased, and it was just more than 50 % at the 10 µg/mL inhibitor concentration. This result 
indicated that the cooked shrimp shell extract contained a higher amount tropomyosin than 
other shrimp shell extracts.  
 
For the Banana shrimp, the shell extracts of all processing methods had similar percentage 
inhibition at low inhibitor concentration (0.01 – 0.1 µg/mL). However, the percentage 
inhibition of the raw and cooked shell extracts increased steadily at higher inhibitor 
concentration, while the percentage inhibition of the heat-treated shell extracts just slightly 
increased. 
 
In general, the tail protein extracts from both Black Tiger shrimp and Banana shrimp had 
higher percentage inhibition to both rabbit sera than the shell protein extracts. The cooked 
shell extracts expressed the significantly higher percentage inhibition than other shell extracts.  
 
4.3.4.2 Immunoreactivity of shrimp protein extracts to rabbit serum pAbαTM 
4.3.4.2.1 The bindings of shrimp protein extracts to rabbit serum pAbαTM 
The bindings of different shrimp protein extracts to rabbit serum pAbαTM were similar to the 
rabbit serum pAbαCR but at higher bindings (Figure 4.9A). The absorbance values of 
different shrimp protein extracts to rabbit serum pAbαTM are different significantly at p < 
0.05 (Appendix – Chapter 4, Table A.4.10). 
 
Most tail extracts expressed high binding with the rabbit serum pAbαTM, except the heat-
treated tail extract from Black Tiger shrimp. Their immunoreactions were as strong as the 
0.01 and 0.1 µg/mL tropomyosin reaction. Most protein extracts from the shrimp shell had 
lower immunoreactions which can be compared as the reaction of the 0.0001 µg/mL 
tropomyosin concentration. However, the cooked shell extract from Black Tiger shrimp 
showed as high immunoreactions as the tail extracts. 
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Figure 4.9: Immunoreactivity of shrimp protein extracts to rabbit serum pAbαTM  
A - Absorbance values of the bindings of different shrimp protein extracts to pAbαTM 
B - Tropomyosin concentration (µg/mL) of shrimp protein extracts 
C - Percentage of tropomyosin compared to total protein extracted 
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4.3.4.2.2 Evaluation of tropomyosin content in shrimp protein extracts 
Based on the binding of known concentrations from purified tropomyosin (Figure 4.9A), the 
tropomyosin concentration in each shrimp protein extracts was also estimated. The 
absorbance values of known concentrations from purified tropomyosin were used as a 
standard curve for the conversion from absorbance values to tropomyosin concentration 
values. The result was presented in Figure 4.9B. There were significant differences between 
these values at p < 0.05 (Appendix – Chapter 4, Table A.4.12). 
 
All the tail protein extracts had higher concentration of tropomyosin than the shell extracts. 
Among them, the heat-treated extract from the Black Tiger shrimp had the lowest 
tropomyosin concentration (1.4 µg/mL). This result reflected the binding of these extracts in 
Figure 4.9A.  
 
The tropomyosin concentrations in the shell extracts from Banana shrimp were rather similar 
at approximately 1.3 µg/mL. On the other hand, the tropomyosin concentration in the cooked 
shell extracts from Black Tiger shrimp was very high and comparable to the tropomyosin 
concentration in the tail extracts.  
 
The percentage of tropomyosin concentration over the total protein of each extract has been 
calculated in order to compare the level of tropomyosin among these extracts (Figure 4.9C). 
 
The results presented in Figure 4.9C demonstrated that the percentage of tropomyosin to total 
shrimp protein in each extract was in general very low with about 0.2 – 0.6 %. Most extracts 
had a tropomyosin percentage less than 0.5 %. Amongst all shrimp protein extracts, the 
cooked tail extract from Banana shrimp had the highest percentage at 1.6 %. As even very 
small amounts of allergens can cause allergic reactions (Lopata and Lehrer, 2010), these 
allergen concentrations can be considered high. 
 
4.3.4.2.3 Percentage inhibition of shrimp protein extracts to rabbit serum pAbαTM 
The percentage inhibition of shrimp protein extracts to rabbit serum pAbαTM was carried out 
using inhibition ELISA. The results were presented in Figure 4.10 and 4.11. 
 
The percentage inhibition to rabbit serum pAbαTM of different protein extracts from Black 
Tiger shrimp increased with the increasing concentration of the inhibitors (Figure 4.10). The 
differences were significant at p < 0.05 (Appendix – Chapter 4, Table A.4.15). 
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Figure 4.10: Percentage inhibition to rabbit serum pAbαTM of different protein extracts from 
Black Tiger shrimp 
 
The cooked protein extracts from Black Tiger shrimp expressed the highest percentage 
inhibition. It seemed to reach the maximum percentage inhibition (100 %) at the 10 µg/mL 
inhibitor concentration. The results of the inhibition ELISA confirm the data of the indirect 
ELISA in Figure 4.8, that cooked tail and shell extracts have the highest concentrations of 
tropomyosin and the raw shell extracts have the lowest values. 
 
All the tail protein extracts from Black Tiger shrimp had higher percentage inhibition than the 
shell extracts. This was consistent with the tropomyosin concentrations (µg/mL) in the tail 
extracts being higher than the shell extracts.  
 
Amongst the shell protein extracts from Black Tiger shrimp, the cooked shell extract had the 
highest percentage inhibition with the maximum percentage inhibition (100 %) at the 10 
µg/mL inhibitor concentration. The percentage inhibitions of other shell extracts were just 
more than 50 % at the 10 µg/mL inhibitor concentration. This result was consistent with the 
cooked shrimp shell containing a high amount tropomyosin. It is similar to the result obtained 
from the above indirect ELISA. 
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The percentage inhibition of different concentration of protein extracts from Banana shrimp to 
rabbit serum pAbαTM also increased with the increasing concentration of the inhibitors 
(Figure 4.11). The differences were significant at p < 0.05 (Appendix – Chapter 4, Table 
A.4.17). 
 
 
Figure 4.11: Percentage inhibition to rabbit serum pAbαTM of different protein extracts from 
Banana shrimp 
 
All the tail protein extracts from Banana shrimp had higher percentage inhibition than the 
shell extracts due to their higher tropomyosin concentration.  
 
All the tail extracts reached the maximum percentage inhibition (100 %) at the 10 µg/mL 
inhibitor concentration. At lower inhibitor concentration, the cooked tail extract had the 
highest percentage inhibition with more than 90 % at the 0.01 µg/mL inhibitor concentration. 
The heat-treated tail extract and the raw tail extract had lower percentage inhibition with 
approximately 65 % and 40 % at the 10 µg/mL inhibitor concentration, respectively. 
 
Among the shell protein extracts from Banana shrimp, the heat-treated shell extract had the 
lowest percentage inhibition with 40 - 45 percentage inhibition when the inhibitor 
concentration increased from 0.01 to 10 µg/mL. This result indicated that the heat-treated 
shrimp shell contained the least amount tropomyosin than others.  
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4.3.4.3 The 50 % inhibition value (IC50) of shrimp protein extracts to rabbit sera 
The IC50 is the median concentration that causes 50 % inhibition. From the percentage 
inhibition results of Section 4.3.4.1 and Section 4.3.4.2, the IC50 of different shrimp protein 
extracts to the two rabbit sera were calculated (Table 4.1). 
 
Table 4.1: IC50 (µg/mL) value of shrimp protein extracts to rabbit sera pAbαCR and pAbαTM 
  Shrimp protein extracts  pAbαCR pAbαTM 
Black Tiger raw shell extract  4 9 
Black Tiger heat-treated shell extract  1 5.5 
Black Tiger heat-treated tail extract  0.3 0.3 
Black Tiger cooked shell extract  0.025 0.01 
Black Tiger cooked tail extract  0.008 0.0065 
Black Tiger raw tail extract  0.022 0.0025 
   
Banana heat-treated shell extract  9.8 6.5 
Banana cooked shell extract  0.55 0.5 
Banana raw shell extract  0.24 0.2 
Banana raw tail extract  0.02 0.03 
Banana cooked tail extract  0.0065 0.0055 
Banana heat-treated tail extract  0.0092 0.008 
 
 
For the rabbit anti-crustacean protein antibody pAbαCR, the highest IC50 were observed at the 
heat-treated shell extract of the Banana shrimp (9.8 µg/mL), then the raw shell and the heat-
treated shell extracts of the Black Tiger shrimp (4 µg/mL and 1 µg/mL, respectively). Other 
extracts had very low IC50 (less than 0.5 µg/mL). 
 
For the rabbit anti-shrimp tropomyosin antibody pAbαTM, the highest IC50 were observed at 
the raw shell extract of the Black Tiger shrimp (9 µg/mL), then the heat-treated shell extracts of 
Banana and Black Tiger shrimp (6.5 µg/mL and 5.5 µg/mL, respectively). Other extracts had 
very low IC50 (less than 0.5 µg/mL). 
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4.4 GENERAL DISCUSSION AND CONCLUSION 
The protein concentration of the protein extracts from Black Tiger and Banana shrimp varied 
depending on the shrimp species, body part of shrimp and the processing method. There was 
still a remarked amount of protein in the shell extracts although the shrimp was pre-treated by 
boiling at high temperature. Most proteins in the shrimp extracts concentrated near the 75, 37 
and 20 kDa regions of the SDS-PAGE. Other studies also showed that thermal processing 
affected sharply the amount of allergenic proteins from seafood (Liu et al., 2010; Lopata, 
2010). However, because tropomyosin is a heat-stable allergen, it can still exist in the 
processed food (Hoffman et al., 1981; Lopata and Lehrer, 2010; Nagpal et al., 1989; Reese et 
al., 1999). The 75 kDa protein is most likely a dimer of tropomyosin, whereas the 20 kDa is a 
large fragment of tropomyosin (Kamath, 2012). 
 
The immunobloting of these extracts with monoclonal antibody as well as crustacean 
sensitive patients has confirmed the presence of tropomyosin in these extracts. The 
tropomosin concentrations in the tail extracts and shell extracts were approximately at 3.5 
µg/mL and 1.0 µg/mL, respectively. In another study, Rahman et al. (2010) analysed the 
allergenic proteins in Black Tiger shrimp using peptide mass finger printing and peptide 
fragment fingerprinting methods. Their study found the presence of tropomyosin, myosin 
light chain, and arginine kinase at 33 kDa, 20 kDa and 40 kDa, respectively (Rahman et al., 
2010). Due to thermal process, the quantities of proteins in heat-treated and whole-cooked 
samples were less than the raw samples; however, their percentage amount of tropomyosin 
compared to total proteins were significantly higher. 
 
Most of the IC50 values for shrimp protein extracts were obtained at very low concentration 
of inhibitor (less than 0.5 µg/mL). These results indicated that the affinity between the 
tropomyosin and the sera was very strong. Therefore, special care should be given to the 
processing of shrimp derived products to prevent contamination with tropomyosin, which 
could cause negative health effects in crustacean sensitized people. 
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Chapter 5 
INVESTIGATION OF THE ALLERGENICITY  
OF RESIDUAL PROTEINS IN CHITIN AND CHITOSAN 
 
 
5.1 INTRODUCTION 
Chitin, an animal polysaccharide, is a major structural component of the exoskeleton of 
invertebrates (Shahidi et al., 1999). It is composed of poly (β-(1-4)-N-acetyl-D-glucosamine). 
It can be extracted from a variety of sources such as marine animal, insect and fungi (Mathur 
and Narang, 1990; Stevens, 2005). The major source of chitin from marine animal is from 
crustacean shell waste (Rinaudo, 2006) which contain 20 – 30 % chitin (Agulló et al., 2003).  
 
Chitosan, derived from chitin through a deacetylation process, is composed of poly (β-(1-4)-
N-acetyl-D-glucosamine). Therefore, it has more active properties than chitin due to its 
solubility and cationic property in queous acidic conditions (Hudson and Jenkins, 2002; 
Rinaudo, 2006). Due to the natural source of these subtances, chitin, chitosan and their 
derivative compounds are promising materials with non-toxic, biodegrable and biocompatible 
properties (Arai et al., 1968; Carreño-Gómez and Duncan, 1997; Kean and Thanou, 2010; 
Rao and Sharma, 1997; Richardson et al., 1999; VandeVord et al., 2002; Zhang et al., 2002). 
They have been applied in many industrial fields, especially in the production of functional 
foods, pharmaceutics and cosmetics due to their binding property, film-forming property and 
antimicrobial properties (Ilium, 1998; Muzzarelli and Muzzarelli, 2005; Ravi Kumar, 2000; 
Rinaudo, 2006; Shahidi and Abuzaytoun, 2005).  
 
Although the safety of these products is highly appreciated (Paul, 2010; Rao and Sharma, 
1997; Waibel et al., 2011), some residual proteins from shrimp shell such as tropomyosin and 
arginine kinase could remain in these products and cause allergic reactions among consumers. 
Until now there is no obvious evidence which indicates chitin and chitosan could cause 
adverse reactions. However, some cases of anaphylaxis related to chitin and chitosan have 
been reported (Cleenewerck et al., 1994; Kato Y, 2005; Pereira et al., 1998). Therefore, this 
study attempts to evaluate the presence of possible allergenic protein(s) residues in chitin and 
chitosan preparations. 
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Summary of Chapter 5:  
This study focuses on the characterisation of possible residual allergenic proteins in chitin and 
chitosan. Various methods were utlized to extract the proteins from chitin and chitosan 
samples. However, due to the small amount of protein residue and the resistant property of 
tropomyosin, it is difficult to isolate the protein residue from chitin and chitosan using SDS-
PAGE and Western blot. However, the Dot blot results demonstrated that there are 
considerable quantities of the allergenic tropomyosin remaining in the chitin and chitosan 
samples. The inhibition ELISA also confirmed the immunoreaction of the protein residue in 
chitin and chitosan sample to rabbit sera which are specific to crustacean protein and shrimp 
tropomyosin. This result is consistent with the observed allergenic responses that experience 
when exposed to products containing chitin and chitosan.  
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5.2 MATERIALS AND METHODS 
5.2.1 Extraction of proteins from chitin 
5.2.1.1 Materials 
A chitin sample produced in Vietnam was used to examine its protein residue. It was donated 
by Prof. Willem F. Stevens, Mahidol University, Thailand. This is technical chitin obtained 
from shrimp waste by decalcification (using HCl) and deproteination (using 1 N NaOH). It 
has a degree of deacetylation between 5 and 15 %.  
 
5.2.1.2 Extraction methods 
5.2.1.2.1 Extraction method 1: Using a combination of chemicals 
1 g of chitin (dry basis) was treated with 20 ml of 0.2 M NaOH, 0.001 M EDTA, 0.001 M 
mercapto-ethanol at 70 
o
C for 4 hours with 5 times sonication, each time 5 seconds every 15 
minutes. Then, 5 mL of 5 M NaCl was added and incubated for 10 minutes at room 
temperature following by sonication as previous step. The mixed solution was centrifuged at 
3600 g  for 30 min at 4 
o
C. The supernatant I was collected and filtered through 0.45 µm 
cellulose acetate membrane.  This sample was named “Chitin – supernatant I”. 
 
The pellet was suspended in 20 mL of 0.2 M phosphoric acid at room temperature for 1 hour 
with 5 times sonication, each time 5 seconds for every 15 minutes. Then, 5 mL of 5 M NaCl 
was added and followed the procedure as previous step. The supernatant II was collected after 
centrifugation and filtration process. It was then run through 3 kDa ultra-filtration until reach 
3 mL residual volume. Then 5 mL of 0.1 M phosphate buffer pH 7 was added and applied 
ultra-filtration for 2 times. The collected supernatant after ultra-filtration was named “Chitin – 
supernatant II”.  Both supernatants were aliquoted in 1 mL quantities and kept at -20 oC for 
further analysis. 
 
5.2.1.2.2 Extraction method 2: Using phosphoric acid 
1 g (dry basis) chitin was soaked in 20 mL of 0.2 M phosphoric acid at room temperature for 
1 h with 5 times sonication for every 15 min, each time 5 sec. Next, 5 mL of 5 M NaCl was 
added and incubated for 10 min at room temperature following by 5 times sonication for 
every 15 min, each time 5 sec. The mixed solution was centrifuged at 3600 g  for 30 min at 4 
o
C. The supernatant I was collected filtered through 0.45 µm cellulose acetate membrane and 
estimated the protein concentration. After that, the supernatant was concentrated by running 
through the 3 kDa ultra-filtration until reach 3 mL residual volume. Then 5 mL of 0.1 M 
phosphate buffer pH 7 was added and applied ultra-filtration for 2 times. The concentrated 
supernatant after ultra-filtration was named “Chitin – phosphoric”. 
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5.2.1.3 Analytical requirements 
The protein extracts from chitin sampples were estimated for their protein concentration and 
calculated the percentage of protein loss. After that they were separated by SDS-PAGE and 
blotted onto Western blot to examine the presence of the allergenic protein tropomyosin. 
 
5.2.2 Extraction of proteins from chitosan 
5.2.2.1 Materials 
A chitosan sample produced in Vietnam was used to examine its protein residue. It was donated 
by Prof. Willem F. Stevens, Mahidol University, Thailand. This is technical chitosan obtained 
from shrimp waste by decalcification (using HCl), deproteination (using 1 N NaOH) and 
deacetylation (using 12.5 N NaOH at 70 
o
C). It has the degree of deacetylation of about 85 %.  
 
5.2.2.2 Extraction methods 
Table 5.1: Protein extraction from chitosan using different buffers 
Sample Extraction methods 
A1 
1 g chitosan was soaked in 50 mL Phosphate buffer saline pH 7.4. It was ultra-
sonicated for 5 min before shaking overnight at 4 
o
C. 
A2 
1 g chitosan was soaked in 50 mL Ammonium sulphate 50 %. It was ultra-sonicated 
for 5 min before shaking overnight at 4 
o
C.  
A3 
1 g chitosan was soaked in 50 mL 0.2 M Phosphate buffer pH 9. It was ultra-
sonicated for 5 min before shaking overnight at 4 
o
C.  
A4 1 g chitosan was dissolved in 100 mL acetic acid 1 % by shaking overnight at 4 
o
C.  
A5 Extraction A4 was adjusted to pH 10 by NaOH.  
A6 Extraction A5 was neutralised to pH 7 by HCl. 
A7 1 g chitosan was dissolved in 100 mL acetate buffer pH 4 by shaking overnight at 4 
o
C   
A8 Extraction A7 was adjusted to pH 10 by NaOH.  
A9 Extraction A8 was neutralised to pH 7 by HCl. 
A10 
Extraction A4 was adjusted to pH 8 by NaOH before adding 1 % (w/v) SDS. Next, 
it was heated at 90 
o
C for 10 min and adjusted to pH 10 by NaOH.  
A11 
Chitosan solution (A4) was adjusted to pH 8 by NaOH before adding 1 % (w/v) 
SDS and 0.2 % (w/v) DTT. Next, it was heated at 90 
o
C for 10 min and adjusted to 
pH 10 by NaOH.  
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Similar to chitin, several methods have been employed in an effort to extract the proteins from 
the chitosan sample. The methods of extraction protein from chitosan sample were described 
in Table 5.1. 
 
All the extracted protein solutions were filtered through cellulose acetate membrane 0.45 µm 
to remove all insoluble materials or precipitates. The filtrate were collected and kept at -20 
o
C 
for further analysis. 
 
5.2.2.3 Analytical requirements 
The protein extracts from chitin and chitosan sampples were evaluated by their protein 
content. They were separated by SDS-PAGE to examine their protein profiles. The 
immunoblottings of these extracts to different antibodies by Western blot, Dot blot and 
ELISA was aimed at finding the presence of the allergenic protein tropomyosin. 
 
The protein concentration of each extract was quantified by Bradford method using Quick 
Start Bradford Protein Assay (Bio-Rad) (Chapter 2 – Section 2.3.1.4). 
 
The 12% SDS polyacrylamide gel electrophoresis was used to separate the proteins in the 
protein extracts by molecular weight (Chapter 2 – Section 2.3.2). 
 
The presence of tropomyosin was examined by Western blot teachnique (Chapter 2 – Section 
2.3.3.1) and Dot blot technique (Chapter 2 – Section 2.3.3.2). The immunoblotting was 
conducted with the monoclonal antibody and sera of two patients with clinical symptoms to 
crustacean: 
- Monoclonal antibody mAbαTM: Commercial rat anti-tropomyosin insect IgG 
antibody, MAC-141 (Abcam).  
- Rabbit serum pAbαCR: Rabbit serum containing antibodies which was raised against 
the whole-cooked crustacean protein 
- Rabbit serum pAbαTM: Rabbit serum containing antibodies which was raised against 
the shrimp tropomyosin 
- Human serum AN01: Serum from patient who has allergic symptom with specific IgE 
against lobster, crab and shrimp. 
- Human serum JB21: Serum from patient who has allergic symptom with specific IgE 
against crab and shrimp. 
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The percentage inhibition (PI) of protein extracts from chitin and chitosan samples was 
examined by inhibition ELISA (Chapter 2 – Section 2.3.4.2). In this assay, the wells were first 
coated with antigen (0.01 µg/mL of purified tropomyosin for rabbit serum pAbαTM or 0.1 
µg/mL of crustacean protein for rabbit serum pAbαTM). The inhibitors were the different 
protein extracts from chitin and chitosan preparation. The inhibitor was mixed with rabbit 
serum pAbαTM or pAbαCR (depending on the coated antigen) at different concentrations 
before coating onto the wells. The goat anti-rabbit polyclonal antibody labelled with HRP was 
used as the secondary antibody. After adding TMB One-Step Substrate System, the reaction 
was stopped by HCl and the OD read at 450 µm.   
 
The percentage inhibition of each protein extract was calculated following the below formula: 
Percentage inhibition (%) = 100 x (Ymax – Y) / Ymax 
Where  Ymax: the absorbance of the well containing no inhibitor 
  Y: the absorbance of the well containing inhibitior 
 
The 50 % inhibition value of different protein extracts were recorded based on the percentage 
inhibition. 
 
 
5.2.3 Data analysis 
The experiments were conducted in triplicate. The data were analysed by Microsoft Excel 
2007 program and the analysis of variances were obtained by SPSS 17.0 programs. 
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5.3 RESULTS AND DISCUSSION 
Commercial chitin/chitosan products still contain a certain amount of proteins which are 
always stated by the manufacturer. The chitin and chitosan samples used in this study were 
extracted from shrimp in which the most dominant allergenic protein is tropomyosin. 
Therefore, this study focusses on evaluation of tropomyosin in chitin and chitosan products. 
 
Several methods have been used in order to separate the protein from the chitin and chitosan 
samples. However, the collected protein amount was too low to express distinct bands on 
SDS-PAGE and Western blots. 
 
5.3.1 Extraction of protein from chitin sample 
Chitin is a biopolymer which is hardly dissolved in normal chemical solution. On the other 
hand, the protein residue in chitin sample often less than 1 %.  Therefore, it is difficult to 
extract protein out of the chitin sample. Some methods have been employed in order to extract 
protein out of chitin sample to investigate its allergenicity. 
 
5.3.1.1 Extraction method 1 
In this method, a combination of chemical agents has been employed in order to detach 
proteins out of chitin sample. At high alkaline condition (pH >10), chitin will be more or less 
neutral while protein will be negative. The OH- of the solvent will also weaken the binding of 
the dissociated carboxylate groups of the protein and possible cationic sites on chitin. 
Mercapto-ethanol (ME) was used to open the disulfide bridges in the protein structure. 
Ethylenediaminetetraacetic acid (EDTA) can bind metal ions and so withdraws metal ions 
that might play a role in ligand formation between chitin and protein. Sonic treatment can 
assist in providing a more effective chemical treatment. Moderate amounts of salt can 
enhance the dielectric property of the solvent and weaken electrostatic forces between chitin 
and protein. Ultra-filtration was used to remove all low molecular weight material, including 
the salt prior applying in SDS-PAGE. 
 
After the extraction process as described in Section 5.2.1.2.1, the protein fractions were 
measured for volume and protein concentration. The results were presented in Table 5.2 and 
Table 5.3. 
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Table 5.2: Protein fractions extracted from chitin 
 Total volume of 
added buffer  
Volume before 
ultra-filtration 
Volume after ultra-
filtration 
Supernatant I: 
Replicate 1 
Replicate 2 
 
25 mL 
25 mL 
 
15 mL 
15.5 mL 
 
1 mL 
1.6 mL 
Supernatant II: 
Replicate 1 
Replicate 2 
 
25 mL 
25 mL 
 
21 mL 
21 mL 
 
2.4 mL 
3.1 mL 
 
Table 5.3: Protein fraction concentration (mg/mL)  
 
Before 
ultra-filtration 
After 
ultra-filtration 
Protein loss (%) 
Supernatant I: 
Replicate 1 
Replicate 2 
 
0.1646 
0.1776 
 
1.6259 
1.1953 
 
34.15 
30.52 
Supernatant II: 
Replicate 1 
Replicate 2 
 
Not detected 
Not detected 
 
0.0324 
0.0138 
 
Not available 
Not available 
 
The result in Table 5.3 showed that the protein concentration in the supernatant I is relatively 
high while the protein concentration in the supernatant II cannot be detected before ultra-
filtration and very low after ultra-filtration. This indicated that the extraction procedure of 
supernatant I could extract most of proteins in chitin sample. 
 
The protein loss after ultra-filtration was relatively high (> 30 %). This might be because the 
small molecular-weight proteins can pass through the membrane during filtration under high 
centrifugation speed. 
 
From the result obtained, the total protein content in chitin sample can be roughly estimated 
by taking the sum of protein amount of both supernatant I and II. 
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Total protein in 1g chitin = (Protein concentration before ultra-filtration x Total volume of 
added buffer) of supernatant I + (Protein concentration after ultra-filtration x Total collected 
volume after ultra-filtration) of supernatant II. 
 The amount of total protein in Replication 1: 4.1932 mg/g chitin (0.42 %  (w/w)) 
 The amount of total protein in Replication 2: 4.4824 mg/g chitin (0.45 % (w/w)) 
 
The extracted protein fractions were separated by SDS-PAGE. However, no band appeared on 
the gel. This could be because most of the protein residue in chitin had the molecular weight 
less than 10 kDa due to the deproteinization process. 
 
The gel was immunoblotted with anti-tropomyosin monoclonal antibody, rabbit anti-shrimp 
tropomyosin polyclonal antibody and rabbit anti-crustacean protein polyclonal antibody. The 
results were expressed in Figure 5.1.  
 
   
           1       2       3       4 
Monoclonal antibody 
mAbαTM 
          1       2       3      4 
Rabbit serum  
pAbαTM 
           1       2       3       4 
Rabbit serum  
pAbαCR 
Note:  1 and 2 are two replicates of Chitin - supernatant I. 
3 and 4 are 2 replicates of Chitin - supernatant II. 
The red line indicated suspected area where the allergenic protein tropomyosin can be.  
The molecular weight of tropomyosin is 32-37 kDa. However, it can exist as a dimer or a 
fragment, so it can be somewhere in the range 20-75kDa. 
Figure 5.1: Immunoblottings of proteins extracted from chitin by method 1 
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The Chitin – supernatant I (extraction with NaOH, EDTA and ME) showed significantly dark 
bands in the low molecular range of about 10 kDa compared to the Chitin – supernatant II 
(extraction with phosphoric acid). 
 
The polyclonal antibodies bind strongly to proteins at 10 kDa. At other ranges, the extracted 
protein solutions showed some bindings with polyclonal antibodies, but still unclear. In 
contrast, the monoclonal antibody did not show any binding. 
 
5.3.1.2 Extraction method 2  
In the previous method, the supernatant II which had proteins extracted in phosphoric acid 
still contained a small amount of proteins. However, the protein quantity was too small to run 
on the SDS-PAGE. Therefore, this second method tried to extract proteins in phosphoric acid 
to examine whether more proteins can be extracted. 
 
Table 5.4: Protein fractions extracted from chitin by method 2 
 Total volume of 
added buffer  
Volume before 
ultra-filtration 
Volume after ultra-
filtration 
Chitin - Phosphoric: 
Replication 1 
Replication 2 
 
25 mL 
25 mL 
 
17 mL 
17.5 mL 
 
1.94 mL 
1.62 mL 
 
Table 5.5: Protein fraction concentration (mg/ml) method 2 
Sample 
Protein concentration (mg/mL) 
Replication 1 Replication 2 
Chitin – Phosphoric - before ultra-filtration Not be detected 
Chitin – Phosphoric - after ultra-filtration 0.0446 0.0592 
Chitin – Phosphoric  < 3 kDa Not be detected 
 
This method aimed to weaken the electrostatic forces between the chitin and the proteins by 
changes in the pH. Chitin is a weak cationic compound so acidic condition (pH < 5) will make 
it positively charged. However, the protein in general will be cationic below their isoelectric 
point. Tropomyosin is an acidic protein which has the pI at 4.5 (Reese et al., 1999). 
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Therefore, acidic condition might assist to repel the protein from the chitin. In this method, 
the polyvalent phosphate ions will be beneficial for protein extraction, especially at lower pH. 
 
The sample Chitin-Phosphoric < 3 kDa is the supernatant which go through the 3 kDa ultra-
filtration membrane. The protein concentration was meaasured to check the protein loss. 
However, the protein concentration in the supernatant before ultra-filtration as well as in the 
supernatant < 3 kDa cannot be detected, so the protein loss cannot be measured. 
 
From the obtained result, the total extracted protein content from chitin sample by method 2 
can be roughly estimated as the following:  
Replication 1: 
0.0446 mg/mL  x  1.94 mL  =  0.0865 mg protein / 1g chitin (0.0087 %) 
Replication 2: 
0.0592 mg/mL  x  1.62 mL  =  0.0959 mg protein / 1g chitin (0.0096 %) 
 
The concentration of protein extracted in phosphoric acid only (< 0.01 %) was much lower 
than in the first extraction method (in NaOH + EDTA + ME) (> 0.4 %). Therefore, it can be 
assumed that the NaOH + EDTA + ME combination method was more effective than the 
phosphoric acid method in the extraction of protein from chitin sample.  
 
The concentrated protein extracted in phosphoric acid was separated by SDS-PAGE and 
compared with other extractions from method 1. However, no band appeared on the gel from 
these extractions. This could be because most of the protein residue in chitin had the 
molecular weight less than 10 kDa due to the deproteinization process. 
 
The gel was also immunoblotted with monoclonal antibody mAbαTM and two rabbit sera 
pAbαTM and pAbαCR. The results are expressed in Figure 5.2.  
 
All samples showed bands at 37 kDa when blotting with monoclonal antibody. That means 
there is tropomyosin present in these chitin extracts. Although the protein concentration in 
Chitin - phosphoric sample was much less than that in Chitin - supernatant I sample, they both 
showed stronger bands than Chitin - supernatant II sample. 
 
The samples Chitin - supernatant I and Chitin - phosphoric also showed bindings with the 
anti-tropomyosin rabbit serum at 37 kDa. Moreover, there were some bands at lower 
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molecular weight (20 - 25 kDa) at Chitin - supernatant I sample. Therefore, these bands might 
contain fragments of tropomyosin. 
 
All samples showed band at 37 kDa when blotting with the anti-crustacean protein rabbit 
serum at 37 kDa. The Chitin - phosphoric sample showed stronger band than other samples at 
37 kDa. The Chitin - supernatant I sample had strong bands at 10 kDa and 250 kDa while 
other samples also had faint bands at 10 kDa.  
 
   
      1       2       3       4 
Monoclonal antibody 
mAbαTM 
      1       2       3       4 
Rabbit serum 
pAbαTM 
         1       2      3      4 
Rabbit serum 
pAbαCR 
Note:  1. Protein extracted in NaOH+EDTA+ME (Chitin - supernatant I sample) 
 2. Protein extracted in phosphoric acid (Chitin - supernatant II sample)  
 3. Protein extracted in phosphoric acid only (Chitin - phosphoric sample) 
 4. Protein extracted from cooked Black Tiger shrimp shell  
The red line indicated suspected area where the allergenic protein tropomyosin can be.  
Figure 5.2: Immunoblottings of proteins extracted from chitin sample 
 
 
In summary, these extraction methods demonstrated the presence of tropomyosin in chitin 
samples. The extraction of protein from chitin sample can be conducted in a combination of 
NaOH, EDTA and ME or with phosphoric acid.  
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5.3.2 Extraction of protein from chitosan sample 
The extraction of proteins from chitosan sample was much more difficult than from chitin 
sample because the protein amount in chitosan samples is even less than that in chitin. Most 
deproteination methods might also lead to the destruction of the protein of interest, although 
protein allergens might be extra resistant.  
 
Several methods have been employed in an effort to extract the proteins from chitosan sample 
(Table 5.1). The deproteination has been tried on the solid chitosan as well as on dissolved 
chitosan in acetic acid. The deproteination on the solid chitosan has the advantage that 
chitosan can be removed easily out of the solution by filtration. On the other hand, the 
deproteination on dissolved chitosan in acetic acid can affect proteins located in the interior of 
the chitosan particle.  
 
The chitosan No. 1 has been used for this experiment. The protein concentration in each 
extraction has been measured to examine which method was more effective (Table 5.6).  
 
Table 5.6: Protein concentration (%, w/w) of extractions from chitosan sample 
Sample Original extractions Concentrated extractions 
A1 0.0624 ± 0.0103 0.0029 
A2 0.1311 ± 0.0178 0.0258 
A3 0.1102 ± 0.0150 0.0125 
A4 0.6736 ± 0.0692 Not available 
A5 0.3081 ± 0.0476 0.0355 
A6 0.2454 ± 0.0450 0.0167 
A7 1.0222 ± 0.0940 Not available 
A8 0.2719 ± 0.0267 0.0413 
A9 0.2287 ± 0.0428 0.0327 
A10 0.0516 ± 0.0045 Not available 
A11 0.1228 ± 0.0321 Not available 
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The results in Table 5.6 showed that samples A4, A5, A7 and A8 got higher amount of 
proteins than other samples. However, the samples A2, A4 and A7 cannot be separated by 
SDS-PAGE due to high amount of salt or acidic condition. All samples showed no band after 
applying on SDS-PAGE. 
 
After those samples were concentrated by ultra-filtration with 3 kDa molecular weight cut-off, 
the protein concentration was droped even more to 5-20 times lower. That could be because 
most of the proteins were degraded and break down into small fragments. Due to little amount 
of proteins, these samples also showed no bands on the SDS gel. 
 
The protein extractions were immunoblotted with the monoclonal antibody mAbαTM to see if 
there is any presence of tropomyosin in those extracts (Figure 5.3). 
 
 
     1      2      3      4       5      6       7      8      9     10     11     C2      C1 
Note:  C1: Control – Black Tiger Shrimp Tail protein extract 
 C2: Control – Black Tiger Shrimp Shell protein extract 
 1 11: Protein extracts A1  A11 from chitosan (Table 5.1) 
Figure 5.3: Immunoblotting of different protein extracts from chitosan with the monoclonal 
antibody mAbαTM 
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There were some smears on the blot from the extractions A8, A10 and A11 at the position of 
25 - 37 kDa. Therefore, it can be assumed that there could be the presence of tropomyosin in 
these extractions. The sodium hydroxide seemed to be effective in isolating protein and 
chitosan (sample A8). The result of samples A10 and A11 showed that the combination of 
sodium hydroxide, SDS and DTT might be able to extract protein from chitosan sample to 
examine its allergenicity. 
 
5.3.3 Immunoblottings of proteins extracted from chitin and chitosan 
 
Table 5.7: Methods of extraction protein from chitin and chitosan samples 
No. Extraction methods description 
1 1 g chitosan was dissolved in 100 mL acetate buffer pH 4 by shaking overnight at 
4 
o
C. 
2 1 g chitosan was dissolved in 100 mL acetate buffer pH 4 by shaking overnight at 
4 
o
C. It was adjusted to pH 8 by NaOH before adding 1 % (w/v) SDS and 0.2 % 
(w/v) DTT. Next, it was heated at 90 
o
C for 10 minutes and adjusted to pH 10 by 
NaOH.  
3 1 g of chitin / chitosan was treated with 20 mL of 0.2 M NaOH, 0.001 M EDTA, 
0.001 M mercapto-ethanol at 70 
o
C for 4 hours with 5 times sonication, each time 
5 seconds every 15 minutes. Then, 5 mL of 5 M NaCl was added and incubated 
for 10 minutes at room temperature following by sonication as previous step. The 
mixed solution was centrifuged at 3600 g  for 30 minutes at 4 
o
C. The supernatant 
was collected and filtered through 0.45 µm cellulose acetate membrane.  It was 
then run through 3 kDa ultra-filtration for concentration and changed to phosphate 
buffer pH 7.   
4 1 g chitosan was treated with 20 mL of 0.2 M phosphate buffer pH 9, 0.001 M 
EDTA, 0.001 M mercapto-ethanol at 70 
o
C for 4 hours with 5 times sonication, 
each time 5 seconds every 15 minutes. Then, 5 mL of 5 M NaCl was added and 
incubated for 10 minutes at room temperature following by sonication as previous 
step. The mixed solution was centrifuged at 3600 g  for 30 minutes at 4 
o
C. The 
supernatant was collected and filtered through 0.45 µm cellulose acetate 
membrane.  It was then run through 3 kDa ultra-filtration for concentration and 
changed to phosphate buffer pH 7.   
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No. Extraction methods description 
5 20 mL of 0.2 M NaOH, 0.001 M EDTA, 0.001 M mercapto-ethanol at 70 
o
C for 4 
hours with 5 times sonication, each time 5 seconds every 15 minutes. Then, 5 mL 
of 5 M NaCl was added and incubated for 10 minutes at room temperature 
following by sonication as previous step. The mixed solution was centrifuged at 
3600 g  for 30 minutes at 4 
o
C. The pellet was suspended in 20 mL of 0.2 M 
phosphoric acid at room temperature for 1 hour with 5 times sonication. Then, 5 
mL of 5 M NaCl was added and incubated for 10 minutes at room temperature 
following by sonication. The mixed solution was centrifuged at 3600 g  for 30 
minutes at 4 
o
C. The collected supernatant was then run through 3 kDa ultra-
filtration for concentration and changed to phosphate buffer pH 7.   
6 1 g chitin was soaked in 20 mL of 0.2 M phosphoric acid at room temperature for 
1 hour with 5 times sonication, each time for 5 seconds, for every 15 minutes. 
Next, 5 mL of 5 M NaCl was added and incubated for 10 minutes at room 
temperature following by sonication. The mixed solution was centrifuged at 3600 
g  for 30 minutes at 4 
o
C. The supernatant was collected and filtered through 0.45 
µm cellulose acetate membrane. It was then run through 3 kDa ultra-filtration for 
concentration and changed to phosphate buffer pH 7.   
 
 
From the prior trial extractions, the chitin and chitosan samples were extracted again using the 
most effective methods from above with modification. The detail extraction methods were 
described in Table 5.7.  
 
Two types of immunoblotting methods have been carried out, the Western blot and the Dot 
blot. The PVDF membrane was used in Western blot while the nitro-cellulose membrane was 
used in Dot blot. The advantage of the Dot blot is that viscous samples such as chitosan 
solution can be applied easily onto the membrane. 
 
Due to the high viscosity and high acidic condition, the chitosan solutions cannot be applied 
in SDS-PAGE. The fish (Baramundi) sample was used as a negative control in Dot blot.  
 
  
108 
 
Table 5.8: List of sample preparation for immunoblotting 
No Sample code Extraction method 
1 CTS1-Acetate Chitosan No. 1, extraction method 1  
2 CTS1-SDS-DTT Chitosan No. 1,  extraction method 2 
3 CTS1-NaOH Chitosan No. 1,  extraction method 3 
4 CTS1-Phosphate Chitosan No. 1,  extraction method 4 
5 CTS2- Acetate Chitosan No. 2, extraction method 1  
6 CTS2-SDS-DTT Chitosan No. 2,  extraction method 2 
7 CTS2-NaOH  Chitosan No. 2,  extraction method 3 
8 CTS2-Phosphate Chitosan No. 2,  extraction method 4 
9 CT-Supernatant I Chitin No. 1,  extraction method 3 
10 CT-Supernatant II Chitin No. 1,  extraction method 5 
11 CT-Phosphoric Chitin No. 1,  extraction method 6 
12 TROP 
Mixed purified tropomyosin from 4 shrimp species: 
Banana, School, Vannamei and Black Tiger 
13 CRUS 
Mixed proteins extracted from Black Tiger shrimp, Mud 
crab, and Morton Bay Bug 
 
 
Different types of antibodies were used in this experiment. They were: 
- Monoclonal antibody mAbαTM: Commercial rat anti-tropomyosin IgG antibody, 
MAC-141 (Abcam). 
- Rabbit serum pAbαTM: Rabbit serum pAbαTM containing antibodies which was 
raised against the shrimp tropomyosin  
- Rabbit serum pAbαCR: rabbit serum pAbαCR containing antibodies which was raised 
against the whole-cooked crustacean protein 
- Human serum AN01: Serum from patient who has allergic symptoms with specific 
IgE against lobster, crab and shrimp.  
- Human serum JB21: Serum from patient who has allergic symptoms with specific IgE 
against crab and shrimp. 
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Table 5.9: SDS-PAGE and Western Blot design for immunoblottings of proteins extracted 
from chitin and chitosan 
No Sample 
1 Marker 
2 CTS1-NaOH (Double loaded) 
3 CTS1-Phosphate (Double loaded) 
4 CTS2-NaOH (Double loaded) 
5 CTS2-Phosphate (Double loaded) 
6 CT-Supernatant I (Double loaded) 
7 CT-Supernatant II (Double loaded) 
8 CT-Phosphoric (Double loaded) 
9 TROP (2.5 g/well) 
10 CRUS (2.5 g/well) 
 
  
Table 5.10: Dot blot design for immunoblottings of proteins extracted from chitin and 
chitosan 
Sample 
Triplicates Triplicates Triplicates 
1 2 3 4 5 6 7 8 9 
A TROP 1 µg/ml CTS1- Acetate CTS2- Acetate 
B TROP 10 µg/ml CTS1-SDS-DTT CTS2-SDS-DTT 
C TROP 100 µg/ml CTS1-NaOH CTS2-NaOH 
D CRUS 1 µg/ml CTS1-Phosphate CTS2-Phosphate 
E CRUS 10 µg/ml CT-Supernatant I CT-Phosphoric 
F CRUS 100 µg/ml CT-Supernatant II Fish (Baramundi) 
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5.3.3.1 SDS-PAGE of protein extractions from chitin and chitosan 
 
 
 
     1            2         3          4         5         6          7         8         9       10 
Note:  The red area indicates tropomyosin range 
 
Figure 5.4: The SDS-PAGE of protein extractions from chitin and chitosan 
 
Four extractions from chitosan samples and three extractions from chitin sample have been 
run through the SDS-PAGE (Figure 5.4). Due to their low protein concentration, these 
samples were double loaded (40 µL/well) into the wells in order to have more proteins for the 
SDS-PAGE. 
 
The resulted gel showed that no visible band could be seen from chitosan extractions. This 
could be because the protein concentrations in these extractions were too low to be detected 
on SDS-PAGE.  
 
Lane 6, which was the position of chitin supernatant I sample, presented a smear column from 
the top to the end of the gel without any distinct band. Lane 8, which was the position of 
chitin supernatant I sample, presented a smear around 250 kDa. The results proved that chitin 
sample still contain certain amount of protein. 
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5.3.3.2 Immunoblottings of protein extractions from chitin and chitosan with 
monoclonal antibody mAbαTM 
 
Dot blot Western blot 
   
      1      2     3     4     5     6     7     8     9        1      2      3      4      5      6     7    8     9   10 
                   Chitosan               Chitin 
 
Note:  The red area indicates tropomyosin range. 
Figure 5.5: The immunoblottings of protein extracts from chitin and chitosan with 
monoclonal antibody mAbαTM 
 
In the Western blot, there were very dark bands at 37 kDa of purified tropomyosin and whole 
cooked crustacean protein. It indicated the strong bindings between tropomyosin in the 
shrimp extracts with the monoclonal antibody mAbαTM. More important, there was the 
presence of a cloud at the position of chitosan samples in the range of 20 - 37 kDa. This could 
be because of the binding of protein in chitosan samples with the monoclonal antibody. There 
were also faint bands at the position of chitin samples but at lower molecular weight (10 – 20 
kDa).  
 
The result from the Western blot was strongly confirmed by Dot blot. There were very strong 
reactions with the monoclonal antibody mAbαTM from both chitosan samples which were 
dissolved in Acetate buffer pH 4. The intensity of the dots from these samples was even more 
than the 100 µg/ml tropomyosin or crustacean protein. There was also positive response from 
chitosan samples with extraction method 3 and 4. The chitin-supernatant I preparation also 
showed strong binding to the monoclonal antibody The dot intensity was equivalent to the 10 
µg/ml tropomyosin or crustacean protein. 
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5.3.3.3 Immunoblottings of protein extracts from chitin and chitosan with rabbit serum 
pAbαCR 
 
 
Dot blot Western blot 
 
  
    1      2      3      4      5       6      7      8     9         1     2     3     4     5      6      7      8      9   10 
                   Chitosan             Chitin 
 
Note:  The red area indicates tropomyosin range. 
Figure 5.6: The immunoblottings of protein extracts from chitin and chitosan with rabbit 
serum pAbαCR 
 
In the Western blot, the rabbit serum pAbαCR did not show much response to chitosan 
preparations. However, it expressed strong bindings with protein extracts from chitin samples 
(lane 6). Although the bands were not very distinct, there were visible bands at the range of 37 
kDa which may indicate the presence of tropomyosin.  
 
In the Dot blot, there were very faint intensity dots with chitosan No.1 – NaOH and phosphate 
extractions. However, there was strong reaction between the pAbαCR and the chitin – 
supernatant I with high intensity dots which equivalent to about 10 µg/ml tropomyosin or 
crustacean protein. 
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5.3.3.4 Immunoblottings of protein extracts from chitin and chitosan with rabbit serum 
pAbαTM 
 
Dot blot Western blot 
 
 
 
      1     2      3      4      5      6      7     8      9        1     2     3    4    5     6      7      8     9    10 
                Chitosan            Chitin 
 
Note:  The red area indicates tropomyosin range. 
Figure 5.7: The immunoblottings of protein extracts from chitin and chitosan with rabbit 
serum pAbαTM 
 
In the Western blot, there was not much response from chitosan samples. However, the chitin-
supernatant I showed a dark column with some distinct bands at 250 and 10 kDa positions. 
There were also bands at 10 kDa of the chitin preparations (lane 6 – 8) which might contain 
fragments of tropomyosin.  
 
In the Dot blot, the rabbit anti - purified shrimp tropomyosin serum only recognised the 
chitosan – NaOH and chitosan - phosphate preparations with low intensive dots (less than 1 
µg/ml tropomyosin or crustacean protein). The chitin-supernatant I preparation also showed 
strong reaction to the rabbit serum. The dot intensity was equivalent to about 10 µg/ml 
tropomyosin or crustacean protein. 
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5.3.3.5 Immunoblottings of protein extracts from chitin and chitosan with human serum 
AN01 
 
Dot blot Western blot 
 
  
    1      2      3     4      5      6      7      8     9        1      2      3     4     5      6     7      8      9   10 
                 Chitosan              Chitin 
 
Note:  The red area indicates tropomyosin range. 
Figure 5.8: The immunoblottings of protein extractions from chitin and chitosan with human 
serum AN01 
 
Human serum AN01 was donated from a patient who has urticarious allergic reaction to 
lobster, crab and shrimp. The results in Figure 5.8 showed that the serum had positive reaction 
to both chitosan and chitin sample (lane 2, 6), especially chitosan No. 1.  
 
In the dot blot, sample CTS – acetate, CTS – NaOH, CTS – phosphate, CT – supernatant II 
and CT – phosphoric showed intensive black dots compared to the purified tropomyosin and 
crustacean protein. The result indicated that human serum AN01 was very sensitive to protein 
in the chitin and chitosan samples. This also might be due to the presence of tropomyosin in 
these samples. 
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5.3.3.6 Immunoblottings of protein extractions from chitin and chitosan with human 
serum JB21 
 
Dot blot Western blot 
 
 
 
     1      2     3      4     5     6      7     8     9         1      2      3     4      5       6     7     8      9   10 
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Note:  The red area indicates tropomyosin range. 
Figure 5.9: The immunoblottings of protein extractions from chitin and chitosan with human 
serum JB21 
 
Human serum JB21 was donated from a patient who has anaphylaxis allergic reaction to crab 
and shrimp. The immunoblotting of this serum with chitin and chitosan samples did not show 
many bindings, except sample CTS2 – phosphate which showed some faint bands at around 
250 kDa (lane 5).  
 
However, very large and intensive dots could be seen from the Dot blot of both chitin and 
chitosan samples. This result indicated that there were very strong reactions between human 
serum JB21 and protein in chitin and chitosan samples.  
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5.3.3.7 Summary of immunoblottings between protein extractions from chitin and 
chitosan with different antibodies by Western blot and Dot blot 
The antibodies were coded as the followings: 
- A : Monoclonal antibody mAbαTM 
- B : Rabbit serum pAbαCR 
- C : Rabbit serum pAbαTM 
- D : Human serum AN01 
- E : Human serum JB21 
 
In the Western blot, the immunoblotting reaction between protein extractions from chitin and 
chitosan with different antibodies was recorded as positive (+) or negative (-). 
 
Table 5.11: The immunoblotting reaction between protein extractions from chitin and 
chitosan with different antibodies by Western blot 
Antibodies 
Samples 
A B C D E 
CTS1 – Acetate NA NA NA NA NA 
CTS1 – SDS – DTT NA NA NA NA NA 
CTS1 – NaOH + - - + - 
CTS1 – Phosphate + - + - - 
CTS2 – Acetate NA NA NA NA NA 
CTS2 – SDS – DTT NA NA NA NA NA 
CTS2 – NaOH + - + - - 
CTS2 – Phosphate + - - - + 
CT – Supernatant I + + + + - 
CT – Supernatant II + + + - - 
CT - Phosphoric + + + + - 
Note:  NA: not available     +: possitive reaction   -: negative reaction 
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In the Dot blot, the immunoblotting reaction between protein extractions from chitin and 
chitosan with different antibodies was compared to the reaction of TROP and CRUS 
standards and symbolised as the following scale:  
0: no reaction 
1: the reaction was less than the reaction of 1 µg/mL TROP or CRUS 
2: the reaction was equivalent to the reaction of 1 µg/mL TROP or CRUS 
3: the reaction was equivalent to the reaction of 10 µg/mL TROP or CRUS 
4: the reaction was equivalent to the reaction of 100 µg/mL TROP or CRUS 
5: the reaction was more than the reaction of 100 µg/mL TROP or CRUS 
 
Table 5.12: The immunoblotting reaction between protein extractions from chitin and 
chitosan with different antibodies by Dot blot 
Antibodies 
Samples 
Compared to TROP Compared to CRUS 
A B C D E A B C D E 
CTS1 – Acetate 5 0 0 4 5 5 0 0 5 4 
CTS1 – SDS – DTT 0 0 1 0 0 0 0 1 1 0 
CTS1 – NaOH 2 1 1 4 4 2 2 1 4 4 
CTS1 – Phosphate 1 1 1 3 4 2 2 1 4 4 
CTS2 – Acetate 5 0 0 0 4 5 0 0 1 3 
CTS2 – SDS – DTT 0 0 1 0 0 0 0 1 1 0 
CTS2 – NaOH 1 1 1 2 2 1 1 1 3 2 
CTS2 – Phosphate 1 1 0 3 2 2 1 0 4 2 
CT – Supernatant I 2 2 3 5 2 3 2 3 5 2 
CT – Supernatant II 0 0 0 5 5 0 0 0 5 5 
CT - Phosphoric 1 0 0 0 5 1 0 0 0 5 
 
Overall, the data indicated that tropomyosin in addition to other proteins can be detected in 
the chitin and chitosan preparation by a combination of antibodies with different specificity. 
 
In the Western blot, positive bindings could be seen in both chitin and chitosan samples. 
Chitin samples had reactions with almost all antibodies, except the human serum JB21. The 
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reactions of chitosan samples were weak and probably due to the presense of less IgE 
antibody in this patients serum. 
 
However, importantly the dot-blots were very positive. The two chitosan preparations 
of CTS1 - Acetate and CTS2 - Acetate were very strong in the monoclonal antibody dot blots 
and both patient sera. The Chitin – Supernatant I preparation came strong up with all five 
antibodies. 
 
The monoclonal antibody is specific to tropomyosin from insects. However, the dot-blots and 
Western blots confirmed that the tropomyosin of crustacean was also recognised, based on 
their molecular similarity. 
 
The rabbit anti-shrimp tropomyosin and anti-crustacean protein detected both tropomyosin as 
well as other proteins in crustaceans. The specific recognition was shown in the two controls, 
TROP and CRUS, as well as the concentration - dependent increase of reactivity in the dot-
blot. Both antibodies recognised proteins in chitin and chitosan. 
 
In the patient serum, IgE antibody reactivity was examined. Both patients detect tropomyosin 
in the control extracts. These antibody responses are always not very strong as a very small 
quantity of this specific antibody is produced in allergic patients. Importantly very strong 
reactivity was demonstrated in the dot-blots of both chitin and chitosan samples.  
 
The advantage of the Dot blot to the Western blot is that even small antibody binding proteins 
can be detected, as the SDS gel does not separate well below 10 kDa. Secondly, probably 
more important, is that the different pH and salt conditions have a negative effect on the 
separation of proteins eluted from the different preparations. An argument for this would be 
that there were actually no proteins seen on the SDS-gel. Also, tropomyosin can form dimers 
or polymers and it is very possible that smaller fragments bind antibody. It has been shown 
that tropomyosin of brown shrimp has about 8 IgE antibody binding sites which are only 10-
20 amino acid long (Leung et al., 1994). This would mean that tropomyosin -fragment of 
1000-2000 kDa could still bind antibodies, but can not be detected using conventional protein 
separation by SDS-gel electrophoresis. However, these smaller tropomyosin protein 
fragments are still detectable by dot-blot and therefore the preferred method. 
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5.3.3.8 Inhibition ELISA of protein extractions from chitin and chitosan with rabbit sera 
 
 
Figure 5.10: Percentage inhibition of protein extracts from chitin and chitosan samples to 
rabbit serum pAbαCR 
 
 
The results in Figure 5.10 and 5.11 showed that the percentage inhibition of chitin and 
chitosan samples increased with the increase of the inhibition concentration. The percentage 
inhibition values of these samples were different significantly at p < 0.05 (Appendix – 
Chapter 5, Table A.5.2 and Table A.5.4). 
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Figure 5.11: Percentage inhibition of protein extracts from chitin and chitosan samples to 
rabbit serum pAbαTM 
 
 
The percentage inhibition of the rabbit serum pAbαTM was higher than the rabbit serum 
pAbαCR. When comparing the 50 % inhibition values of the rabbit serum pAbαTM one can 
clearly see that much more tropomyosin was present in most of the extracts, inhibition over 
50 % of the binding already at 0.01 µg/mL. In contrast the 50% inhibition values of the rabbit 
serum pAbαCR was in the range from 0.5 to 3 µg/mL of several extracts only. This indicated 
that the different extraction preparations contain about 10-fold different amounts of 
crustacean proteins. 
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5.4 GENERAL DISCUSSION AND CONCLUSION 
Many methods have been tried to isolate and identify the residual proteins in chitin and 
chitosan samples. However, they were not successful. There are many possibilities that make 
it hard to separate proteins from chitin and chitosan sample. Firstly, the residual proteins must 
be combined tightly in the structure of the chitin and chitosan powder, so they can survive 
after treatment with high acidic and alkaline solutions during their extraction. The second 
reason could be related to the solubility of chitin and chitosan. Chitin cannot dissolve in 
normal solution (Pillai et al., 2009; Sannan et al., 1975); if strong chemicals were used to 
dissolve chitin, harsh environment will break down the residual proteins. On the other hand, 
chitosan can dissolve in light acidic condition; however this solution is too viscous to run 
through the filter to separate proteins. Chitosan solutions are also very sticky that they cannot 
be separated by SDS-PAGE. Another reason could be because most of the proteins remaining 
in the chitin and chitosan were degraded and broken down into small fragments during 
extraction from the shrimp shell, so they cannot be separated by SDS-PAGE and Western 
blot.  
 
Although this study cannot isolate the residual proteins from the chitin and chitosan, it can 
demonstrate the presence of tropomyosin in these samples. The immunoreactivities of the 
chitin and chitosan protein preparation were very strong when analysing by Dot blot. It is 
because antibodies can interact with residual proteins while they were still in combination 
with chitosan as well as they can recognise small fragments of proteins.  
 
The IC50 values of these extracts, ussing the rabbit serum pAbαTM, were also obtained at 
very low concentration of inhibitor (approximately 0.01 %). This result demonstrated that 
small fragments of residual protein in chitin and chitosan products may act as an antigen. 
When these allergens bind to the high-molecular-weight chitin and chitosan molecules, they 
can possible cause allergic reaction in sensitized patients. 
 
Overall, the data in this chapter demonstrated the presence of tropomyosin protein in chitin 
and chitosan extracted from shrimp shell. Therefore, special care should be taken when using 
chitin and chitosan in food or medical preparations. Warning statements should state clearly 
the presence of tropomyosin in products derived from chitin or chitosan, especially when the 
consumers are sensitised to crustaceans. 
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Chapter 6 
CHARACTERIZATION OF THE BIOCHEMICAL AND 
ANTIBACTERIAL PROPERTIES OF CHITIN AND 
CHITOSAN 
 
 
6.1 INTRODUCTION 
Crustacean shell waste contains 20 - 30% of chitin which can be extracted to be a more 
valuable product (Kandra et al., 2012; Kurita, 2006; Stevens, 2005). The amount of chitin in 
marine sources worldwide is currently about 1560 million tons (Agulló et al., 2003), of which 
over 50 thousand tons will be commercially produced by 2012 (eMediaWire, 2008). The 
world market for chitin is estimated at USD 1 billion per year (Archer and Russell, 2008). 
Shrimp shell products such as chitin, chitosan and glucosamine from the seafood industry can 
be used in the production of functional foods, pharmaceutics and cosmetics due to their 
excellent characteristics such as biochemical, absorption, film-forming and anti-microbial 
properties (Agulló et al., 2003; Alishahi and Aïder, 2011; Coma et al., 2003; Dutta et al., 
2009; Helander et al., 2001; Hudson and Jenkins, 2002; Kurita, 2006; Muzzarelli and 
Muzzarelli, 2005; Muzzarelli, 1983; No et al., 2007; Rabea et al., 2003; Ravi Kumar, 2000; 
Rinaudo, 2006; Stevens, 2005; Zheng and Zhu, 2003). 
 
The anti-microbial property of chitosan is based on the binding between cation groups on 
chitosan molecules to the negative group on the outer membrane of the bacteria. This reaction 
changes the permeability of the cells as well as inhibits the production of toxin and microbial 
growth (Cuero et al., 1991; Rabea et al., 2003). This property depends on the molecular 
weight, degree of deacetylation of chitosan and the pH of chitosan solution (No et al., 2002; 
Rabea et al., 2003). There have been many studies on the application of anti-microbial 
properties of chitosan in the preservation of food (Darmadji and Izumimoto, 1994; 
Devlieghere et al., 2004; Friedman and Juneja, 2010; Kanatt et al., 2008a, 2008b; Simpson et 
al., 1997).  
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The aim of work described in this chapter is to examine some properties of chitin and chitosan 
samples and compare the anti-microbial properties of normal and purified chitosan for 
application in preservation of food. 
 
 
Summary of Chapter 6:  
This chapter contains four main parts: 
 
The first part focuses on the characterization of the biochemical properties of some 
commercial chitin and chitosan products. All samples were examined the following 
properties: moisture content, ash content, heavy metal content, and protein content. The 
results indicated that these chitin and chitosan samples have acceptable biochemical 
properties that are suitable for application in food industry. 
 
The second part examined the antimicrobial property of normal chitosan at different chitosan 
concentrations against two types of bacteria, Gram negative (Escherichia coli) and Gram 
positive (Staphylococcus aureus) bacteria. The results showed that chitosan at 0.05 % and 0.1 
% concentration can inhibit totally the development of both E. coli and S. aureus after 4 hours 
of incubation. 
 
The third part compared the antimicrobial properties between normal chitosan and purified 
chitosan by MIC, MBC and Disc diffusion methods. The results demonstrated that purified 
chitosan retains its antimicrobial property compared to the normal chitosan. 
 
The last part compared the antimicrobial property between normal chitosan and purified 
chitosan by application in the preservation of shrimp. Both normal and purified chitosan can 
reduce the development of bacteria on shrimps during 15 days of storage at 0 – 4 oC while 
controlling their weight loss and hardness better than the non-treated shrimps. 
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6.2 MATERIALS AND METHODS 
6.2.1 Characterization of biochemical properties of some chitin and chitosan products 
6.2.1.1 Chitin and chitosan samples 
All the samples were obtained from Prof. Willem F. Stevens, Mahidol University, Thailand. 
 
Table 6.1: Chitin and chitosan samples 
No. Sample Product description 
1 
Chitin 
(CT1) 
This is technical chitin which was produced in a research institution 
in Viet Nam. It is obtained from shrimp waste by decalcification 
(using HCl) and deproteination (using 1 N NaOH). It has the degree 
of deacetylation between 5 and 15 %. 
2 
Chitin 
(CT2) 
This is produced in Mahidol University, Thailand. It has the degree 
of deacetylation between 5 and 15 %. 
3 
Chitin 
(CT3) 
This is produced in Mahidol University, Thailand. It has the degree 
of deacetylation between 5 and 15 %. 
4 
Chitosan 
(CTS1) 
This is technical chitosan made in Viet Nam obtained from technical 
chitin using 12.5 N NaOH at 70 
o
C.  
5 
Chitosan 
(CTS2) 
 This is high quality technical chitosan made in India. Its degree of 
deacetylation is about 85 %.   
6 
Chitosan 
(CTS3) 
This is purified chitosan made from Mahidol University, Thailand. 
Its degree of deacetylation is about 85%. This protein-free chitosan 
was made by dissolution of the chitosan in diluted acetic acid, 
followed by precipitation using NaOH, neutralization and drying.  
 
 
6.2.1.2 Analytical requirements 
Chitin samples were examined their moisture content, ash content, and heavy metal content. 
Chitosan samples were examined the following properties: moisture content, ash content, 
heavy metal content, and protein content.  
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6.2.1.2.1 Moisture content 
The moisture content of the chitin and chitosan samples were examined using the drying 
method as described in Chapter 2 – Section 2.3.1.1 
 
6.2.1.2.2 Ash content 
The standard AOAC method (AOAC, 2000) described in Chapter 2 – Section 2.3.1.2 was 
performed to measure the ash content of the chitin and chitosan samples. 
 
6.2.1.2.3 Heavy metal content 
The heavy metal contentof the chitin and chitosan samples was measured by the atomic 
absorption spectroscopy (AAS) method following the ACIAR procedure (Australian Centre 
for International Agricultural Research, 2007). This test was conducted by the Institute of 
Biotechnology and Environment, Nong Lam University, Ho Chi Minh City, Vietnam. 
 
6.2.1.2.4 Protein content: Bradford assay (as described in Chapter 2 – Section 2.3.1.4) 
 
6.2.2 Characterization of the antimicrobial property of normal chitosan  
The aim of this experiment was to determine the concentration of chitosan at which it can 
inhibit the growth of bacteria.  
 
The antimicrobial property of normal chitosan was investigated at different chitosan 
concentrations and on two types of bacteria, Gram negative (Escherichia coli) and Gram 
positive (Staphylococcus aureus) bacteria. 
 
Two methods have been used in this experiment: 
 
- Method 1: Evaluation of antimicrobial ability of chitosan by spectrophotometric methods. 
This method was performed to monitor the growth kinetics of each bacterium in different 
chitosan solution concentrations. 
 
- Method 2: Evaluation of antimicrobial ability of chitosan by the plate count method. This 
method was performed to examine the viable cell count of each bacterium in different 
chitosan solution concentrations. 
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6.2.2.1 Materials and chemicals 
Chitosan: 85 % DD; 1.08 MDa, made in Vietnam. 
1 % acid acetic 
5 N NaOH   
Sterilised 0.85 % NaCl 
Microbial cultures: Escherichia coliandStaphylococcus aureus obtained from Medical 
University, Ho Chi Minh city, Vietnam. They were kept in nutrient agar slants at 4 
0
C.  
Nutrient broth (NB) media (HiMedia Laboratories, India) 
Mueller Hinton agar (MHA) (HiMedia Laboratories, India)  
 
6.2.2.2 Methodology 
Preparation of chitosan solutions: Determined amounts of chitosan powder were dissolved 
into 1 % acetic acid solution to make 100 mL of chitosan solutions. These solutions were then 
filtered to remove insoluble particles, adjusted to pH 5.5 by 5 N NaOH, and autoclaved at 121 
o
C for 15 minutes.  
 
Preparation of the bacterial enrichment broth: A loop of bacteria was transferred from a slant 
to 10 mL of Nutrient Broth and incubated at 37 
o
C for 18 hours. 
 
The experiment was carried out using the modified protocol from previous studies (Darmadji 
and Izumimoto, 1994; Stubbings et al., 2004). 100 mL of chitosan solutions at 0 %, 0.01 %, 
0.05 % and 0.1 % concentration were prepared as the above description. After that, 0.1 % of 
the enriched bacterial cultures (Escherichia coli and Staphylococcus aureus) were added and 
incubated at 37 
o
C.  
 
The optical density of the mixed solution at 660 nm after 0, 4 and 24 hours was recorded to 
monitor the growth of each bacterium.  
 
At the same time, the viable cell count of each bacterium in different chitosan solution was 
also determined by the aerobic plate count method (Maturin and Peeler, 2001) which is 
described in Chapter 2 – Section 2.3.7.  
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From the viable cell count results, the inhibition rate of chitosan solution was determined as 
the following formula: 
 
η =    x 100 % 
 
Where  η:  inhibition rate of chitosan solution (%) 
N1: number of colonies of the control sample (without chitosan) 
N2 : number of colonies of the sample (with chitosan)  
 
 
6.2.3 Comparison of the antimicrobial property between normal chitosan and purified 
chitosan 
6.2.3.1 Materials and chemicals 
- Normal chitosan (85 % DD, HMW) and purified chitosan (85 % DD, HMW) were 
provided by Prof. Willem F. Stevens, Mahidol University, Thailand. 
- Test micro-organisms (Escherichia coli ATCC 25922 and Staphylococcus aureus 
ATCC 25923) were provided by the Microbiology lab, School of Applied Sciences, 
RMIT University. 
- Mueller-Hinton broth and agar 
- Glacial acetic acid 
 
6.2.3.2 Methodology 
The comparison of the antimicrobial property between normal chitosan and purified chitosan 
was conducted using the antimicrobial susceptibility tests. These tests were performed 
following the micro-dilution method and disc diffusion method described by the National 
Committee of Clinical Laboratory Standards (CLSI, 2006a). The tests were run in triplicate. 
 
The normal chitosan and purified chitosan samples were examined and compared to each 
other based on the minimum inhibition concentration (MIC), minimum bactericidal 
concentration (MBC) and disc diffusion test results to two standard test micro-organisms: the 
Gram negative Escherichia coli ATCC 25922 and the Gram positive Staphylococcus aureus 
ATCC 25923. These methods were described in Chapter 2 – Section 2.3.6. 
 
  
N1 – N2 
______________________________________________________  
N1 
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6.2.4 Comparison of the antimicrobial activity of normal and purified chitosan in the 
preservation of raw shrimp tissue 
6.2.4.1 Materials 
Black Tiger shrimps (Penaeus monodon) with the size of 30-40 items / kg were bought at 
Vietnamese market as fresh. They were kept on ice (< 4 
o
C) during transportation and 
processing. 
 
  
Fresh Black Tiger shrimp Shrimp kept in ice (0-4
o
C) 
Figure 6.1: Black Tiger shrimps (Penaeus monodon) 
 
Normal and purified chitosan were used in this experiment. An amount of 0.5 g chitosan (dry 
basis) was dissolved in 100 mL of 1.5 % acetic acid and its solution was filtered to remove all 
insoluble particles. Their pH was adjusted to 5.5 prior conducting the experiment. 
 
6.2.4.2 Methodology  
Pre-treatment: The fresh shrimpswere peeled with tail-on and then washed with sterilised 
NaCl 0.85 %. 
 
 
Figure 6.2: Pre-treated shrimp 
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Four treatments were examined in this experiment: 
- Shrimps were soaked into normal chitosan solution (0.5 % Chitosan in 1.5 % acetic 
acid solution) (nCTS) 
- Shrimps were soaked into purified chitosan solution (0.5 % Chitosan in 1.5 % acetic 
acid solution) (pCTS)  
- Shrimps were soaked into 1.5 % acetic acid solution (Acetic) 
- Non-treated shrimps (Control) 
 
The soaking time was 5 minutes for each treatment. After that, all treated shrimps were kept 
dry in the freezer 5 minutes before being put on trays, wrapped and stored in the fridge (0 – 4 
o
C) (Figure 6.3). Three trays of shrimp were taken out for analysis after 5, 10 and 15 days of 
storage. 
 
6.2.4.3 Analytical requirements 
The shrimp treatments were examined for their weight loss, texture and total plate counts 
before storage and after 5, 10 and 15 days of storage.  
 
6.2.4.3.1 Weight loss 
The weight of shrimp in each tray was obtained before storage and after 5, 10 and 15 days of 
storage. Data were used to calculate the percentage of weight loss during storage. 
The weight loss (%) = (Wi – Wt) / Wi  x 100% 
Where  Wi: the initial weight of the shrimp before storage 
Wt: the weight of the shrimp at the time of analysis  
 
6.2.4.3.2 Texture  
The texture of shrimp was expressed by the hardness index which was evaluated by a texture 
machine (Zwick/Roell, Germany) using the TestXpert II V3.1 program. The hardness of the 
shrimp was conducted by a penetration test and was defined as the maximum force (N) of the 
load application. 
 
6.2.4.3.3 Total plate counts 
The total plate count of shrimp treatments during storage was measured following the method 
in Chapter 2 – Section 2.3.7.  
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Shrimp soaked in acetic acid  Shrimp soaked in chitosan solution 
  
  
Shrimp treated in normal chitosan Shrimp treated in purifed chitosan 
  
  
Shrimp treated with acetic acid Shrimp without treatment 
  
 
(a)                 (b)  
Acetic acid (a) before and  
(b) after treament 
Shrimp stored in the fridge  
at 0 – 4 oC 
Figure 6.3: Treatment of shrimp   
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6.2.5 Data analysis 
The experiments were conducted in triplicate. The data were analysed by Microsoft Excel 
2007 program and the analysis of variances were conducted using SPSS 17.0 program. 
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6.3 RESULTS AND DISCUSSION 
6.3.1 Characterization of some properties of chitin and chitosan products 
6.3.1.1 Moisture content 
The moisture content of chitin and chitosan samples varied between 4 % and 11 %. The data 
were expressed in Figure 6.4.  
 
0
2
4
6
8
10
12
Chitin 1 Chitin 2 Chitin 3 Chitosan 1 Chitosan 2 Chitosan 3
% Moisture content (%)
 
Figure 6.4: Moisture content of chitin and chitosan samples 
 
The chitin samples seemed to generally have less moisture content than the chitosan samples. 
This could be because the chitosan samples were not properly dried after deacetylation 
process.  Among them, chitosan 3, the purified one, had the highest moisture content (10.9278 
%). 
 
The difference in moisture content could also be seen among chitin samples and among 
chitosan samples. This indicated that the quality of chitin and chitosan samples from different 
sources were not similar.  
 
Statistical analysis results demonstrated that the differences in moisture content between these 
chitin and chitosan samples were significant at 95 % of confidence (Appendix – Table A.6.2). 
Therefore, it is important to measure the moisture content of chitin and chitosan before using 
to determine the exact quantity as required in an industrial application. 
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6.3.1.2 Ash content 
 
 
Figure 6.5: Ash content of chitin and chitosan samples 
 
The results in Figure 6.5 demonstrated that the ash content in chitin and chitosan samples was 
very low, less than 1%, except the chitosan 2. This product had the highest value in ash 
content (5.8325 %). This could be because this product might not been deionised thoroughly 
during the extraction process.   
 
The differences in ash content between chitin and chitosan samples were significant at p < 
0.05 (Appendix – Table A.6.4). 
 
6.3.1.3 Heavy metal content 
The heavy metal content of these chitin and chitosan samples was tested by the Institute of 
Biotechnology and Environment, Nong Lam University, Ho Chi Minh City, Vietnam. The 
results are presented in Table 6.2. 
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Table 6.2: The heavy metal content of chitin and chitosan samples 
 
Sample Pb (ppm) Cd (ppm) As (ppb) Hg (ppb) 
Chitin 1 < 0.01 <0.002 <0.2 <0.2 
Chitin 2 < 0.01 <0.002 <0.2 <0.2 
Chitin 3 < 0.01 <0.004 <0.2 <0.2 
Chitosan 1 < 0.01 <0.002 <0.2 <0.2 
Chitosan 2 < 0.01 <0.004 <0.2 <0.2 
Chitosan 3 < 0.01 <0.002 <0.2 <0.2 
Methods 
ACIAR-AAS 
015-2007 
ACIAR-AAS 
004-2007 
ACIAR-AAS 
001-2007 
ACIAR-AAS 
009-2007 
Detection limits 0.01 0.002 0.2 0.2 
Trace detection 
limits 
0.02 0.004 0.4 0.4 
Australian MPC  
(Anon, 1987) (
*
) 
1.5 ppm 0.2 ppm 1.0 ppm 0.5 ppm 
Note: (
*
) MPC (maximum permitted concentration) of heavy metal in crustacean (Australian 
food standards – 1987) 
 
This test was focused on four heavy metals which might affect to the health of the consumers: 
lead (Pb), cadmium (Cd), arsenic (As) and mercury (Hg). Most of the samples did not have 
heavy metal content above the detection limit of the machine using ACIAR-AAS methods. 
Among these samples, only chitin 3 and chitosan 2 showed the presence of cadmium at trace 
level. This implicated that both chitin and chitosan samples can contain a certain amount of 
heavy metal.  
 
However, the concentration of these selected heavy metals in chitin and chitosan samples are 
very low compared to the Australian food standards for maximum permitted concentration of 
heavy metal in crustaceans (Anon, 1987). This indicated that these chitin and chitosan 
samples are safe for usage in food industry. 
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6.3.1.4 Protein content 
Chitin samples could not have their protein concentration determined because of their poor 
solubility (Hudson and Jenkins, 2002; Kurita, 2006; Muzzarelli, 1983). Chitosan samples 
were examined the protein content by dissolving in 0.1 N acetate buffer pH 4 (Shepherd et al., 
1997). The results were presented in Table 6.3. 
 
Table 6.3: The protein content of chitosan samples 
Sample Protein content (%) 
Chitosan 1 0.6353 ± 0.0233 
Chitosan 2 0.4436 ± 0.1807 
Chitosan 3 Too low to be detected 
 
Table 6.3 showed that there was certain amount of protein in chitosan samples although they 
had to pass a deproteinization process with sodium hydroxide (Hudson and Jenkins, 2002; 
Nguyen Van et al., 2006). The protein concentration varied between samples. This could be 
because these chitosan samples were produced under different conditions. The processing 
procedure such as reaction temperature and processing time significantly affects the chitosan 
properties (Rege and Block, 1999). 
 
The protein concentration in chitosan 3 cannot be estimated because this is a purified 
chitosan. The normal chitosan has been dissolved in acetic acid, filtered and precipitated by 
sodium hydroxide to collect the purified chitosan. This process removes protein. Therefore, 
the protein amount in this sample is too low to be detected. 
 
Overall, the properties of these chitin and chitosan samples varied due to their different 
source. Another study about the differences between the labelled value and the value 
determined by the researchers on the degree of deacetylation and degree of the polymerization 
of some commercial chitosans demonstrated that the quality control procedure of chitin and 
chitosan should be improved (Rege and Block, 1999). Therefore, chitin and chitosan samples 
should be examined their properties before each application, especially in food and drug 
industry, for the safety of the consumers as well as the accuracy of processing technology.  
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6.3.2 Antimicrobial properties of normal chitosan  
This experiment was aimed at studying the antimicrobial property of the normal chitosan. The 
growth of microbiology and the number of viable cells in cultures added with different 
concentrations of chitosan were investigated by spectrophotometric method and viable cell 
count method.  
 
6.3.2.1 Spectrophotometric method 
The growth of bacteria increases the mass density, hence prevents the transmission of the 
light. Therefore, the optical density (OD) index can be used to indicate the turbidity of the 
culture which is indicative of the growth of the bacteria. The optical density of E. coli and S. 
aureus cultures were expressed by absorbance values at 600 nm wavelength. 
 
6.3.2.1.1 The growth of E. coli in media with different chitosan concentrations 
 
 
Figure 6.6: The optical density of E. coli after incubation in nutrient broth with different 
chitosan concentrations  
 
The observed OD data in Figure 6.6 and statistical analysis showed that the growth of E. coli 
in nutrient broth medium with different chitosan concentrations were different significantly at 
p < 0.05 (Appendix – Chapter 6, Table A.6.6). 
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The OD of the control sample and the 0.01% chitosan sample increased rapidly, from 0.011 to 
0.841 and from 0.073 to 0.645 respectively, after 24 hours of incubation. The turbidity of the 
broths of these samples indicated that the growth of E. coli was very good (Figure 6.7).   
 
In contrast, the OD of E. coli in nutrient broth medium with 0.05 % and 0.1 % chitosan 
concentration was still very low after 4 hours and 24 hours of incubation. The broths with 
0.05% and 0.1% chitosan still remained their clear solution. This demonstrated that chitosan 
at 0.05 % and 0.1 % concentrations can completely inhibit the growth of E. coli, a Gram-
negative bacterium.  
 
    
0 % chitosan/ 0 h 0.01 % chitosan/ 0 h 0.05 % chitosan/ 0 h 0.1 % chitosan/ 0 h 
    
0 % chitosan / 4 h 0.01 % chitosan / 4 h 0.05 % chitosan / 4 h 0.1 % chitosan / 4 h 
    
0 % chitosan / 24 h 0.01 % chitosan / 24 h 0.05 % chitosan / 24 h 0.1 % chitosan / 24 h 
Figure 6.7: The development of E. coli in nutrient broth with different chitosan concentrations 
 
In Figure 6.7, the treatment F0 (0.01 % chitosan / 0 hour) looked a bit cloudy. This might due 
to the precipitation of chitosan when changing to the new medium with higher pH than its 
pKa. In this case, the concentration of chitosan used to mix with the culture was too low, and 
hence it could be affected easily by the new medium. 
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6.3.2.1.2 The growth of S. aureus in media with different chitosan concentrations 
Similar to E. coli, the development of S. aureus in nutrient broths without chitosan was 
significantly different from the broths with 0.05 % and 0.01 % chitosan at p < 0.05 (Appendix 
– Chapter 6, Table A.6.7). The OD of the broths with 0.01 % chitosan and without chitosan 
increased sharply to more than 0.8 after 24 hours of incubation, while the OD of the broths 
with 0.05 % and 0.01 % chitosan were still less than 0.03 (Figures 6.8 and 6.9).  
 
This result demonstrated that chitosan at 0.05 % and 0.1 % concentration also effectively 
prevents the growth of S. aureus, a Gram-positive bacterium. 
 
In general, chitosan at 0.05 % and 0.1 % concentration can inhibit the development of both 
Escherichia coli, a Gram-negative bacterium, and Staphylococcus aureus, a Gram-positive 
bacterium. 
 
 
 
Figure 6.8: The optical density of Staphylococcus aureus after incubation in nutrient broth 
with different chitosan concentration  
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0 % chitosan / 0 h 0.01 % chitosan / 0 h 0.05 % chitosan / 0 h 0.1 % chitosan / 0 h 
    
0 % chitosan / 4 h 0.01 % chitosan / 4 h 0.05 % chitosan / 4 h 0.1 % chitosan / 4 h 
    
0 % chitosan / 24 h 0.01 % chitosan / 24 h 0.05 % chitosan / 24 h 0.1 % chitosan / 24 h 
 
Figure 6.9: The development of Staphylococcus aureus in nutrient broth with different 
chitosan concentrations  
 
 
6.3.2.2 Plate count method 
The spectrophotometric method is a quick method to detect the development of bacteria. 
However, this method is affected by many factors such as the broth composition or substances 
released during metabolized process of the bacteria which cause the change in the optical 
density of the solution. Therefore, viable cell plate count method was used to determine the 
exact quantity of bacteria in a solution.  
 
6.3.2.2.1 The viable E. coli count 
The development of E. coli after incubation in nutrient broth with different chitosan 
concentrations was described in Table 6.4 and Figure 6.10. 
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Table 6.4: Number of E. coli (CFU/mL) after incubation in nutrient broth with different 
chitosan concentrations  
Time 
Chitosan 
concentrations 
0 hour 4 hours 24 hours 
Inhibition 
rate η (%) 
after 4 h 
Inhibition 
rate η (%) 
after 24 h 
0% 
1.70E+09  
± 1.00E+08 
2.40E+11  
± 5.29E+10 
1.87E+12  
± 1.53E+11 
- - 
0.01% 
1.73E+09  
± 2.52E+08 
1.90E+11  
± 1.00E+10 
1.60E+12  
± 1.00E+11 
- - 
0.05% 
1.87E+09  
± 2.31E+08 
1.57E+04  
± 1.15E+03 
2.03E+04  
± 4.93E+03 100 100 
0.1% 
1.73E+09  
± 2.31E+08 
1.60E+04  
± 1.00E+03 
1.63E+04  
± 4.04E+03 100 100 
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Figure 6.10: Number of E. coli (log10 CFU/mL) after incubation in different chitosan 
concentrations  
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The result showed that chitosan had a high antimicrobial effect to E.coli. In the control as well 
as the 0.01% chitosan treatment, the number of E.coli increased steadily to 24 hours of 
incubation, from approximately 9 to 12 log10 CFU/mL. In contrast, the number of E.coli 
decreased sharply after 4 hours of incubation in nutrient broth containing 0.5 % or 1 % 
chitosan, from approximately 9 to 4 log10 CFU/mL. This result indicated that the 0.01 % 
chitosan concentration was too low to inhibit the development of E.coliwhile the 0.05 and 0.1 
% chitosan concentrations had an effective inhibition to E.colijust after 4 hours of incubation. 
 
Statistical analysis also showed that the numbers of E.coli developed in different chitosan 
concentration as well as after different incubation times were different significantly at p < 
0.05 (Appendix – Chapter 6, Table A.6.9). 
 
6.3.2.2.2 The viable S. aureus count 
The development of S. aureusafter incubation in nutrient broth with different chitosan 
concentrations was described in Table 6.5 and Figure 6.11. 
 
Table 6.5: Number of S. aureus(CFU/mL) after incubation in nutrient broth with different 
chitosan concentrations  
Time 
Chitosan 
concentrations 
0 hour 4 hours 24 hours 
Inhibition 
rate η (%) 
after 4 h 
Inhibition 
rate η (%) 
after 24 h 
0% 
1.17E+09 
± 1.53E+08 
1.63E+10 
± 3.51E+09 
2.80E+10 
± 1.00E+09 
- - 
0.01% 
1.37E+09 
± 2.89E+08 
1.70E+10 
± 2.65E+09 
2.20E+10 
± 3.46E+09 
- - 
0.05% 
1.17E+09 
± 2.08E+08 
2.50E+02 
± 0.00E+00 
2.50E+02 
± 0.00E+00 100 100 
0.1% 
1.16E+09 
± 2.16E+08 
2.50E+02 
± 0.00E+00 
1.60E+03 
± 2.34E+03 100 100 
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Figure 6.11: Number of S. aureus (log10 CFU/mL) after incubation in nutrient broth with 
different chitosan concentrations 
 
Similar to E. coli, the result showed that the 0.05% and 0.1% chitosan solution can inhibit S. 
aureus effectively with a 100 % inhibition rate after 4 hours and 24 hours of incubation while 
the 0.01% chitosan concentration cannot inhibit the development of S. aureus. The difference 
of the growth of S. aureus in different chitosan concentrations as well as after different 
incubation time was significant at p < 0.05 (Appendix – Chapter 6, Table A.6.10). 
 
In general, the plate count method gave similar results to the spectrophotometric method in 
the development of both E. coliand S. aureus in nutrient broth with different chitosan 
concentrations, except the 0.01 % chitosan treatment. In the 0.01 % chitosan treatment, the 
growth of E. coli and S. aureus after 4 hours of incubation could not be detected by the 
spectrophotometric method while it was recognised as increasing by viable cell method. This 
could be due to the decrease of pH of the medium after 4 hours that make the chitosan 
dissolved, hence the OD looked unchanged (Table 6.6).  
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Table 6.6: The pH of the culture media in the control treament 
Time 
Bacteria 
0 hour 4 hours 
Escherichia coli 6.8567 ± 0.2511 6.5133 ± 0.2804 
Staphylococcus aureus 7.0267 ± 0.4373 6.7533 ± 0.6424 
 
 
The pH recorded at the beginning and after 4 hours of incubation (Table 6.6) showed that the 
pH of bacteria culture was higher than the pKa of chitosan which is normally at 6.2 (Rabea et 
al., 2003). 
 
The result of this experiment was similar to that observed in a  previous study (Domínguez et 
al., 2001). Similar to the other research, the growth of these bacteria could be almost 100 % 
inhibited when incubated with 0.05 % - 0.1 % chitosan in the medium (Kanatt et al., 2008a).  
 
In another study, Darmadji and Izumimoto showed that 0.01 % chitosan can inhibit the 
growth of both E. coliand S. aureus in yeast extract peptone glucose broth (Darmadji and 
Izumimoto, 1994).This dissimilar finding maydue to the different culture and chitosan used 
for the research because the antimicrobial property of chitosan depends on many factors such 
as the pH, the age of cell, the molecular weight, and degree of deacetylation of chitosan (No 
et al., 2002; Tsai and Su, 1999; Zheng and Zhu, 2003).  
 
In our study, the 0.01 % chitosan concentration cannot inhibit the development of E. coliand 
S. aureus might be because of the low chitosan concentration or the high pH of the culture 
media (Table 6.6). Chitosan can inhibite the growth of bacteria better at lower pH values (No 
et al., 2002; Tsai and Su, 1999). When the pH of the culture media is higher than the pKa of 
the chitosan, there are less cation groups on the structure of chitosan, therefore, it doesn’t 
react as strongly with the negative-charged outer membrane of the bacteria (Rabea et al., 
2003).  
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6.3.3 Comparison the antimicrobial property between normal chitosan and purified 
chitosan 
In order to test whether the purified chitosan can still keep its original property, the 
susceptibility tests were performed to compare between a normal chitosan and a purified one 
based on guidance of the National Committee for Clinical Laboratory Standards.  
 
The minimum inhibitory concentration technique (MIC) (CLSI, 2006a), minimal bactericide 
concentration technique (MBC) (Fernandez-Saiz et al., 2009; No et al., 2002; Wiegand et al., 
2008), and disc diffusion technique (CLSI, 2006b) have been used in this experiment. 
 
6.3.3.1 Minimum inhibitory concentration (MIC) 
The chitosan stock solution (1000 mg/L) was serially diluted from 1 to 1/128 in 0.85 % sterile 
NaCl. When being mixed with the bacterial suspension at the same volume, the final 
concentration of chitosan in incubation culture would be in the range from 3.77 to 500 mg/L. 
 
The MIC is defined as lowest concentration of an antimicrobial agent that prevents the visible 
growth of a microorganism (CLSI, 2006a). The more resistant an organism is, then the higher 
will be the MIC. 
 
Table 6.7: The MICs of chitosan samples to E. coli and S. aureus 
Microorganism Replication nCTS pCTS Acetate 
Escherichia coli 
1 31.25 ppm 31.25 ppm 62.5 ppm 
2 31.25 ppm 31.25 ppm 125 ppm 
3 31.25 ppm 31.25 ppm 125 ppm 
 
Staphylococcus aureus 
1 31.25 ppm 31.25 ppm 62.5 ppm 
2 31.25 ppm 31.25 ppm 125 ppm 
3 31.25 ppm 31.25 ppm 125 ppm 
Note: nCTS: normal chitosan 
 pCTS: purified chitosan 
 Acetate: 0.2 N acetate buffer pH 4.3 (control) 
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The MIC of chitosan to E. coli and S. aureus is presented in Table 6.7. The MIC results 
demonstrated that chitosan can inhibit the growth of both Gram negative and Gram positive 
bacteria. From Table 3.8, it could be concluded that the MIC of the normal chitosan and the 
purified chitosan was 31.25ppm to both E. coli and S. aureus, while MIC of acetate buffer 
was 125ppm.  
 
This result was close to the results of another research (Seo et al., 1992) , which showed that 
the MIC of chitosan to both E. coli and S. aureus was 20 ppm. This experiment showed that 
the purified chitosan can retain its antimicrobial property at the same level of the normal 
chitosan. 
 
6.3.3.2 Minimal bactericideconcentration (MBC) 
For each well that didn’t show the visible growth of bacteria after 24h of the MIC test, the 
number of bacteria was counted by the plate count method on Muller-Hinton agar. The 
concentration of chitosan that resulted in no colony on the plate count was obtained as the 
MBC. The MBC of chitosan to E. coli and S. aureus is presented in Table 6.8.  
 
Table 6.8: The MBC of chitosan to E. coli and S. aureus 
Microorganism Replication nCTS pCTS Acetate 
Escherichia coli 
1 62.5ppm 62.5ppm 250ppm 
2 31.25ppm 31.25ppm 250ppm 
3 31.25ppm 31.25ppm 500ppm 
 
Staphylococcus aureus 
1 62.5ppm 31.25ppm 250ppm 
2 62.5ppm 62.5ppm 500ppm 
3 125ppm 125ppm 500ppm 
Note: nCTS: normal chitosan 
 pCTS: purified chitosan 
 Acetate: 0.2 N acetate buffer pH 4.3 (control) 
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From Table 6.8, it could be concluded that the MBC result of normal chitosan and purified 
chitosan is 31.25 ppm for E. coli and 62.5 ppm for S. aureus while MBC of Acetate buffer 
was 250 ppm for E. coli and 500 ppm for S. aureus. Tsai et al. also showed that the MBC of 
shrimp chitosan to E. coli and S. aureus was about 100 ppm (Tsai et al., 2002). 
 
There was no difference between purified chitosan and the normal chitosan in the term of 
MBC value. 
 
6.3.3.3 Disc diffusion 
The inhibitory activity of chitosan was evaluated based on the clear zone surrounding a 
circular disc. If there is no clear zone, it is assumed that there is no inhibition of bacterial 
growth.  
 
An amount of 200 µg of each type of chitosan was dropped into separate discs. The 30-µg 
chloramphenicol disc and 10-µg ampicilin discs were used as positive control, while the 
acetate buffer was used as negative control. The diameter (mm) of the growth-inhibition zone 
including the disc diameter was measured after 24 h incubation using a ruler (CLSI, 2006b; 
Mayachiew et al., 2010). 
 
Table 6.9 expressed antimicrobial activity of chitosan by the disc diffusion method. The 
antibiotic action of chitosan was very low compared to chloramphenicol and ampicillin. This 
is because chitosan is not a real antibiotic but only a biopolymer which has the antimicrobial 
property.  
 
Table 6.9: The antibiotic circle diameter (mm) 
No. Chitosan /Antibiotics Escherichia coli Staphylococcus aureus 
1 Normal chitosan 9.17 ± 0.76 7.33 ± 0.58 
2 Purified chitosan 9.17 ± 0.76 7.17 ± 0.76 
3 Acetate buffer 6.50 ± 0.00 6.00 ± 0.00 
4 Chloramphenicol 24.00 ± 0.00 24.67 ± 1.15 
5 Ampicillin 18.83 ± 0.00 33.33 ± 1.15 
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Chitosan seems to inhibit Gram-negative bacteria better than Gram-positive bacteria, while 
chloramphenicol and ampicillin showed higher antibiotic property to Gram-positive bacteria 
(Figure 6.12). Normal chitosan and purified chitosan had the same effects on bacterial 
inhibition to both E. coli and S. aureus. There was no significant difference at p < 0.05 
(Appendix – Chapter 6, Table A.6.13). 
 
 
 
                                 (A)                                                          (B) 
Figure 6.12: Zone inhibition of discs containing (1) normal chitosan, (2) purified chitosan,  
(3) chloramphenicol, (4) acetate buffer, and (5) ampicillin in petri dishes with culture of     
(A) E. coli and (B) S. aureus. 
 
 
In general, through the MIC, MBC and disc diffusion tests, chitosan showed its antimicrobial 
property which still remains after the purification process. Although the antibiotic activity of 
chitosan is rather low, it can be applied in food preservation. The following experiment was a 
trial to confirm this property of chitosan.  
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6.3.4 Comparison of the antimicrobial activity of normal and purified chitosan in 
preservation of raw shrimp 
6.3.4.1 Weight loss 
The weight of shrimp decreases during the storage at cool temperature. The weight loss (%) 
of shrimp in different preservation methods was presented in Figure 6.13. 
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Figure 6.13: Weight loss (%) of shrimp during storage 
 
The results in Figure 6.13 and statistical analysis in Appendix – Chapter 6, Table A.6.15 
demonstrated that the weight loss (%) of shrimp in all treatments increased gradually over 
time during storage (p < 0.05). Among them, shrimps soaked in acetic acid solution showed 
the highest weight loss which was significantly different to other treatments at p < 0.05. 
 
There were no significant difference between chitosan-treated shrimp and the control at p < 
0.05. This result demonstrated that chitosan has no effects on preventing the loss of weight in 
shrimp during storage at 0 – 4 oC. However, the weight loss of shrimp treated with normal 
chitosan and purified chitosan different significantly at p < 0.05. The normal chitosan can 
help shrimp remains its moisture content slightly better than the purified one with the mean 
difference just around 0.25 % (Appendix – Chapter 6, Table A.6.15). 
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6.3.4.2 Texture  
The texture of shrimp in this experiment was expressed as the hardness index. It was 
measured by texture equipment from Zwick/Roell company (Germany). The hardness is 
defined as the maximum force at load application and measured in Newton. The result was 
presented in Figure 6.14. 
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Figure 6.14: Hardness of shrimp (force - N) during storage 
 
The texture of shrimp changed with different treatments and decreased during storage. All 
treatments resulted in better texture of shrimp when compared to the control. The differences 
among treatments were significant at p < 0.05 (Appendix – Chapter 6, Table A.6.17). 
Although there was a slight difference in the texture of shrimp between normal chitosan and 
purified chitosan treatments (p = 0.048), both treatments showed higher hardness value than 
others. 
 
However, there was no significant difference in the hardness of shrimps between 5 days and 
10 days of storage, especially with the chitosan-treated shrimps (p < 0.05). After 15 days of 
storage, the hardness of shrimps treated with chitosan decreased while other treatments 
seemed unchanged. 
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6.3.4.3 Total plate counts 
The micribiological index of shrimp during storage was measured by the total plate counts. 
The results were presented in Figure 6.15. 
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Figure 6.15: Total plate counts (log10 CFU/mL) of shrimp during storage 
 
The total plate counts (log10 CFU/mL) of shrimp increased sharply after 10 days of storage at 
0 – 4 oC and slightly decreased after 15 days. This could be because the spoilage of shrimp 
occurred during storage time. After 10 days, the growth of bacteria started to decrease. This 
might be due to the accumulation of toxic waste that they excreted during their metabolism. 
This result was similar to the research of Simpson et al. on preservation of Pandalus borealis 
shrimp (Simpson et al., 1997). According to their findings, Bacillus cereus required chitosan 
concentrations of 0.02 % (for bactericidal effect), while Escherichia coli and Proteus vulgaris 
showed minimal growth at 0.005 %, and complete inhibition at  0.0075 %. 
 
Figure 6.15 showed that the total plate counts in shrimps were reduced significantly (p < 0.05) 
by chitosan treatments as compared with the control up to 15 days of storage. This result 
indicated that chitosan has good effect on the inhibition of bacterial growth on shrimp. There 
was no significant difference in total plate counts between shrimps treated with normal 
chitosan and purified chitosan (Appendix – Chapter 6, Table A.6.20). This result 
demonstrated that purified chitosan can still keep its antimicrobial property as the normal one. 
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Figure 6.16: Shrimp images after 0, 5, 10 and 15 days of storage at 0 – 4 oC 1
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Figure 6.16 presented the change of shrimp colour during preservation. The shrimp 
turned pink after treated in acetic acid. This could be due to the acidic condition. 
Although chitosan was also dissolved in acetic acid, its solution had the pH raised up to 
5.5 before treatment of shrimp. Therefore, the acetic acid did not affect the colour of the 
shrimp. The increasing pH was aimed to prevent the shrimp from being affected by the 
smell and taste of the acetic acid. 
 
The images in Figure 6.16 demonstrated that treated shrimp still retain their original 
colour after 5 days of storage at 0 – 4 oC. Their colour started to change after 10 days of 
storage with some small black spot on the skin of the shrimp. However, their 
appearance still looked fresh even after 15 days of storage. 
 
In contrast, the colour of shrimp in the control treatment changed significantly during 
15 days of storage. The black spots appeared just after 5 days of storage. The black 
spots are composed of melanin pigments formed by the oxidation of phenolic 
compound with the activation of polyphenol oxidases (Simpson et al., 1997). The 
shrimp start to have bad smell with darker skin after 10 days of storage. It was 
completely spoiled after 15 days of storage with the darkening on the whole shrimp. 
The shrimp had very bad smell and soft texture at this stage. 
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6.4 GENERAL DISCUSSION AND CONCLUSION 
The biochemical properties of selected chitin and chitosan samples varied due to their 
different sources. Most chitin and chitosan samples have moisture content less than 10 
%. Their ash contents were less than 1 %, except for chitosan 2. The heavy metal 
content of these samples were very low compared to the Australian food standards for 
maximum permitted concentration of heavy metal in crustacean (Anon, 1987). It 
appears that each of the tested samples would be safe product for use in the food 
industry. The protein content of normal chitosan samples was less than 1 %, while it 
cannot be detected in the purified sample. The results indicated that chitin and chitosan 
need to be characterized and standardized their properties before application in food 
industry. 
 
Chitosan at 0.05 % and 0.1 % concentration can inhibit the development of Escherichia 
coli, a Gram-negative bacterium, and Staphylococcus aureus, a Gram-positive 
bacterium. It can absolutely inhibit the growth of the E. coli and S. aureus after 4 hours 
of incubation. This result was confirmed by other researches (Devlieghere et al., 2004; 
Rabea et al., 2003; Zheng and Zhu, 2003). 
 
The purified chitosan can still retain its antimicrobial property as the normal chitosan 
through MIC, MBC and disc diffusion results. Their MICs to E. coli and S. aureus were 
31.25 ppm while their MBCs were 31.25 ppm to E. coli and approximately 62.5 ppm to 
S. aureus. These chitosan samples inhibit the Gram-negative bacteria better than Gram-
positive bacteria although the antibiotic activity of chitosan is rather low compared to 
chloramphenicol and ampicilin. Due to its antimicrobial property, chitosan is a 
promising material in the preservation of food products. 
 
The application of chitosan in shrimp preservation has confirmed its antimicrobial 
property. Both purified and normal chitosan can reduce the development of bacteria on 
shrimps during 15 days of storage at 0 – 4 oC. Moreover, it can help the shrimp to lower 
the weight loss and keep their hardness higher than the non-treated ones during storage. 
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Chapter 7 
FORMULATION OF CHITOSAN-BASED EDIBLE FILM 
FOR APPLICATION IN INSTANT FOOD CASING 
 
 
7.1 INTRODUCTION 
During recent years, the food industry is developing very fast to fulfill the requirements of the 
consumers. The food producers always want to make new food products to supply for the 
higher demands of the consumers as well as try to develop new materials that are friendly to 
the environment. On the other hand, due to the development of the industrial society, people’s 
lives are getting busier. Therefore, fast foods become more dominant in the market because of 
their ease (Buckley et al., 2007; de Boer et al., 2004; Glanz et al., 1998). 
 
Instant noodles are among the instant foods that are used very frequently due to their cheap 
price, nutritious value and ease of preparation (Fu, 2008; Tan et al., 2009). However, the 
consumers must open their spice sachets by knife, scissors or by hands that can cause 
contamination or loss of spice. These spice sachets are usually made of plastics which are not 
degradable and can affect the environment and human health. Many researchers are trying to 
make self-degradable packaging to solve this problem (Duncan, 2011; Farris et al., 2009; 
Siró, 2012; Tharanathan, 2003). However, there are still no studies on making edible films for 
spice casing in instant food. 
 
Vietnam is a tropical country which has the coastal length of more than 3,000 kilometers. 
Therefore, the seafood industry is very developed and gives out large amount of seashell 
which is considered as waste. Only 5% of shrimp waste which contains head and body 
carapace (48-56 % of the raw shrimp) (Sachindra et al., 2007) is used for animal feed (Kandra 
et al., 2012). The shrimp waste composed mainly of protein (40%), minerals (35%) and chitin 
(14–30%) (Synowiecki and Al-Khateeb, 2003). Nowadays, people can isolate chitin from the 
shell of crustacean such as shrimp and crab.  
 
Chitin and its derivatives such as chitosan and glucosamine are being applied widely in many 
fields (Dutta et al., 2009; Friedman and Juneja, 2010; Kurita, 2006; Muzzarelli and 
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Muzzarelli, 2005; Ravi Kumar, 2000; Rinaudo, 2006; Stevens, 2005). In the food industry, 
chitosan can be used as a protective membrane or film (Alishahi and Aïder, 2011; Fernández-
Saiz and Lagaron, 2011; Mohammed, 2010; Rathke and Hudson, 1994). Therefore, the use of 
chitosan film in food production should be more developed.  
 
This research aimed to use chitosan as a biomaterial to make spice sachets which can be used 
in instant food products. They should have the following properties: edible, soluble in hot 
water, and sealable. However, chitosan film has very poor solubility in neutral or alkaline 
solution. Therefore, it is necessary to mix chitosan with other water-soluble materials to apply 
it in instant food casing. 
 
Summary of Chapter 7: 
In work described in this chapter, the film forming capacity of chitosan has been investigated 
to find appropriate methods for making chitosan film. Besides that, the film forming ability of 
some other biopolymers were also examined to find out which polymer to combine with 
chitosan to make films with desired properties. The composite edible film was investigated 
for its formulation as well as antimicrobial properties. The use of this edible film in spice 
casing for instant noodles is an attempt to apply chitosan-based films in the instant food 
industry.  
 
This study found that the neutralization process, the degree of deacetylation of chitosan and 
the chitosan concentration affected significantly the solubility of chitosan film. Among the 
tested biopolymers, gelatin showed the best appropriate properties to blend with chitosan in 
forming soluble and sealable edible film. The composition of 0.5 % chitosan and 5 % gelatin 
has been shown as the most appropriate formulation to make the desired edible film. This 
edible film showed excellent antimicrobial property to both gram negative and positive 
bacteria. Therefore, it could be used in the preservation of food products. This composite 
chitosan/gelatin edible film was applied in making seasoning and oil sachets for instant 
noodles to examine the feasibility of this film. The spice stored in these edible film sachets 
can still keep their quality after 6 months of storage. These sachets should be kept in another 
container to prevent the exposure to humidity. Overall, this edible film is suitable for 
application in spice casings for instant noodles. 
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7.2 MATERAILS AND METHODS 
7.2.1 Materials and equipments 
7.2.1.1 Materials 
– Agar: Food grade (Viet Nam) 
– Carrageenan: Food grade (Denmark)  
– Carboxymethyl cellulose: Food grade (Japan) 
– Chitosan: Food grade (Viet Nam) 
Two types of chitosan which have 94 % and 76 % degrees of deacetylation were used in this 
study. They both have less than 1 % ash content, 1 % protein content, 1.5 NTU turbidity, and 
450 cps viscosity. They were purified before using in this study. 
– Gelatin: Food grade (Japan) 
– Pectin: Food grade (USA) 
– Corn starch: Food grade (France) 
 
7.2.1.2 Chemicals 
– Plasticizer: glycerol (C3H8O3) 98 % purity 
– Glacial acid acetic (CH3COOH, Merck) 
– Saturated potassium cloride (KCl, Merck) 
– Saturated potassium acetate (CH3COOK, Merck) 
– Seasoning powder (Knorr, Viet Nam) 
– Vegetable oil (Crisco, Australia) 
– Other chemicals for analysis 
 
7.2.1.3 Equipments 
– Film casting tray 
– Drying machine 
– Analytical balance (0.0001 – 220 g) (Sartorius Gottingen, Germany) 
– Panme ruler (Mitutoyo, Japan) 
– Texture machine (Zwick/Roell, Germany) 
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7.2.2 Method of making edible films 
7.2.2.1 Method of making homogeneous edible films 
The homogeneous edible film was cast following the diagram in Figure 7.1. 
 
 
Figure 7.1: Process of casting homogeneous edible film 
 
Chitosan was dissolved in 1.5 % acetic acid containing 10 % glycerol (w/w, dry basis) as a 
plasticizer by stirring overnight using a magnetic stirrer. Other biomaterials were dissolved in 
distilled water containing 10 % glycerol (w/w, dry basis) as a plasticizer by stirring overnight 
using a magnetic stirrer at 100 
o
C. All solutions were filtered before casting to remove 
insoluble particles. A volume of 50 mL of each solution was poured onto a casting tray with a 
dimension of 20 x 20 cm. It was dried at 40 
o
C for 24 hours in a drying machine. The forming 
film was taken out of the tray and stored in desiccators prior to analysis. 
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7.2.2.2 Method of making composite edible film 
The casting of composite edible films was conducted following the diagram in Figure 7.2. 
 
 
Figure 7.2: Process of casting composite edible film 
 
Chitosan was dissolved in 1.5 % acetic acid containing 10 % glycerol (w/w, dry basis) as a 
plasticizer by stirring overnight using magnetic stirrer. Other biomaterials were dissolved in 
distilled water containing 10 % glycerol as plasticizer by stirring overnight using magnetic 
stirrer at 100 
o
C. Chitosan solution was mixed with other biopolymer solution(s) with a 
determined ratio. The combined solution was then filtered after mixing thoroughly by stirring 
to remove insoluble particles.  
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A 50 mL volume of the mixed solution was poured onto a casting tray with a dimension of 20 
x 20 cm. It was dried at 40 
o
C for 24 hours in a drying machine. The forming film was taken 
out of the tray and stored in desiccators prior to analysis. 
 
7.2.3 Investigation of film forming capacity of chitosan 
7.2.3.1 Evaluation of the effect of the neutralization to the solubility of chitosan films  
This experiment was aimed at finding the appropriate process for making chitosan film which 
has better solubility in hot water. 
 
The chitosan film was made following the procedure in Section 6.2.2.1. Chitosan with 94 % 
degree of deacetylation was used in this assay. One gram chitosan was dissolved in 100 mL of 
1.5 % acetic acid. The solution was filtered to remove all insoluble substances before pouring 
into the casting tray. The chitosan films were formed after drying at 40 °C for 24 hours.  
 
The chitosan film was cut into two parts:  
- The first part was neutralized by soaking in 1 N NaOH solution for 5 minutes, then 
washed thoroughly by distilled water. The neutralized film was dried again before 
storage in a desiccator. 
- The second part was stored in a desiccator without neutralization. 
 
The solubility of each type of chitosan film was measured following the method described in 
Chapter 2 – Section 2.3.8.4. The chitosan films were conditioned in desiccators for at least 24 
hours before performing the test. The experiment was performed in triplicate. The film 
treatment which resulted in better solubility was chosen to conduct in the next experiments. 
 
7.2.3.2 Evaluation of the effect of the degree of deacetylation of chitosan and the 
concentration of chitosan solution on the properties of chitosan film 
This experiment was aimed at finding the appropriate degree of deacetylation of chitosan and 
the concentration of chitosan solution to make chitosan film which has better solubility in hot 
water. 
 
The chitosan film was made following the procedure in Session 7.2.2.1. Two variants were 
examined in this experiment: 
- Types of chitosan: Chitosan 1 (94 % DD) and chitosan 2 (76 % DD) 
- Concentration of chitosan (w/v): 0.5 %, 1 % and 1.5 % 
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The formed chitosan films were evaluated for their thickness, solubility and mechanical 
properties. The films were conditioned in desiccators for at least 24 hours before performing 
the tests. The film which has better solubility and mechanical properties was chosen to 
conduct the next experiments. 
 
7.2.4 Improvement of the solubility and seal-ability of chitosan films 
The chitosan films had poor seal-ability and low solubility in water. Therefore, this study 
attempted to find another biomaterial to mix with chitosan to improve these properties for 
application in food casing. 
  
7. 2.4.1 Evaluate the film forming capacity of some biopolymers  
The aim of this experiment was to determine the biopolymer which can make sealable and 
soluble films. 
 
Different concentrations of agar, carrageenan, carboxyl methyl cellulose (CMC), chitosan, 
gelatin, pectin, and corn starch were examined to make homogeneous biofims which have the 
desired properties. The chosen concentrations were different depending on the polymer: 
- Agar: 1 %, 2 %, and 3 % 
- Carrageenan: 2 %, 3 %, and 4 % 
- CMC: 1 %, 1.5 %, and 2 % 
- Gelatin: 3 %, 4 %, and 5 % 
- Pectin: 1 %, 1.5 %, and 2 % 
- Corn starch: 1 %, 2 %, and 3 % 
 
The forming films were measured for the following criteria:  
- Film thickness 
- Solubility in hot water 
- Mechanical properties 
- Water vapor permeation 
- Sealability 
 
The films were conditioned in desiccators for at least 24 hours before performing the tests. 
The biopolymer which had better sealable and soluble properties would be chosen to use in 
the next experiments. 
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7. 2.4.2 Evaluate the effect of blending ratio to the forming film properties 
This experiment was aimed at finding the appropriate concentration of chitosan solution and 
another biopolymer to make composite film which is sealable and soluble in hot water. 
 
The composite film was made following the procedure in Session 6.2.2.2. From the results of 
the previous experiments, the blending ratio of chitosan and other biopolymer was chosen 
based on the best concentrations of chitosan and other biopolymer in making films with 
desired properties. Two variants were examined in this experiment: 
- Chitosan ratio: 100 %, 75 %, and 50 % of the best chitosan concentration obtained 
from Section 7.3.1.2. 
- Other biopolymer ratio: 100 %, 80 %, and 60 % of the best concentration of other 
biopolymer obtained from Section 7.3.2.1. 
 
The formed composite edible films were evaluated their thickness, solubility, mechanical and 
antimicrobial properties. The composite films were conditioned in desiccators for at least 24 
hours before performing the tests. The experiment was carried out in triplicates. The film 
which had better properties, especially the solubility and sealability was chosen to conduct the 
next experiments. 
 
7. 2.5 Characterization of the microbiological properties of composite film 
The composite film was prepared using the best results from the previous experiments. After 
that, it was examined for its microbiological properties before application in instant food 
casing. In this study, the bacterial growth and the viable cell count methods have been used. 
 
For the microbial property characterization, the composite film was cut into 50 mm diameter 
circular pieces and placed onto the petri dish. After that, the plate count agar medium was 
poured onto the whole film and allow to settle on top of the film. The plate was incubated at 
37 
o
C for 24 hours. The number of bacterial colonies formed on top of the film was then 
counted (Thomas et al., 2009). 
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For the antimicrobial activity characterization, the viable cell count method was used 
(Thomas et al., 2009; Zivanovic et al., 2007). Test films of 50-mm diameter were soaked into 
9 mL of culture tubes containing approximately 10
6
 CFU of the bacterium species E. coli 
(ATCC 25922) or S. aureus (ATCC 29213). The tubes were vortexed to make the films 
contact thoroughly with the media. A tube containing only bacteria culture (without film) was 
used as the positive control. A tube containing only 0.85 % NaCl was used as the negative 
control. All tubes were then incubated at 37 
o
C for 24 hours. After 2 h, 4 h and 24 h of 
incubation, a volume of 1 mL of the innoculum was spread onto a PCA petri dish and 
incubated at 37 
o
C overnight. The number of surviving bacteria was determined by counting 
the colonies formed after incubation.  
 
The percentage reduction of tested bacteria was determined following the below formula 
(Abou-Zeid et al., 2011): 
Percentage reduction (%) = (C – A) / C x 100 
where  C: the colonies counted from the plate of the control sample 
  A: the colonies counted from the plate of the treated sample. 
  
7. 2.6 Application of composite edible films in spice casing for instant noodles 
This experiment was aimed at examination of the feasibility of application of the composite 
edible film in food casing.  
 
The composite edible films with the dimension of 50 x 120 mm were folded and sealed to 
make sachets with the size 40 x 50 mm. Approximately 1 g of seasoning or oil was put into 
the sachets and sealed tightly. These sachets were stored at two different conditions to 
examine their stability: in oriented polypropylene (OPP) wrap and in ambient environment. 
The OPP wrap is a common material for instant noodles packaging. The PE sachets was used 
to store the spice instead of composite sachets as a control. 
 
The experiment was carried out within six months. The sachets were evaluated their sensory 
quality by observation of their appearance. The oil and seasoning powder in each sachet was 
measured for weight loss and total plate counts after each month of storage. The measurement 
was conducted in triplicates. 
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The weight loss of spice sachet during storage was calculated using the following formula:  
The weight loss (%) = (Wi – Wt) / Wi  x 100% 
Where  Wi: the initial weight of the spice sachet before storage 
Wt: the weight of the spice sachet at the time of analysis  
 
The total plate counts was determined as described in Chapter 2 - Session 2.3.7. 
 
7.2.7 Data analysis 
The data were analysed by Microsoft Excel 2007 and presented as mean with standard 
derivation (STD). The SPSS 17.0 programs were used to examine the difference between 
treatments. 
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7.3 RESULTS AND DISCUSSION 
7.3.1 Film forming capacity of chitosan 
7.3.1.1 Effect of the neutralization to the solubility of chitosan films 
The solubility of the neutralised and non-neutralised chitosan films were examined to 
determine which method is suitable for this study. The chitosan films were conditioned in 
desiccators for at least 24 hours before performing the test. The results were presented in 
Figure 7.3. 
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Figure 7.3: The solubility of neutralised and non-neutralised chitosan films 
 
It could be clearly observed from the figure that the solubility of the non-neutralised chitosan 
(15.42 %) was almost double the solubility of the neutralized one (8.18 %). The difference in 
the solubility of these films was significant at p < 0.05 (Appendix – Chapter 7, Table A.7.2). 
 
The chitosan powder had to be dissolved completely in diluted acetic acid prior casting into 
chitosan film. In the acidic solution, the –NH2 groups in the chitosan structure were ionized to 
NH3
+
 groups (Kurita, 2006; Rinaudo, 2006). After casting into film, these cations are still 
present and easily combine with water. This makes the non-neutralised chitosan more soblule 
in water. 
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When the film was neutralized with sodium hydroxide, the NH3
+
 groups were reversed into –
NH2 groups. These groups are less active when the chitosan film is soaked in water. This 
makes the neutralized chitosan film have lower solubility in water than the non-neutralised 
one. 
 
The aim of this study is to make a film which can dissolve easily in hot water. Therefore, the 
non-neutralised film was chosen to be processed in the next experiments. 
 
7.3.1.2 Effect of the degree of deacetylation of chitosan and the concentration of chitosan 
solution on the properties of chitosan film  
7.3.1.2.1 Thickness 
Six types of chitosan films have been prepared with differences in the degree of the 
acetylation and the chitosan concentration. The thickness of these films was measured by the 
Panme rular (Mitutoyo, Japan). The results were presented in Figure 7.4. 
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Figure 7.4: The thickness of chitosan films 
Note:  CTS Conc.: Chitosan concentration 
DD: Degree of deacetylation   
 
           Film A         Film B       Film C Film D         Film E       Film F 
   CTS Conc.:   0.5 %             1 %            1.5 %           0.5 %            1 %              1.5 %       
   DD:            76 %                              94 %  
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The results demonstrated that the thickness of chitosan films changed depending on the 
chitosan concentration. Their thickness increased together with the increase of the chitosan 
concentration. This result is due to the increase of the chitosan mass in the film. The 
difference in the thickness of chitosan films with different chitosan concentration was 
significant at p < 0.05 (Appendix - Chapter 7, Table A.7.4).  
 
On the other hand, the degree of deacetylation did not have any effect on the thickness of 
chitosan films. There was no significant difference at p < 0.05 in the thickness of chitosan 
films made from chitosan with different degree of deacetylation (Appendix - Chapter 7, Table 
A.7.4). 
 
Therefore, the thickness of chitosan film can be controlled by adjusting the chitosan 
concentration. 
 
7.3.1.2.2 Solubility 
The solubility of chitosan films was presented in Figure 7.5. 
 
0
2
4
6
8
10
12
14
16
18
Film 1 Film 2 Film 3 Film 4 Film 5 Film 6
S
o
lu
b
il
it
y
 (
%
)
 
Figure 7.5: The solubility of chitosan films 
Note:  CTS Conc.: Chitosan concentration 
DD: Degree of deacetylation   
          Film A         Film B      Film C Film D         Film E       Film F 
   CTS Conc.:   0.5 %             1 %            1.5 %           0.5 %            1 %              1.5 %       
   DD:            76 %                                 94 %  
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The solubility of chitosan films was relatively low. The films did not dissolve totally in 
distilled water. The films mostly absorbed water and swelled. 
 
The obtained data demonstrated that the chitosan concentration did not affect the solubility of 
chitosan films. There was no significant difference between the films with different 
concentrations (p > 0.05). 
 
Conversely, the degree of deacetylation had a significant effect on the solubility of chitosan 
films (p < 0.05).  Chitosan which has higher degree of deacetylation will lead to films which 
have higher solubility. The results were related to the amino (-NH2) groups on the polymer 
chain of chitosan (Rinaudo, 2006). Chitosan with a higher degree of deacetylation has more 
amino groups. When chitosan film is soaked into water, the amino groups will be protonated 
into -NH3
+
 groups. These groups will make hydrogen bonds with the OH
-
 groups of the water 
molecules. Therefore, the films can dissolve in water. However, because just a few amino 
groups was ionised at pH higher than 6, only part of chitosan film is dissolved in water 
(Fernández-Saiz and Lagaron, 2011; Kurita, 2006). 
 
7.3.1.2.3 Mechanical properties 
The tensile strength and the deformation of chitosan films were tested to examine their 
mechanical properties. The tests were followed the standard DIN EN 527-1 (CEN, 1996) 
using the Zwick/Roell texture testing machine. The results were presented in Figures 7.6 and 
7.7. 
 
The degree of deacetylation of chitosan and the chitosan concentration did not have a large 
effect on the tensile strength of chitosan films. The tensile strength of chitosan film is 
approximately 40 MPa. The difference between the films was not significant at p > 0.05. This 
result is close to the study of Butler (1996) which confirmed that the mechanical properties of 
chitosan film were as strong as films of other commercial polymers such as high density 
polyethylene (HDPE) and low density polyethylene (LDPE) (Butler et al., 1996; Rabea et al., 
2003). 
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On the other hand, the deformation of chitosan films was affected by the concentration of 
chitosan. The 0.5 % chitosan concentration films had lowest percentage of deformation 
(approximately 17 %) which was significantly different to other films at p < 0.05. The 
percentage of deformation of the 1 % and 1.5 % chitosan concentration films were not 
different at p < 0.05. The degree of deacetylation also did not have any effects on the 
deformation of chitosan films. (Appendix – Chapter 7, Table A.7.8) 
 
The results demonstrated that the 1 % and 1.5 % chitosan concentration films can be stretched 
longer than 0.5 % chitosan concentration films without changing the tensile strength.  
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Figure 7.6: The tensile strength of chitosan films 
Note:  CTS Conc.: Chitosan concentration 
DD: Degree of deacetylation   
 
 
          Fil  A         Fil  B      Fil  C        Fil  D         il  E     il  F 
   CTS Conc.:   0.5 %             1 %           1.5 %           0.5 %            1 %             1.5 %       
   DD:            76 %                                 94 %  
169 
 
0
5
10
15
20
25
30
35
Film 1 Film 2 Film 3 Film 4 Film 5 Film 6
D
e
fo
r
m
a
ti
o
n
 (
%
)
 
Figure 7.7: The deformation of chitosan films 
Note:  CTS Conc.: Chitosan concentration 
DD: Degree of deacetylation   
 
 
Overall, the data obtained from this experiment showed that there were no differences 
between the films made from chitosan with 76 % DD and 94 % DD in terms of thickness, 
tensile strength and deformation. However, the 94 % DD chitosan film had higher solubility 
than the 76 % DD chitosan film. This is an important requirement to apply chitosan for 
packaging in instant food product. Therefore, the 94 % DD chitosan was chosen for usage in 
the next experiments.  
 
The concentration of chitosan did not have a large effect on the solubility or the tensile 
strength of chitosan film. However, the 0.5 % chitosan concentration film has very low 
thickness and deformation. Between the 1 % and 1.5 % chitosan concentration films, the 1 % 
chitosan concentration film consumed less chitosan but still has similar properties of the 1.5 
% chitosan concentration film. Therefore, the 1 % chitosan concentration film was chosen to 
conduct the next experiments.  
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7.3.2 Improvement of the solubility and seal-ability of chitosan films 
Chitosan is a very promising materials for apllication in the food industry due to its 
biodegradable and non-toxic properties. However, the main dissadvantage of chitoasn film is 
its low solubility. Therefore, chitosan needs to be formulated with other biopolymers to 
enhance its solubility as well as sealability to make it feasible for application in instant food 
casing.  
 
Some biopolymers were investigated for film forming properties. The biomaterials which can 
make the films with high solubility and sealability will be chosen to mix with chitosan. The 
concentration of each biopolymer chosen for examination varied depending on its intrinsic 
film-forming properties and the results of previous studies (Chen et al., 1996; Cheng et al., 
2003; De Yao et al., 1996; Hambleton et al., 2009; Jo et al., 2005; Phan et al., 2005; 
Tharanathan, 2003). 
 
7.3.2.1 Evaluate the film forming capacity of some biopolymers  
7.3.2.1.1 Thickness  
The thickness of some homogenous edible films was presented in Figure 6.8. For each type of 
edible film, ten measurements have been conducted. The measurements were repeated three 
times. The data were presented as the mean and the standard deviation of the three 
replications (Appendix - Chapter 7, Table A.7.9).  
 
The results in Figure 6.8 indicated that the thickness of edible films made from a biopolymer 
with different concentration was different significantly at p < 0.05 (Appendix A.7.10). The 
thickness of edible film increased when the concentration of biopolymer increased. Among 
seven biololymers, gelatin film had the highest thickness. This is obvious because of the high 
gelatin concentration used to cast the film. Comparing with other edible films with the same 
concentration, the thickness of chitosan film was similar to the pectin and CMC films and 
much lower than corn starch and agar films. 
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Figure 7.8: The thickness of homogenous edible films  
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7.3.2.1.2 Solubility  
The solubility of homogeneous edible films was measured in triplicate. The results were 
presented in Figure 7.9. The solubility of selected edible films was significantly higher than 
that of the chitosan film. 
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Figure 7.9: The solubility of homogenous edible films 
 
The results showed that the solubility of chitosan and corn starch was very low (< 40%) 
compared to other biopolymers. The difference was significant at p < 0.05 (Appendix - 
Chapter 7, Table A.7.12). Most of the corn starch film was not dissolved in hot water but only 
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absorbed water and swelled to make gel. The film which had higher starch concentration had 
lower solubility which was significantly different at p < 0.05. 
 
Agar, pectin, carrageenan, CMC and gelatin had high solubility in the hot water. They 
dissolved more than 70 % in water at 70 
o
C for 5 minutes. This may be due to their 
hydrophylic properties. As the melting point of gelatin is just at the body temperature (Achet 
and He, 1995), it can dissolve easily in hot water.  
 
Overall, their solubility decreased in reverse proportion to their concentrations. The solubility 
of agar, carrageenan and gelatin films was higher at lower polymer concentration. The 
difference was significant at p < 0.05.  
 
However, the solubility of pectin and CMC films at different biopolymer concentrations was 
not different at p < 0.05. They can dissolve more than 90 % in hot water.  
 
7.3.2.1.3 Mechanical properties  
The tensile strength and deformation properties of edible films was tested by a texture 
machine (Zwich/Roell, Germany) to evaluate their mechanical propeties. The speed of pulling 
force was 100 mm.min
-1
. The results wre presented in Figure 7.10 and Figure 7.11. 
  
7.3.2.1.3.1 Tensile strength 
In this experiment, the tensile strength of edible films fluctuated depending on the 
concentration of each biopolymer.  
 
The tensile strength of corn starch film increased when the concentration increased from 1 % 
to 2 %. However, when the concentration of corn starch was raised to 3 %, the tensile strength 
slightly decreased. Conversely, the tensile strength of carrageenan film and CMC film 
decreased and then increased when the concentration of these biopolymers increased. 
 
The tensile strength of pectin and agar film increased proportional to their concentration while 
the tensile strength of gelatin film seemed unchanged with the change of gelatin 
concentration. This could be because there was the presence of the plasticizer glycerol which 
enhances the mechanical property of the edible film. Chitosan film had rather high tensile 
strength compared to other films. The difference was significant at p < 0.05 (Appendix - 
Chapter 7, Table A.7.14). 
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Figure 7.10: The tensile strength of homogenous edible films 
 
 
7.3.2.1.3.2 Deformation 
The deformation of edible films was presented in Figure 7.11. Overall, the deformation of 
edible films increased with the increase of their concentrations, except pectin and CMC films. 
The percentages of deformation of edible films with different concentrations were 
significantly different at p < 0.05 (Appendix - Chapter 7, Table A.7.14).  
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Figure 7.11: The deformation of homogenous edible films 
 
The deformation of chitosan films (31.58 %) was rather high compared to other edible films 
while the corn starch film had the lowest percentage of deformation (1.64 % – 2.33 %). Not 
only the corn starch but the cassava starch, rice starch and sticky rice starch also make films 
which have very low percentage of deformation (2.64 %, 2.07 %, and 0.72 %, respectively) 
(Phan et al., 2005). Most of the films made from starch are very brittle. 
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7.3.2.1.4 Water vapor permeation (WVP) 
The WVP of homogenous edible films was measured at 25 
o
C in an environment with the 
water activity changed from 0.22 to 0.84. The low density polyethylene (LDPE) film was 
measured as the control. The experiment was conducted in triplicate. The average results were 
presented in Figure 7.12. 
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Figure 7.12: The water vapor permeation of homogenous edible films 
 
The concentration of biomaterials had marked effect to the WVP of edible films. The films 
which had higher biomass concentration had higher WVP. 
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The 2 % agar film had high water vapor permeation (28.2 x 10
-11
g.m
-1
. s
-1
.Pa
-1
) which was 
significantly different to other concentrations at p < 0.05 (Appendix - Chapter 7, Table 
A.7.16). The 3 % corn starch film, 5 % gelatin film and 4 % carrageenan film had medium 
WVP ( around 15 x 10
-11
g.m
-1
. s
-1
.Pa
-1
) while the other films had lower WVP (< 10 x 10
-
11
g.m
-1
. s
-1
.Pa
-1
). 
 
Chitosan film is among the films which has low WVP. This property of chitosan film make it 
feasible for application in food packaging to protect the food from the outer environment. 
 
The WVP of all examined biofims were higher than the LDPE film. This result showed that 
these edible films can transfer a certain amount of water through the film after a period of 
time. This is due to the hydrophylic property of biomaterials. Especially gelatin is a strong 
polar protein, therefore it can transfer water which is also a polar subsstance (Miller and 
Krochta, 1997).  
 
On the other hand, the WVP of edible films also increase when the concentration of 
plasticizer increases (Bertuzzi et al., 2007; Park and Chinnan, 1995). The incorporation of 
plasticizer into a polymer matrix can enhance the flexibility of the polymeric chain, therefore 
the edible film can transfer moisture easier (Arvanitoyannis and Biliaderis, 1998, 1999; 
Trommsdorff and Tomka, 1995). 
 
7.3.2.1.5 Sealability  
The film was sealed at 100 
o
C for 15 seconds. The testing samples were conditioned for 24 
hours at room temperature before measuring the tensile strength of the seal. The sealability 
was estimated based on the tensile strength of the seal that makes the film separated or 
broken.  
 
The results showed that carrageenan, chitosan, and corn starch films cannot be sealed. The 
agar, CMC and pectin films can be sealed, but the seals were too weak to be measured 
because they were separated before the force reached the threshold value (FMin = 0,1 N).  
 
Among the investigated edible films, only the gelatin films can be sealable. The film melted 
very quickly at 100 
o
C. The films were very dry and britlle at the seal position of 3 % and 4 % 
gelatin films. So, they were torn at the side of the seal before the force reached the threshold 
value.  
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Only the seal of the 5 % gelatin film can be measured for its mechanical properties by the 
texture machine (Zwich/Roell, Germany). It had the tensile strength of 1.61 MPa with 10.55 
% deformation (Appendix - Chapter 7, Table A.7.17). Most seals were not separated but torn 
at the side of the seal due to the changes of the thickness of the film during the sealing 
process. 
 
In general, the results from this experiment showed that only the 5% gelatin can fullfil the 
requirements for application in food casing of instant noodles: 
- The sealablity: The film can be made into small sachets which are tight, stable and can 
protect an amount of seasoning or oil. 
- The solubility: The film can dissolve in hot water. Therefore, the spice sachet can dissolve 
by itself within 3-5 minutes. 
 
Therefore, the 5 % gelatin was chosen for combination with chitosan to make spice sachets 
for instant noodles. 
 
7.3.2.2 The effect of blending ratio to the forming film properties 
From the results of previous experiments, gelatin was chosen to mix with chitosan to enhance 
the sealbility and solubility of edible films for application in food casing of instant noodles. 
Different ratio of  gelatin solution (at 100 %, 80 % and 60 % of the 5 % gelatin solution) and 
chitosan solution (at 100 %, 75 % and 50 % of the 1 % chitosan solution) were blended 
together to examine which ratio was appropriate to make composite film with the required 
properties. The ratio of gelatin and chitosan were converted to the concentration of gelatin and 
chitosan in the film-forming solution. The blending concentration of gelatin and chitosan were 
described in Table 7.1. 
 
The experiment was designed randomly with 2 factors and 3 replications. Chitosan solutions 
were mixed thoroughly with gelatin solutions by a homogenizer. A volume of 50 mL of the 
blending solution was casted onto a flat glass tray to make edible film. After drying at 40 
o
C 
for 24 hours, these films were taken off the trays and stored in desiccators for at least 24 hours 
before analysis of their properties. 
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Table 7.1 The concentration of gelatin and chitosan in film-forming solution for composite 
edible films 
 
Concentration (%, w/v) of gelatin Concentration (%, w/v) of chitosan 
Film 1 3 0.50 
Film 2 3 0.75 
Film 3 3 1.00 
Film 4 4 0.50 
Film 5 4 0.75 
Film 6 4 1.00 
Film 7 5 0.50 
Film 8 5 0.75 
Film 9 5 1.00 
 
 
7.3.2.2.1 Thickness 
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Figure 7.13: The thickness of chitosan and gelatin composite films 
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The thickness of the composite film was presented in Figure 7.13. Each film was measured 10 
times for each replication. Three replications were conducted. 
 
The thickness of edible films increased proportionally to the biomass of the film-forming 
solution. Film 1 (0.5 % chitosan, 3 % gelatin) had the lowest thickness (40.18 µm) due to its 
lowest biomass content while film 9 (1 % chitosan, 5 % gelatin) had the highest thickness 
(60.70 µm) due to its highest biomass content. The difference of the thickness of these films 
was significant at p < 0.05 (Appendix - Chapter 7, Table A.7.19). 
 
The statistical analysis showed that both chitosan concentration and gelatin concentration had 
obvious effects on the thickness of edible films (Appendix - Chapter 7, Table A.7.19). At the 
same chitosan concentration, the thickness of the composite film increased when the gelatin 
concentration increased. Similarly, at the same gelatin concentration, the thickness of the 
composite film increased when the chitosan concentration increased.  
 
7.3.2.2.2 Solubility 
The solubility of each composite film was measured three times. The average and its standard 
derivation were presented in Figure 7.14.  
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Figure 7.14: The solubility of chitosan and gelatin composite films 
 
The result showed that the solubility of composite film changed with the change of 
concentration of gelatin and chitosan in the film forming solution.  
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The film which had a higher gelatin concentration had better solubility. Film 7 had higher 
solubility (84.69 %) than film 4 (80.29 %) and film 1 (77.98 %). The difference was 
significant at p < 0.05 (Appendix - Chapter 7, Table A.7.21) 
 
Conversely, the film which had a higher chitosan concentration had lower solubility. Film 3 
had lower solubility (73.67 %) than film 2 (75.86 %) and film 1 (77.98 %). The difference 
was significant at p < 0.05 (Appendix - Chapter 7, Table A.7.21). 
 
Comparing the solubility between composite film and homogeneous chitosan film, the 
composite film had distinctly higher solubility than the chitosan film (15.41 %). This result 
demonstrated that the combination of gelatin has successfully increased the solubility of the 
edible film. 
 
7.3.2.2.3 Mechanical properties 
7.3.2.2.3.1 Tensile strength 
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Figure 7.15: The tensile strength of chitosan and gelatin composite films 
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The results in Figure 7.15 showed that the concentration of chitosan and gelatin affected 
significantly the tensile strength of the composite film at p < 0.05 (Appendix - Chapter 7, 
Table A.7.23).    
 
At the same chitosan concentration, the increase of gelatin concentration will lead to a film 
with lower tensile strength. For example, the tensile strength of composite film decreased 
respectively from 26.78 MPa (film1) to 24.05 MPa (film 4) and 23.03 (film 7). 
 
On the other hand, at the same gelatin concentration, the increase of chitosan concentration 
will lead to a film with higher tensile strength. For example, the tensile strength of composite 
film increased respectively from 26.78 MPa (film1) to 28.11 MPa (film 2) and 29.88 MPa 
(film 7). 
 
The tensile strength of the composite film (29.88 MPa) was higher than the homogeneous 
gelatin film (15.25 MPa) but lower than the chitosan film (40.54 MPa).  The results could be 
due to the intrinsic properties of gelatin and chitosan. Gelatin is a protein which can easily 
absorb water, while chitosan, the polysaccharide, is more resistent to water. The combination 
of these two polymers produces a film which has the average tensile strength. Moreover, the 
addition of plasticizer glycerol also affected the tensile strength of the edible film (Butler et 
al., 1996). The tensile strength of edible film can raise up to 50 % when added 30 % of 
plasticizer (Arvanitoyannis et al., 1998).  
 
7.3.2.2.3.2 Deformation 
The deformation of the composite films was presented in Figure 7.16.   
 
The results showed that the concentration of chitosan and gelatin also affected significantly 
the deformation of the composite film at p < 0.05 (Appendix - Chapter 7, Table A.7.23). The 
deformation increased with the increasing concentration of gelatin but it decreased with the 
increasing concentration of chitosan.  
 
Among examined films, film 4, film 7, film 8 and film 9 had the highest percentage of 
deformation. 
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Figure 7.16: The deformation of chitosan and gelatin composite films 
 
7.3.2.2.4 Water vapor permeation (WVP) 
 The WVP of composite edible films was measured at 25 
o
C in an environment with the water 
activity changed from 0.22 to 0.84. The LDPE film was measured as the control. The 
experiment was conducted in triplicate. The average results were presented in Figure 7.17. 
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Figure 7.17: The water vapor permeation of composite edible films 
 
184 
 
The WVP of the composite edible films was higher than the homogeneous edible films and 
the LDPE film. It increased proportionally to the ratio of gelatin and inversely proportionally 
to the ratio of chitosan. The difference was significant at p < 0.05 (Appendix - Chapter 7, 
Table A.7.25). Film 7 (4 % gelatin and 0.5 % chitosan) had the highest WVP among the 
examined films. 
 
This result is due to the hydrophylic properties of gelatin film (Gómez-Guillén et al., 2011). 
Moreover, the presence of glycerol as a plasticizer increases the transportation of water 
molecules (Park et al., 1994). 
 
7.3.2.2.5 Sealability 
In this experiment, the sealing temperature and time were reduced to enhance the tensile 
strength of the seal. The composited films were sealed at 90
o
C for 10 seconds. The testing 
samples were conditioned for 24 hours at room temperature before measuring the tensile 
strength of the seal. The sealability was estimated based on the tensile strength of the seal. 
The results were presented in Figure 7.18. 
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Figure 7.18: The sealability of composite edible films 
 
The results showed that the sealability of the composite films improved markedly over the 
homogeneous films. The tensile strength increased from 1.61 MPa (gelatin film) to more than 
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6 MPa (composite film). Most seals were not separated but torn at the side of the seal due to 
the changes of the film thickness during the sealing process. 
 
At lower blending ratio of gelatin (60 % and 80 %), there was no significant difference among 
the tensile strength of the composite films at p < 0.05 (Appendix - Chapter 7, Table A.7.27). 
However, the tensile strength increased sharply when the film was formed by 100 % gelatin 
and 50 % chitosan (film 7). The tensile strength of the seal decreased when the blending ratio 
of chitosan increased. 
 
Throughout this experiment, the results showed that the properties of the composite edible 
films have been enhanced markedly compare to the homogeneous edible films.  
 
Among the examined films, film 7 has better properties than other composite films: 
- The thickness is around 58 µm. This film thickness is enough to make a small bag to contain 
the seasoning and oil of the instant food product. 
- The solubility is the highest (approximately 85 %). This is one of the most important criteria 
to choose the film for application in instant noodles food casing because it need to dissolve in 
hot water as soon as possible. 
-  The tensile strength (23 MPa) is not so high comparing to other composite films. However, 
it is better than the gelatin homogenous film and strong enough to store the food inside its 
bag. Moreover, its high percentage of deformation (67 %) is an advantage for this film to 
dissolve in hot water. 
- The water vapor permeation of this film is the highest (1.94 x 10
-10
 g.m
-1
. s
-1
.Pa
-1
). This 
property is really a disadvantage of this edible film in the application in food casing because it 
cannot prevent the transfer of moisture between the food and the outer environment. 
However, in this study, edible film is aimed to make small bags for the storage of the spice 
(seasoning and oil) of instant noodles. These small bags are covered by an OPP bag which has 
better moisture resistance. Therefore, this disadvantageous property of the film is not too 
much of a concern. 
- The sealability of this film is very good. The seal has the highest tensile strength (13.27 
MPa) comparing to other composite films. This property is an advantage for the edible film 
application in food casing. 
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Due to its excellent properties, film 7 was chosen for application in making spice sachets for 
instant noodles. This film is formed by a combination of 5 % (w/v) gelatin concentration and 
0.5 % (w/v) chitosan concentration in the film-forming solution.  
 
7.3.3 Characterization of properties of composite edible film  
The best results from previous experiments were chosen to formulate an edible film which 
can dissolve in hot water and has good sealablity for application to instant food casing. The 
film was prepared and examined for its physical-chemical properties and microbiological 
properties before application in instant noodle spice casing. 
 
7.3.3.1 Preparation of the composite edible film 
The composite edible film used in this study was formed with the following formulation: 
- Chitosan concentration: 0.5 % (w/v) 
- Gelatin concentration: 5 % (w/v) 
- Glycerol concentration: 10 % (w/w, dry matter) 
 
To prepare the composite edible film, chitosan solution and gelatin solution were prepared 
separately before mixing them together. An amount of 0.25 g of chitosan was dissolved in 25 
mL of 1.5 % acetic acid solution by shaking overnight. The pH of the chitosan solution was 
3.8. An amount of 2.5 g of gelatin was dissolved in 25 mL of distilled water by heating to 100 
o
C for 1 minute with stirring. The pH of the gelatin solution was 5.5. Chitosan solution and 
gelatin solution was mixed together and 0.275 g glycerol added as a plasticizer.  
 
The blending solution was homogenized for 5 minutes to mix all the components thoroughly. 
It was then filtered through a Whatman filter paper to remove all insoluble particles. The 
solution was degassed by heating to 100 
o
C on a hot-plate magnetic-stirrer device with gentle 
stirring to form a clear solution. The resulting film forming solution had the pH of 4.1 which 
was then raised to pH 6.0 by adding 1 N NaOH solution.  
 
The film forming solution was poured carefully onto a casting tray with the dimension of 20 x 
20 cm so that no bubble was formed. It was settled flatly in the drying machine. It was dried 
at 40 
o
C for 24 hours. The forming film was peeled off the tray and stored in a PE bag in 
desiccators for at least 24 hours prior analysis.  
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The physical-chemical properties of the composite edible film are summarized in Table 7.2. 
The formed composite film had high solubility. Its mechanical properties was strong enough 
to make edible bags for storage of a small amount of food. The high sealablity of this film 
makes it feasible for application in food casing. 
  
Table 7.2: The physical-chemical properties of the composite edible film 
No. Parameters Value 
1 Thickness  60 µm 
2 Moisture content 10 % 
3 Solubility 85 % 
4 Tensile strength 23 MPa 
5 Percentage of deformation 67 % 
6 Water vapor permeation 1.94 x 10
-10
 g.m
-1
. s
-1
.Pa
-1
 
7 Tensile strength of the seal 13.27 MPa 
 
 
7.3.3.2 Microbiological properties of the composite edible film 
The microbiological properties of composite chitosan/gelatin film were examined followed 
modified method from previous studies (Abou-Zeid et al., 2011; Li et al., 2010; Thomas et 
al., 2009; Zivanovic et al., 2007). 
 
The bacterial growth on the composite edible film was examined 3 months after casting. The 
1 % chitosan film was used as the control. The results are presented in Table 7.3 and Figure 
7.19. The obtained data showed that the composite film had better microbial properties than 
the homogeneous chitosan film. There were no bacteria on the petri dish containing the 
composite chitosan/gelatin film, while there are bacteria on the chitosan film.  
  
When casting into a membrane, chitosan may lose its effectiveness that it has in its solution 
form because it can only exhibit its antibacterial activity in acidic conditions (Fernández-Saiz 
and Lagaron, 2011; Rabea et al., 2003). Possitive charges on the chitosan molecule are lost 
when the pH of the film forming solution is increased to pH 6. Moreover, some charges are 
involved in gel forming when casted into film. This is the reason why chitosan film loses its 
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antimicrobial activity. This result indicated that the combination of gelatin and chitosan can 
enhance the microbial inhibition ability of the chitosan-based edible film. 
 
Table 7.3: The microbial activity of the composite edible film 
Sample Replication CFU 
Chitosan film 
1 185 
2 174 
3 92 
Composite film 
1 0 
2 0 
3 0 
 
 
  
(a) chitosan film (b) composite film 
Figure 7.19: Bacterial growth in PCA petri dishes containing edible films 
 
 
The antimicrobial activity of the composite edible film was determined by the viable cell 
count method. The films were soaked in bacteial suspensions of E. coli (ATCC 25922) or S. 
aureus (ATCC 29213). The viable cells were enumerated by incubating 1 mL of the 
suspension on the plate count agar petri dishes after 2 hours, 4 hours and 24 hours of 
immersion for 24 hours at 37 
o
C. The results were presented in Table 7.4 and Table 7.5. 
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Table 7.4: Effect of the edible films on the survival of E. coli (ATCC 25922) (CFU)  
 
Replication 0 h 2 h 4 h 24 h 
Chitosan 
film 
1 1.1 x 10
7
 73 22 20 
2 1.1 x 10
7
 71 20 0 
3 1.1 x 10
7
 67 30 0 
Composite 
film 
1 1.1 x 10
7
 0 0 0 
2 1.1 x 10
7
 0 0 0 
3 1.1 x 10
7
 0 0 0 
Positive control  
(without film) 
1.1 x 10
7
 1.6 x 10
7
 1.1 x 10
8
 1.8 x 10
7
 
 
 
Table 7.5: The effect of the edible films on the survival S. aureus (ATCC 29213) (CFU)  
 
Replication 0 h 2 h 4 h 24 h 
Chitosan 
film 
1 2.3 x 10
6
 1465 180 20 
2 2.3 x 10
6
 0 0 0 
3 2.3 x 10
6
 0 0 0 
Composite 
film 
1 2.3 x 10
6
 0 0 0 
2 2.3 x 10
6
 393 245 14 
3 2.3 x 10
6
 416 335 8 
Positive control  
(without film) 
2.3 x 10
6
 2.5 x 10
6
 1.1 x 10
7
 1.0 x 10
7
 
 
The percentage reduction (%) of E. coli ATCC 25922 and S. aureus ATCC 29213 was 
calculated based on the viable cell counts. The results were presented in Table 7.6. 
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Table 7.6: Effect of the edible films on the percentage reduction (%) of E. coli ATCC 25922 
and S. aureus ATCC 29213 
 
Sample 2 h 4 h 24 h 
E. coli 
ATCC 25922 
Chitosan film 
99.9994  
± 0.0000 
99.9998  
± 0.0000 
99.9999  
± 0.0001 
Composite film 
100.0000  
± 0.0000 
100.0000  
± 0.0000 
100.0000  
± 0.0000 
Positive control -46.5021 -895.8848 -69.5473 
S. aureus 
ATCC 29213 
Chitosan film 
99.9968  
± 0.0000 
99.9989  
± 0.0000 
99.9999  
± 0.0000 
Composite film 
100.0000  
± 0.0000 
100.0000  
± 0.0000 
100.0000  
± 0.0000 
Positive control -5.9387  54.5977  57.4713  
 
 
The results showed that most bacteria were killed only after 2 hours of incubation with the 
edible films. The composite film exhibited 100 % of its effectiveness on the inhibition of the 
bacterial growth to both bacteria while the chitosan film seemed to have more effect on the 
Gram-negative bacterium.  
 
Other researches also found that when chitosan is blended with other substances such as 
polyethylene oxide, cellulose acetate or nanosilver, the antibacterial activity of the film 
increased significantly (Abou-Zeid et al., 2011; Thomas et al., 2009; Zivanovic et al., 2007). 
 
  
191 
 
7.3.4 Application of composite edible films in spice casing for instant noodles  
The composite edible films were applied to spice casing for instant noodles to examine their 
effectiveness for practical application. Small sachets with the dimension of approximately 40 
x 50 mm were prepared for the containing of seasoning powder and vegetable oil (Figure 
7.20).  
 
   
Composite edible film Edible film sachet PE sachet 
Figure 7.20: Composite edible film and small sachets ready for spice storage 
 
Approximately 1 g of seasoning powder or 1 mL of vegetable oil was put into each sachet. 
The sachets were sealed tightly at 90 
o
C for 10 seconds to prevent the loss of spice. The PE 
sachets were used as the control to determine the stability of the edible film sachets.  
 
The spice sachets were stored 6 months at ambient environment and in OPP wrap to 
investigate the effect of the storage condition to the stability of the edible film sachets. The oil 
and seasoning in each bag were evaluated for their sensory properties and had their weight 
loss and total plate counts measured after each month. 
 
7.3.4.1 Sensory evaluation 
The spice sachets were evaluated for their sensory properties before and during 6 months of 
storage. The evaluation was carried out by observation the status of the sachets and the inside 
seasoning powder and vegetable oil. The observation was recorded in Table 7.7 and Table 
7.8. 
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Table 7.7: Sensory evaluation of seasoning sachets during 6 months of storage  
Sample Status of sachets Status of seasoning 
Before storage 
A, B, C, D Dry, tight Dry, yellowish, good smell 
After 1 month of storage 
A, B, C, D Dry, tight Dry, yellowish, good smell 
After 2 months of storage 
A, B, C, D Dry, tight Dry, yellowish, good smell 
After 3 months of storage 
A, B Dry, tight Dry, faint yellowish, good smell 
C, D Dry, tight Dry, yellowish, good smell 
After 4 months of storage 
A Dry, tight, slightly soft Dry, white, good smell  
B Dry, tight Dry, white, good smell  
C, D Dry, tight Dry, yellowish, good smell 
After 5 months of storage 
A Dry, tight, slightly soft Slighly wet, white, good smell  
B Dry, tight Dry, white, good smell  
C, D Dry, tight Dry, yellowish, good smell 
After 6 months of storage 
A Dry, tight, soft, elastic Wet, white, good smell  
B Dry, tight Slighly wet, white, good smell  
C Dry, tight, slightly soft Dry, yellowish, good smell 
D Dry, tight Dry, yellowish, good smell 
Note:  A: Edible film sachets - Ambient environment     C: Edible film sachets - OPP wrapped 
B: PE sachets - Ambient environment     D: PE sachets - OPP wrapped 
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Table 7.8: Sensory evaluation of oil sachets during 6 months of storage  
Sample Status of sachets Status of oil 
Before storage 
A, B, C, D Dry, tight Clear, good smell 
After 1 month of storage 
A, B, C, D Dry, tight Clear, good smell 
After 2 months of storage 
A, C Little leakage at the seal Clear, good smell 
B, D Dry, tight Clear, good smell 
After 3 months of storage 
A, C Little leakage at the seal Clear, good smell 
B, D Dry, tight Clear, good smell 
After 4 months of storage 
A, C Little leakage at the seal Clear, good smell 
B, D Dry, tight Clear, good smell 
After 5 months of storage 
A 
Dry, tight, slightly soft and elastic, little 
leakage at the seal 
Clear, good smell 
B, C Dry, tight, little leakage at the seal Clear, good smell 
D Dry, tight Clear, good smell 
After 6 months of storage 
A 
Dry, tight, slightly soft and elastic, little 
leakage at the seal 
Clear, good smell 
B, C Dry, tight, little leakage at the seal Clear, good smell 
D Dry, tight Clear, good smell 
Note:  A: Edible film sachets - Ambient environment     C: Edible film sachets - OPP wrapped 
B: PE sachets - Ambient environment     D: PE sachets - OPP wrapped 
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The results showed that during 6 months of storage, the composite edible film sachets still 
retained their original shape no matter whether they were being stored in another packaging 
such as OPP or in contact directly with the ambient environment. 
 
The seasoning sachets showed no leakage during storage. The seal was still in a good position 
without any detachment. However, the edible film sachets which were stored in the ambient 
environment started to get wet after 5 months of storage. This could be because this 
composite edible film can absorb water from the environment. The edible film changed its 
properties remarkably after 6 months of storage. It was wet, soft and elastic that can not be 
torn by hands.  
 
There was no change in the appearance of the seasoning powder in both PE bags and edible 
film sachets which were covered by OPP wraps. However, a significant change in the color of 
the seasoning powder which was let in the ambient environment was recognized after 3 
months of storage. The yellow color of the seasoning powder faded gradually over time. After 
4 months, the yellow color was disappeared totally and the seasoning powder had a white 
color. This could be due to the oxidation of active substances in the seasoning powder such as 
iodine. 
 
For the preservation of oil, the oil samples still retained their quality during 6 months of 
storage without any changes in its color and smell. However, there was leakage of oil in the 
edible film sachets at the sealing lines starting from the second month of storage although 
there was no detachment at the seal of the sachets. This may due to the high sealing 
temperature that caused the films to be thinner at the sealing lines and allowed the oil to pass 
through. 
 
After 5 months of storage, there was a significant difference in the sensory properties between 
oil sachets under different storage conditions. Only the PE sachets kept in OPP wrap did not 
show the leakage of oil. The edible film sachets exposed to ambient environment turned soft 
and elastic, so they can not be torn by hand. 
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Spice sachets before storage 
    
Seasoning bio-bag Seasoning PE bag Oil bio-bag Oil PE bag 
  
Spice sachets after 6 months of storage 
Ambient environment OPP wrapped 
    
Seasoning bio-bag Seasoning PE bag Seasoning bio-bag Seasoning PE bag 
    
Oil bio-bag Oil PE bag Oil bio-bag Oil PE bag 
Figure 7.21: Seasoning and oil sachets before and after 6 months of storage 
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7.3.4.2 Weight loss 
The weight of seasoning sachets and oil sachets were recorded before storage and at each 
testing time. From these data, the percentage weight loss of seasoning sachets and oil sachets 
were calculated. The results were presented in Figure 7.22 and Figure 7.23. 
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Figure 7.22: The weight loss (%) of the seasoning sachets during 6 months of storage 
Note:  A: Edible film sachets - Ambient environment     C: Edible film sachets - OPP wrapped 
B: PE sachets - Ambient environment     D: PE sachets - OPP wrapped 
 
The percentage weight loss of the seasoning sachets fluctuated during 6 months of storage. 
However, the changes in the weight of these sachets, except the edible film sachets at ambient 
environment, were negligible. This could be due to the change of their weights was too low to 
be differentiated by a 4-decimal digit scale. The result showed that these sachets were stable 
at the storage conditions. 
 
The weight loss of the edible film sachets stored at ambient environment fluctuated at higher 
amplitude. Its weight rose up to 0.65 % and 2.5 % after 5 and 6 months of storage, 
respectively. It implied that these edible film sachets were not stable in the ambient 
environment. It can absorb water from the humidity of the environment, especially after 5 
months of storage. This result was compatible with the observation of its appearance in the 
previous section.  
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Figure 7.23: The weight loss (%) of the oil sachets during 6 months of storage 
Note:  A: Edible film sachets - Ambient environment     C: Edible film sachets - OPP wrapped 
B: PE sachets - Ambient environment     D: PE sachets - OPP wrapped 
 
The percentage weight loss of the oil sachets increased over 6 months of storage, except the 
PE sachets stored at ambient environment. The edible film sachets at the ambient environment 
lost weight sharply at the first 3 months of storage, then slowly till the sixth month. This 
could be due to the leakage of oil which was observed after 2 months of storage. The PE 
sachets stored at ambient environment seemed stable within the first 2 months, and then 
slightly increase its weight. The oil sachets stored in OPP wrap were stable with very low 
percentage of weight loss (< 1 %) during 6 months of storage. 
 
In general, the composite edible film sachets will be more stable with a very slight change in 
their weight if they are stored in a tight container such as OPP wrap. This kind of wrap 
prevents the contact between the edible film sachets with the outer environment, and thus 
inhibits the transmission of water through the edible film. 
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7.3.4.3 Total plate counts 
The seasoning powder and the vegetable oil stored in composite edible film sachets and PE 
sachets under different storage conditions were examined for their anti-microbiological 
properties by total plate count method (Table 7.9). 
 
Table 7.9: Total plate counts (CFU/g or CFU/mL) of seasoning powder and the vegetable oil 
during 6 months of storage 
Sample 0 month 1 month 2 months 3 months 4 months 5 months 6 months 
Seasoning powder 
A < 10 < 250 < 10 < 10 < 250 < 10 < 10 
B < 10 < 10 < 10 < 10 < 10 < 10 < 10 
C < 10 < 250 < 10 < 250 < 250 < 10 < 10 
D < 10 < 10 < 10 < 10 < 10 < 10 < 10 
Vegetable oil 
A < 10 < 250 < 10 < 10 < 10 < 10 < 10 
B < 10 < 10 < 10 < 250 < 10 < 10 < 10 
C < 10 < 250 < 10 < 10 < 10 < 10 < 10 
D < 10 < 250 < 10 < 10 < 10 < 10 < 10 
Note:  A: Edible film sachets - Ambient environment     C: Edible film sachets - OPP wrapped 
B: PE sachets - Ambient environment     D: PE sachets - OPP wrapped 
 
The results in Table 7.9 demonstrated that there is very limited growth of bacteria in these 
samples during 6 months of storage. This could be due to the high level of salt in the 
seasoning powder and the hydrophobic property of vegetable oil. The antibacterial property of 
the composite edible film could also take part in this inhibition activity. Therefore, although 
the edible film sachets were wet after 6 months of storage, the seasoning powder and the 
vegetable oil can still keep out bacteria. The moisture content of seasoning powder and 
vegetable oil was 0.5 % and 1 %, respectively. This low moisture content can also help the 
spice avoid the growth of bacteria. 
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7.4 GENERAL DISCUSSION AND CONCLUSION 
Throughout this work, a formulation of edible film for application in spice casing for instant 
noodles has been developed. This edible film was a combination of chitosan and gelatin with 
the support of glycerol as a plasticizer.  
 
The film forming solution is composed of 0.5 % (w/v) of chitosan which has 94 % DD, 5 % 
(w/v) of gelatin and 10 % (w/w dry matter) of glycerol. The film was formed after the 
solution was cast and dried at 40 
o
C for 24 hours. This kind of film had high solubility and 
sealability. Its mechanical properties were as strong as other polymers. It could inhibit the 
growth of bacteria better than the homogeneous chitosan film. Therefore, this film can be 
applied in instant food casing. 
 
The attempt to use this composite chitosan/gelatin edible film in making seasoning and oil 
sachets for instant noodles have confirmed the usability of this film. The spice stored in these 
edible film sachets can still keep their sensory quality and can avoid the presence of bacteria 
after 6 months of storage. These sachets retain their quality better if they are kept in another 
container to prevent contact with the outer environment. Therefore, this edible film is suitable 
for application in spice casing for instant noodles. 
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Chapter 8 
CONCLUSION AND FUTURE DIRECTIONS 
 
 
8.1 CONCLUSION 
 
Two rabbit polyclonal antibodies were successfully generated and are suitable for further 
studies. These antibodies were raised against the purified tropomyosin from four species of 
shrimp and against the total crustacean proteins from Mud crab, Slipper lobster, and Black 
Tiger shrimp. The rabbit sera showed high affinity and specificity to their antigen in Western 
blotting. The antibody titration was carried out using the indirect ELISA. The 
immunoreactivity of the rabbit sera were still very strong when the antibody was diluted 
30,000 times at very low concentrations of the purified tropomyosin and the crustacean 
protein, with 0.01 µg/mL and 0.1 µg/mL respectively. This indicated that the rabbit sera are 
very sensitive for the detection of the presence of tropomyosin. In addition, the rabbit serum 
against total crustacean proteins also recognised other proteins at higher mass. The strong 
reaction between the rabbit serum against proteins extracted from other species of shrimp as 
well as other crustacean species confirms the cross reactivity of the allergenic tropomyosin. 
 
The protein concentration of the extracts from Black Tiger and Banana shrimp varied and 
depended on shrimp species, part of the shrimp and the processing method. There was still a 
marked amount of protein in the shell extracts although the shrimp was treated by boiling. 
Most proteins in the shrimp extracts concentrated near the 75, 37 and 20 kDa regions in SDS-
PAGE. The immunobloting of these extracts with monoclonal antibody as well as crustacean 
sensitive patients has confirmed the presence of tropomyosin in these extracts. The 
tropomosin concentrations in the tail extracts and shell extracts were approximately at 3.5 
µg/mL and 1.0 µg/mL, respectively. Most the IC50 values of shrimp protein extracts to rabbit 
sera demonstrate strong cross-reactivity of both sera to most extracts and the highest 
concentration of tropomyosin in cooked shrimp. Therefore, special care should be given to the 
processing of shrimp derived products to prevent contamination with tropomyosin, which 
could cause allergic reactions in crustacean sensitized people. 
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Most of the proteins remaining in the chitin and chitosan could be degraded and broken down 
into small fragments during extraction, reflected in the fact that  no proteins could not be seen 
on the SDS-PAGE and Western blot. However, the immunoreactivities of the chitin and 
chitosan preparation were very strong in the Dot blot. The IC50s of these extracts to the rabbit 
serum pAbαTM were also obtained at very low concentration of inhibitor (approximately 0.01 
%). This result demonstrated that the small fragments of residual proteins in chitin and 
chitosan products may act as an allergen which can cause allergic reaction to sensitized 
patients. When they bind to the high-molecular-weight chitin and chitosan molecules, they 
can cause allergic reaction to sensitized patients. 
 
The biochemical properties of selected chitin and chitosan samples varied due to their 
different sources. Most samples have their moisture content less than 10 %. Their ash contents 
were less than 1 %, except for chitosan 2. The heavy metal content of these samples was very 
low compared to the Australian food standards for maximum permitted concentration of 
heavy metal in crustacean (Anon, 1987). It appears that each of the tested samples would be a 
safe product for use in the food industry. The protein content of normal chitosan samples was 
less than 1 %, while it cannot be detected in the purified sample. The results indicated that 
chitin and chitosan need to be characterized and standardized their properties before 
application in food industry. 
 
Chitosan at 0.05 % and 0.1 % concentration can inhibit the development of Escherichia coli, a 
Gram-negative bacterium, and Staphylococcus aureus, a Gram-positive bacterium. It can 
completely inhibit the growth of E. coli and S. aureus after 4 hours of incubation. The 
purified chitosan can still retain its antimicrobial property comparable to the normal chitosan 
as assayed through MIC, MBC and disc diffusion results. Their MICs to E. coli and S. aureus 
were 31.25 ppm while their MBCs were 31.25 ppm to E. coli and approximately 62.5ppm to 
S. aureus. These chitosan samples inhibit the Gram-negative bacteria better than Gram-
positive bacteria although the antibiotic activity of chitosan is rather low compared to 
chloramphenicol and ampicillin. However, due to its modest antimicrobial property, chitosan 
may be a promising material in the preservation of food products. 
 
The application of chitosan in shrimp preservation has confirmed its antimicrobial property. 
Both purified and normal chitosan can reduce the development of bacteria on shrimps during 
15 days of storage at 0 – 4 oC. Moreover, it can help the shrimp to lower the weight loss and 
keep their hardness higher than the non-treated ones during storage. 
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Throughout this work, a formulation of edible film for application in spice casing for instant 
noodles has been developed. This edible film is a combination of chitosan and gelatin with the 
support of glycerol as a plasticizer. The film forming solution was composed of 0.5 % (w/v) 
of chitosan which has 94 % DD, 5 % (w/v) of gelatin and 10 % (w/w dry matter) of glycerol. 
The film was formed after the solution was cast and dried at 40 
o
C for 24 hours. This kind of 
film has high solubility and sealability. Its mechanical properties were as strong as other 
polymers. It can inhibit the growth of bacteria better than the homogeneous chitosan film. 
Therefore, this film can be applied to instant food casing. The attempt to use this composite 
chitosan / gelatin edible film in making seasoning and oil sachets for instant noodles has 
confirmed the usability of this film. The spice stored in these edible film sachets can still keep 
their sensory quality and can avoid the presence of bacteria after 6 months of storage. These 
sachets retain their quality better if they are kept in another container to prevent contact with 
the outer environment. Therefore, this edible film is suitable for application in spice casing for 
instant noodles. 
 
Overall, the presence of the major allergen tropomyosin in chitin and chitosan could cause 
potential risk to crustacean sensitized consumers. So, commercial chitosan should be purified 
before applying in the food industry to protect consumers from allergic reactions. In addition 
chitosan can be combined with gelatine to form a water-soluble and sealable edible film 
which can be used in instant food casing. 
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8.2 DIRECTIONS FOR FURTHER STUDY 
 
Followings are some suggestions for further study related to this topic: 
 
- This study only detected the presence of the allergenic protein tropomyosin in the 
residual proteins in chitin and chitosan samples. Therefore, the next study should 
focus on the comparison of the immunoreactivity between normal and purified 
chitosan to antibodies against tropomyosin to confirm that tropomyosin has been 
removed completely out of chitin and chitosan.  
 
- In addition to tropomyosin, there are some other proteins in crustaceans such as 
arginine kinase or myosin light chain which could cause allergic reactions. So, there is 
also a need to examine the presence of these proteins in chitin and chitosan. 
 
- In this study, raw shrimp was preserved at cool temperature (0 – 4 oC). However, most 
shrimp in the market are preserved in the frozen state. Therefore, it is necessary to 
examine the antimicrobial property of normal and purified chitosan on shrimp 
preservation at frozen temperature. 
 
- The composite edible film still has some disadvantages such as it is not 100 % soluble, 
and there was some leakage of oil at the seal. Therefore, further studies to improve the 
quality of composite edible film are needed. 
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APPENDIX - CHAPTER 3 
 
 
A.3.1 Screening of the rabbit sera 
 
Table A.3.1: Checkerboard of rabbit sera pAbαCR 
Antibody 
dilution 
Log 
antibody 
dilution 
Crustacean protein concentration 
0.001 
µg/ml 
0.01 
µg/ml 
0.1 
µg/ml 
1 
µg/ml 
10 
µg/ml 
1,000 3.00E+00 
3.6718 
± 0.3946 
2.9762 
± 0.5116 
3.0813 
± 0.4616 
3.2342 
± 0.2631 
2.6948 
± 0.3792 
2,000 3.30E+00 
3.7950 
± 0.1095 
3.4167 
± 0.4723 
3.2463 
± 0.5259 
2.8273 
± 0.4150 
3.0632 
± 0.0299 
5,000 3.70E+00 
4.2450 
± 0.2012 
4.3153 
± 0.0917 
4.3035 
± 0.1870 
4.0057 
± 0.5205 
3.7953 
± 0.3891 
10,000 4.00E+00 
3.8077 
± 0.1771 
4.2145 
± 0.0273 
4.6012 
± 0.0669 
4.3835 
± 0.2969 
3.7882 
± 0.4225 
20,000 4.30E+00 
1.7477 
± 0.1025 
2.9877 
± 0.2336 
4.2428 
± 0.4723 
4.4082 
± 0.1899 
4.2602 
± 0.1905 
40,000 4.60E+00 
0.5640 
± 0.0347 
1.2805 
± 0.0776 
2.1548 
± 0.1674 
2.6562 
± 0.1714 
2.5385 
± 0.1595 
100,000 5.00E+00 
0.7965 
± 0.0304 
1.9485 
± 0.0948 
1.9485 
± 0.1616 
2.0847 
± 0.1475 
2.0943 
± 0.1457 
500,000 5.70E+00 
0.4045 
± 0.3868 
0.3373 
± 0.1373 
0.5347 
± 0.1544 
0.5293 
± 0.0553 
0.5957 
± 0.1007 
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Table A.3.2: Checkerboard of rabbit sera pAbαTM 
Antibody 
dilution 
Log 
antibody 
dilution 
Shrimp tropomyosin concentration 
0.001 
µg/ml 
0.01 
µg/ml 
0.1 
µg/ml 
1 
µg/ml 
10 
µg/ml 
1,000 3.00E+00 
3.4125 
± 0.1252 
3.1398 
± 0.0588 
3.2613 
± 0.0964 
3.2342 
± 0.0703 
3.4408 
± 0.0453 
2,000 3.30E+00 
4.5135 
± 0.3664 
3.3550 
± 0.0665 
3.0453 
± 0.0695 
3.3170 
± 0.1140 
3.4128 
± 0.0730 
5,000 3.70E+00 
4.5235 
± 0.2281 
3.9648 
± 0.1883 
3.8352 
± 0.2407 
3.2687 
± 0.1428 
3.6108 
± 0.1500 
10,000 4.00E+00 
2.4695 
± 0.0038 
4.5185 
± 0.2131 
4.0422 
± 0.2814 
3.7228 
± 0.3085 
3.6117 
± 0.1200 
20,000 4.30E+00 
0.2288 
± 0.0010 
2.7702 
± 0.0764 
2.9075 
± 0.0146 
4.6118 
± 0.1743 
4.7048 
± 0.2657 
40,000 4.60E+00 
0.0753 
± 0.0003 
0.3215 
± 0.0000 
1.1422 
± 0.0012 
2.2512 
± 0.0008 
2.5997 
± 0.0035 
100,000 5.00E+00 
0.1983 
± 0.0003 
0.6183 
± 0.0003 
1.4085 
± 0.0005 
2.1413 
± 0.0030 
2.2432 
± 0.0015 
500,000 5.70E+00 
0.0320 
± 0.0005 
0.0915 
± 0.0005 
0.2753 
± 0.0003 
0.4640 
± 0.0005 
0.5363 
± 0.0003 
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A.3.2 Immunoreactivity of different rabbit sera to the immunogens 
 
Table A.3.3: Sera dilution 1:5,000 
 
Rabbit serum 
 
Pre-bleed Test-bleed1 Test-bleed 2 Bleed-out 
Rabbit 1 – Anti-shrimp tropomyosin serum (pAbαTM) 
Shrimp 
tropomyosin 
0.0020 
± 0.0010 
0.3197 
± 0.0240   
Crustacean protein 
0.0150 
± 0.0108 
1.1713 
± 0.0450   
Rabbit 2 – Anti-shrimp tropomyosin serum (pAbαTM) 
Shrimp 
tropomyosin 
0.0012 
± 0.0010 
2.4588 
± 0.1861 
2.6655 
± 0.3357 
2.7802 
± 0.3235 
Crustacean protein 
0.0705 
± 0.0503 
2.9140 
± 0.1692 
2.7755 
± 0.2587 
3.3503 
± 0.2620 
Rabbit 3 – Anti-crustacean protein serum (pAbαCR) 
Shrimp 
tropomyosin 
0.0050 
± 0.0022 
1.6535 
± 0.0398 
2.5830 
± 0.3058 
2.4517 
± 0.2276 
Crustacean protein 
0.0097 
± 0.0010 
2.5820 
± 0.2493 
3.0913 
± 0.2787 
3.4390 
± 0.0320 
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Table A.3.4: Sera dilution 1:20,000 
 
Rabbit serum 
 
Pre-bleed Test-bleed1 Test-bleed 2 Bleed-out 
Rabbit 1 – Anti-shrimp tropomyosin serum (pAbαTM) 
Shrimp 
tropomyosin 
0.0005 
± 0.0005 
0.1258 
± 0.0013   
Crustacean protein 
0.0030 
± 0.0005 
0.4162 
± 0.0025   
Rabbit 2 – Anti-shrimp tropomyosin serum (pAbαTM) 
Shrimp 
tropomyosin 
0.0015 
± 0.0010 
2.2333 
± 0.0187 
3.8602 
± 0.0739 
2.9775 
± 0.0219 
Crustacean protein 
0.0120 
± 0.0005 
3.7780 
± 0.0331 
4.5453 
± 0.2128 
3.8958 
± 0.0560 
Rabbit 3 – Anti-crustacean protein serum (pAbαCR) 
Shrimp 
tropomyosin 
0.0030 
± 0.0005 
0.6113 
± 0.0070 
1.9902 
± 0.0111 
1.4153 
± 0.0133 
Crustacean protein 
0.0085 
± 0.0000 
2.5258 
± 0.0273 
4.5192 
± 0.1337 
3.4145 
± 0.0236 
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Table A.3.5: Sera dilution 1:30,000 
 
Rabbit serum 
 
Pre-bleed Test-bleed1 Test-bleed 2 Bleed-out 
Rabbit 1 – Anti-shrimp tropomyosin serum (pAbαTM) 
Shrimp 
tropomyosin 
0.0013 
± 0.0003 
0.0720 
± 0.0013   
Crustacean protein 
0.0027 
± 0.0003 
0.1563 
± 0.0016   
Rabbit 2 – Anti-shrimp tropomyosin serum (pAbαTM) 
Shrimp 
tropomyosin 
0.0015 
± 0.0015 
2.9050 
± 0.0864 
3.5563 
± 0.0268 
2.5377 
± 0.0643 
Crustacean protein 
0.0108 
± 0.0008 
3.8753 
± 0.0796 
3.9917 
± 0.0473 
3.4040 
± 0.0545 
Rabbit 3 – Anti-crustacean protein serum (pAbαCR) 
Shrimp 
tropomyosin 
0.0018 
± 0.0019 
0.1432 
± 0.0014 
0.2173 
± 0.0053 
1.0653 
± 0.0324 
Crustacean protein 
0.0012 
± 0.0008 
0.2660 
± 0.0022 
0.4258 
± 0.0038 
3.1582 
± 0.0359 
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A.3.3 Immunoreactivity of rabbit sera to specific crustacean protein extract 
 
Table A.3.6: Sera dilution 1:5,000 
Antigen 
Rabbit serum  
pAbαCR 
Rabbit serum  
pAbαTM 
Mix purified tropomyosin 1.8177 ± 0.1974 1.4950 ± 0.1243 
Black Tiger shrimp - Tropomyosin 1.0543 ± 0.0673 1.8793 ± 0.0624 
Banana shrimp - Tropomyosin 1.9393 ± 0.1161 2.3560 ± 0.1125 
Vannamei shrimp - Tropomyosin 1.8353 ± 0.0723 2.3410 ± 0.1489 
School shrimp - Tropomyosin 1.6088 ± 0.0370 2.1290 ± 0.2683 
King shrimp - Tropomyosin 1.9175 ± 0.2208 1.5322 ± 0.1720 
Mix crustacean protein 1.6548 ± 0.1576 1.5642 ± 0.1917 
Black Tiger shrimp protein 2.0152 ± 0.2652 1.7102 ± 0.2156 
Banana shrimp protein 1.7070 ± 0.2202 1.5498 ± 0.1661 
Vannamei shrimp protein 1.5827 ± 0.1683 1.5372 ± 0.1928 
School shrimp protein 1.6052 ± 0.1437 1.6102 ± 0.1667 
King shrimp protein 1.7917 ± 0.2142 1.6582 ± 0.2112 
Mud crab  protein 1.8980 ± 0.2275 1.4823 ± 0.1096 
Slipper lobster protein 2.1153 ± 0.2523 1.8873 ± 0.2600 
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Table A.3.7: Sera dilution 1:20,000 
Antigen 
Rabbit serum  
pAbαCR 
Rabbit serum  
pAbαTM 
Mix purified tropomyosin 1.2582 ± 0.0055 2.5467 ± 0.0198 
Black Tiger shrimp - Tropomyosin 0.2360 ± 0.0020 0.7483 ± 0.0060 
Banana shrimp - Tropomyosin 0.6490 ± 0.0039 1.6755 ± 0.0140 
Vannamei shrimp - Tropomyosin 0.4378 ± 0.0102 1.2573 ± 0.0077 
School shrimp - Tropomyosin 0.3260 ± 0.0025 0.9793 ± 0.0068 
King shrimp - Tropomyosin 1.4087 ± 0.0077 2.4058 ± 0.0163 
Mix crustacean protein 3.0643 ± 0.0321 3.7307 ± 0.0262 
Black Tiger shrimp protein 1.9397 ± 0.0157 2.9607 ± 0.0237 
Banana shrimp protein 2.7072 ± 0.0234 3.5615 ± 0.1471 
Vannamei shrimp protein 1.6213 ± 0.0153 2.9113 ± 0.0872 
School shrimp protein 3.1420 ± 0.0401 3.8235 ± 0.0490 
King shrimp protein 1.4503 ± 0.0264 3.1778 ± 0.0563 
Mud crab  protein 2.6130 ± 0.0205 3.3458 ± 0.0380 
Slipper lobster protein 0.9223 ± 0.0083 1.9070 ± 0.0148 
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Table A.3.8: Sera dilution 1:30,000 
Antigen 
Rabbit serum  
pAbαCR 
Rabbit serum  
pAbαTM 
Mix purified tropomyosin 1.5818 ± 0.0475 2.3063 ± 0.0471 
Black Tiger shrimp - Tropomyosin 0.1885 ± 0.0064 0.5845 ± 0.0126 
Banana shrimp - Tropomyosin 0.4055 ± 0.0092 0.9482 ± 0.0177 
Vannamei shrimp - Tropomyosin 0.3668 ± 0.0141 0.9812 ± 0.0193 
School shrimp - Tropomyosin 0.3808 ± 0.0391 1.0135 ± 0.0231 
King shrimp - Tropomyosin 1.2545 ± 0.0188 2.1038 ± 0.0687 
Mix crustacean protein 3.2213 ± 0.0990 3.3150 ± 0.0882 
Black Tiger shrimp protein 2.7062 ± 0.0445 3.6382 ± 0.0913 
Banana shrimp protein 2.6853 ± 0.0746 3.6535 ± 0.0642 
Vannamei shrimp protein 1.8495 ± 0.0941 2.7722 ± 0.1005 
School shrimp protein 3.0505 ± 0.0493 3.6595 ± 0.1379 
King shrimp protein 1.4558 ± 0.0436 3.0000 ± 0.0661 
Mud crab  protein 1.1365 ± 0.0215 2.1860 ± 0.0608 
Slipper lobster protein 2.9437 ± 0.0540 3.0058 ± 0.0848 
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APPENDIX - CHAPTER 4 
 
 
A.4.1 Protein concentration of shrimp protein extracts 
 
Table A.4.1: Protein concentration in shrimp extracts (% w/w) 
Shrimp protein extracts Mean STD 
Black Tiger raw tail extract 3.7388 0.1926 
Black Tiger raw shell extract 1.9070 0.0651 
Black Tiger heat-treated tail extract 1.1343 0.0656 
Black Tiger heat-treated shell extract 0.0975 0.0063 
Black Tiger cooked tail extract 1.0580 0.1193 
Black Tiger cooked shell extract 0.3550 0.0282 
Banana raw tail extract 2.1163 0.0723 
Banana raw tail extract 0.6486 0.0641 
Banana heat-treated tail extract 1.2224 0.0248 
Banana heat-treated shell extract 0.0899 0.0081 
Banana cooked tail extract 0.5125 0.0070 
Banana cooked shell extract 0.1460 0.0147 
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Table A.4.2: Statistical analysis of protein concentration (%) of shrimp protein extracts  
Source 
Type III  
Sum of Squares df 
Mean 
Square F Sig. 
Corrected Model 38.106
a
 11 3.464 585.634 .000 
Intercept 42.420 1 42.420 7171.305 .000 
Shrimp 3.159 1 3.159 534.095 .000 
Part 10.687 1 10.687 1806.755 .000 
Status 18.706 2 9.353 1581.152 .000 
Shrimp * Part .091 1 .091 15.462 .001 
Shrimp * Status 3.497 2 1.749 295.613 .000 
Part * Status 1.865 2 .932 157.636 .000 
Shrimp * Part * Status .100 2 .050 8.430 .002 
Error .142 24 .006   
Total 80.669 36    
Corrected Total 38.248 35    
a
. R Squared = .996 (Adjusted R Squared = .995) 
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A.4.2 Immunoreactivity of different shrimp protein extracts to rabbit sera 
A.4.2.1 Immunoreactivity of shrimp protein extracts to rabbit serum pAbαCR  
 
Table A.4.3: The absorbance values of the bindings of different shrimp protein extracts to 
rabbit serum pAbαCR 
Shrimp protein extracts Mean STD 
Black Tiger raw tail extract 1.4736 0.0348 
Black Tiger raw tail extract 0.1069 0.0040 
Black Tiger heat-treated tail extract 0.0807 0.0023 
Black Tiger heat-treated shell extract 0.0888 0.0022 
Black Tiger cooked tail extract 1.5303 0.0346 
Black Tiger cooked shell extract 0.9399 0.0227 
Banana raw tail extract 1.1826 0.0280 
Banana raw tail extract 0.1715 0.0035 
Banana heat-treated tail extract 1.1750 0.0286 
Banana heat-treated shell extract 0.0676 0.0034 
Banana cooked tail extract 1.7280 0.0400 
Banana cooked shell extract 0.1896 0.0070 
Crustacean protein 0.1 µg/mL 2.7492 0.0693 
Crustacean protein 0.01 µg/mL 2.5803 0.0515 
Crustacean protein 0.001 µg/mL 0.1640 0.0046 
Crustacean protein 0.0001 µg/mL 0.0522 0.0019 
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Table A.4.4: Statistical analysis of the absorbance values of the bindings of different shrimp 
protein extracts to rabbit serum pAbαCR  
Source 
Type III  
Sum of Squares df 
Mean 
Square F Sig. 
Corrected Model 14.701
a
 11 1.336 2578.525 .000 
Intercept 19.072 1 19.072 36798.503 .000 
Shrimp .022 1 .022 41.693 .000 
Part 7.857 1 7.857 15159.142 .000 
Status 3.321 2 1.661 3204.120 .000 
Shrimp * Part .729 1 .729 1407.162 .000 
Shrimp * Status 1.110 2 .555 1070.451 .000 
Part * Status .689 2 .345 664.772 .000 
Shrimp * Part * Status .973 2 .486 938.546 .000 
Error .012 24 .001   
Total 33.785 36    
Corrected Total 14.713 35    
 
a
. R Squared = .999 (Adjusted R Squared = .999)  
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Table A.4.5: Percentage inhibition of different Black Tiger shrimp protein extracts to rabbit 
serum pAbαCR 
Inhibitor 
Inhibitor concentration 
0 µg/mL 0.01 µg/mL 0.1 µg/mL 1 µg/mL 10 µg/mL 
Raw tail extract 
0.00 
± 0.0000 
45.01 
± 1.4033 
66.77 
± 1.0513 
80.12 
± 0.6253 
87.10 
± 0.4250 
Raw tail extract 
0.00 
± 0.0000 
36.02 
± 1.9642 
40.72 
± 2.1524 
41.11 
± 1.7490 
63.48 
± 1.1445 
Heat-treated tail 
extract 
0.00 
± 0.0000 
46.97 
± 0.8925 
49.28 
± 1.6170 
52.24 
± 3.6743 
71.78 
± 3.2256 
Heat-treated 
shell extract 
0.00 
± 0.0000 
44.88 
± 0.7377 
47.24 
± 0.7731 
50.23 
± 2.7616 
53.79 
± 2.1953 
Cooked tail 
extract 
0.00 
± 0.0000 
60.95 
± 1.1398 
78.31 
± 0.6252 
87.61 
± 0.3405 
92.83 
± 0.1500 
Cooked shell 
extract 
0.00 
± 0.0000 
43.90 
± 2.3239 
67.27 
± 1.0823 
84.51 
± 0.3917 
92.05 
± 0.1926 
Mix crustacean 
protein 
0.00 
± 0.0000 
61.04 
± 1.0883 
83.06 
± 0.4771 
97.17 
± 0.0901 
100.06 
± 0.0203 
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Table A.4.6: Statistical analysis of the percentage inhibition of different Black Tiger shrimp 
protein extracts to rabbit serum pAbαCR 
 
Source 
Type III Sum 
of Squares df Mean Square F Sig. 
Corrected Model 76800.302
a
 29 2648.286 408.507 .000 
Intercept 218341.997 1 218341.997 33679.980 .000 
Part 2167.569 1 2167.569 334.355 .000 
Status 5571.421 2 2785.710 429.705 .000 
Concentration 62952.684 4 15738.171 2427.665 .000 
Part * Status 1062.891 2 531.446 81.977 .000 
Part * Concentration 609.414 4 152.354 23.501 .000 
Status * Concentration 2829.793 8 353.724 54.563 .000 
Part * Status * 
Concentration 
1606.529 8 200.816 30.977 .000 
Error 388.971 60 6.483   
Total 295531.269 90    
Corrected Total 77189.272 89    
 
a.
 R Squared = .995 (Adjusted R Squared = .993) 
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Table A.4.7: Percentage inhibition of different Banana shrimp protein extracts to rabbit 
serum pAbαCR 
Inhibitor 
Inhibitor concentration 
0 µg/mL 0.01 µg/mL 0.1 µg/mL 1 µg/mL 10 µg/mL 
Raw tail extract 
0.00 
± 0.0000 
47.84 
± 1.8388 
57.64 
± 1.6100 
81.12 
± 1.1078 
87.01 
± 0.3029 
Raw tail extract 
0.00 
± 0.0000 
40.10 
± 1.3966 
44.36 
± 1.3191 
67.05 
± 0.7634 
80.85 
± 0.4205 
Heat-treated tail 
extract 
0.00 
± 0.0000 
54.07 
± 1.0921 
72.89 
± 0.6115 
86.25 
± 0.3192 
90.94 
± 0.2230 
Heat-treated 
shell extract 
0.00 
± 0.0000 
41.00 
± 0.8512 
43.58 
± 1.5168 
46.01 
± 1.2460 
50.41 
± 3.2512 
Cooked tail 
extract 
0.00 
± 0.0000 
77.39 
± 0.5054 
86.97 
± 0.3192 
91.64 
± 0.2143 
94.67 
± 0.1458 
Cooked shell 
extract 
0.00 
± 0.0000 
40.32 
± 1.3911 
41.81 
± 1.3944 
56.42 
± 0.9919 
80.29 
± 0.4853 
Mix crustacean 
protein 
0.00 
± 0.0000 
73.95 
± 0.6036 
89.70 
± 0.2672 
97.94 
± 0.0758 
99.70 
± 0.0181 
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Table A.4.8: Statistical analysis of the percentage inhibition of different Banana shrimp 
protein extracts to rabbit serum pAbαCR 
Source 
Type III Sum 
of Squares df Mean Square F Sig. 
Corrected Model 87852.851
a
 29 3029.409 2661.716 .000 
Intercept 243550.357 1 243550.357 213989.597 .000 
Part 8773.641 1 8773.641 7708.747 .000 
Status 1158.023 2 579.011 508.734 .000 
Concentration 70961.469 4 17740.367 15587.142 .000 
Part * Status 1498.852 2 749.426 658.465 .000 
Part * Concentration 2621.835 4 655.459 575.903 .000 
Status * Concentration 1297.922 8 162.240 142.548 .000 
Part * Status * 
Concentration 
1541.108 8 192.639 169.257 .000 
Error 68.288 60 1.138   
Total 331471.497 90    
Corrected Total 87921.140 89    
a.
 R Squared = .999 (Adjusted R Squared = .999) 
 
 
  
 
 
237 
 
A.4.2.2 Immunoreactivity of shrimp protein extracts to rabbit serum pAbαTM 
 
Table A.4.9: The absorbance values of the bindings of different shrimp protein extracts to 
rabbit serum pAbαTM 
Shrimp protein extracts Mean STD 
Black Tiger raw tail extract 2.4056 0.0620 
Black Tiger raw tail extract 0.3387 0.0073 
Black Tiger heat-treated tail extract 0.6274 0.0114 
Black Tiger heat-treated shell extract 0.2308 0.0064 
Black Tiger cooked tail extract 2.8278 0.0725 
Black Tiger cooked shell extract 2.3788 0.0498 
Banana raw tail extract 2.6768 0.0805 
Banana raw tail extract 0.5263 0.0099 
Banana heat-treated tail extract 2.7570 0.0807 
Banana heat-treated shell extract 0.3890 0.0084 
Banana cooked tail extract 3.3566 0.0988 
Banana cooked shell extract 0.8713 0.0143 
Purified tropomyosin 0.1 µg/mL 3.3209 0.1712 
Purified tropomyosin 0.01 µg/mL 1.8711 0.0440 
Purified tropomyosin 0.001 µg/mL 1.2689 0.0300 
Purified tropomyosin 0.0001 µg/mL 0.2872 0.0104 
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Table A.4.10: Statistical analysis of the absorbance values of the bindings of different shrimp 
protein extracts to rabbit serum pAbαTM 
Source 
Type III  
Sum of Squares df 
Mean 
Square F Sig. 
Corrected Model 47.716
a
 11 4.338 1490.380 .000 
Intercept 93.954 1 93.954 32280.526 .000 
Shrimp .781 1 .781 268.490 .000 
Part 24.583 1 24.583 8446.109 .000 
Status 11.356 2 5.678 1950.785 .000 
Shrimp * Part 4.184 1 4.184 1437.629 .000 
Shrimp * Status 4.020 2 2.010 690.635 .000 
Part * Status .946 2 .473 162.571 .000 
Shrimp * Part * Status 1.845 2 .923 316.985 .000 
Error .070 24 .003   
Total 141.740 36    
Corrected Total 47.786 35    
a
. R Squared = .999 (Adjusted R Squared = .998) 
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Table A.4.11: The tropomyosin concentration (µg/mL) of shrimp protein extracts 
Shrimp protein extracts Mean STD 
Black Tiger raw tail extract 3.242 0.0483 
Black Tiger raw shell extract 1.1099 0.0129 
Black Tiger heat-treated tail extract 1.4079 0.0016 
Black Tiger heat-treated shell extract 0.9986 0.018 
Black Tiger cooked tail extract 3.6776 0.0619 
Black Tiger cooked shell extract 3.2147 0.0559 
Banana raw tail extract 3.5214 0.0509 
Banana raw shell extract 1.3036 0.0054 
Banana heat-treated tail extract 3.6042 0.0495 
Banana heat-treated shell extract 1.1619 0.0114 
Banana cooked tail extract 4.2227 0.0742 
Banana cooked shell extract 1.6596 0.0088 
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Table A.4.12: Statistical analysis of the tropomyosin concentration (µg/mL) of different 
shrimp protein extracts 
Source 
Type III Sum of 
Squares df Mean Square F Sig. 
Corrected Model 58.708
a
 11 5.337 3813.868 .000 
Intercept 45.909 1 45.909 32806.453 .000 
Shrimp 3.032 1 3.032 2166.853 .000 
Part 34.260 1 34.260 24481.981 .000 
Status 12.215 2 6.108 4364.466 .000 
Shrimp * Part .780 1 .780 557.558 .000 
Shrimp * Status .843 2 .421 301.097 .000 
Part * Status 6.606 2 3.303 2360.402 .000 
Shrimp * Part * Status .971 2 .486 347.112 .000 
Error .034 24 .001   
Total 104.652 36    
Corrected Total 58.742 35    
a. R Squared = .999 (Adjusted R Squared = .999) 
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Table A.4.13: Percentage of tropomyosin compared to total protein extracted from Black 
Tiger shrimp and Banana shrimp 
Shrimp protein extracts 
Total protein 
(mg/mL) 
% tropomyosin 
/ total protein 
Black Tiger raw tail extract 1.6863 0.1923 
Black Tiger raw shell extract 1.7452 0.0636 
Black Tiger heat-treated tail extract 1.5741 0.0894 
Black Tiger heat-treated shell extract 0.5446 0.1834 
Black Tiger cooked tail extract 0.5801 0.6339 
Black Tiger cooked shell extract 0.6979 0.4606 
Banana raw tail extract 1.6306 0.2160 
Banana raw shell extract 1.1328 0.1151 
Banana heat-treated tail extract 1.1296 0.3191 
Banana heat-treated shell extract 0.3768 0.3084 
Banana cooked tail extract 0.2614 1.6153 
Banana cooked shell extract 0.9852 0.1685 
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Table A.4.14: Percentage inhibition of different Black Tiger shrimp protein extracts to rabbit 
serum pAbαTM 
Inhibitor 
Inhibitor concentration 
0 µg/mL 
0.01 
µg/mL 0.1 µg/mL 1 µg/mL 10 µg/mL 
Raw tail extract 
0.00 
± 0.0000 
0.01 
± 0.3820 
0.10 
± 0.1503 
1.00 
± 0.0331 
10.00 
± 0.0306 
Raw tail extract 
0.00 
± 0.0000 
42.68 
± 0.7772 
73.11 
± 0.4612 
90.19 
± 0.6068 
98.45 
± 0.2882 
Heat-treated tail 
extract 
0.00 
± 0.0000 
21.57 
± 0.9106 
22.25 
± 0.4061 
24.45 
± 0.1811 
52.43 
± 0.0353 
Heat-treated shell 
extract 
0.00 
± 0.0000 
35.42 
± 0.8062 
44.59 
± 0.4810 
60.97 
± 0.5020 
89.58 
± 0.2199 
Cooked tail extract 
0.00 
± 0.0000 
30.96 
± 0.3105 
32.32 
± 0.0925 
40.85 
± 0.0441 
56.83 
± 0.0704 
Cooked shell extract 
0.00 
± 0.0000 
77.24 
± 0.5519 
89.64 
± 0.2121 
97.77 
± 0.0814 
99.76 
± 0.0585 
Mix purified 
tropomyosin 
0.00 
± 0.0000 
49.22 
± 0.0665 
75.23 
± 0.0447 
95.16 
± 0.0669 
99.38 
± 0.0595 
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Table A.4.15: Statistical analysis of the percentage inhibition of different Black Tiger shrimp 
protein extracts to rabbit serum pAbαTM 
Source 
Type III Sum 
of Squares df Mean Square F Sig. 
Corrected Model 110124.945
a
 29 3797.412 27702.608 .000 
Intercept 225012.000 1 225012.000 1641491.450 .000 
Part 8925.754 1 8925.754 65114.520 .000 
Status 15302.965 2 7651.482 55818.548 .000 
Concentration 71883.603 4 17970.901 131100.030 .000 
Part * Status 3274.455 2 1637.228 11943.785 .000 
Part * Concentration 2563.119 4 640.780 4674.571 .000 
Status * Concentration 4756.613 8 594.577 4337.513 .000 
Part * Status * 
Concentration 
3418.435 8 427.304 3117.241 .000 
Error 8.225 60 .137   
Total 335145.169 90    
Corrected Total 110133.169 89    
a.
 R Squared = 1.000 (Adjusted R Squared = 1.000) 
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Table A.4.16: Percentage inhibition of different Banana shrimp protein extracts to rabbit 
serum pAbαTM 
Inhibitor 
Inhibitor concentration 
0 µg/mL 0.01 µg/mL 0.1 µg/mL 1 µg/mL 10 µg/mL 
Raw tail extract 
0.00 
± 0.0000 
40.09 
± 0.3732 
73.22 
± 0.3296 
88.63 
± 0.0667 
96.59 
± 0.0305 
Raw tail extract 
0.00 
± 0.0000 
38.55 
± 0.1725 
47.21 
± 0.5013 
61.93 
± 0.3736 
74.08 
± 0.5296 
Heat-treated tail 
extract 
0.00 
± 0.0000 
63.79 
± 0.3776 
86.96 
± 0.1489 
96.51 
± 0.0192 
98.97 
± 0.0333 
Heat-treated 
shell extract 
0.00 
± 0.0000 
39.51 
± 1.0815 
41.26 
± 0.9269 
42.47 
± 0.5231 
54.22 
± 0.5089 
Cooked tail 
extract 
0.00 
± 0.0000 
91.97 
± 0.1057 
96.05 
± 0.0305 
99.46 
± 0.0342 
99.54 
± 0.0457 
Cooked shell 
extract 
0.00 
± 0.0000 
37.06 
± 0.8669 
43.36 
± 0.8818 
57.31 
± 0.5246 
81.23 
± 0.1377 
Mix purified 
tropomyosin 
0.00 
± 0.0000 
95.57 
± 0.0319 
98.94 
± 0.0600 
99.08 
± 0.0601 
99.03 
± 0.5792 
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Table A.4.17: Statistical analysis of the percentage inhibition of different Banana shrimp 
protein extracts to rabbit serum pAbαTM 
Source 
Type III Sum 
of Squares df Mean Square F Sig. 
Corrected Model 107442.768
a
 29 3704.923 20150.905 .000 
Intercept 272252.200 1 272252.200 1480767.134 .000 
Part 17107.047 1 17107.047 93044.441 .000 
Status 1412.103 2 706.051 3840.181 .000 
Concentration 78331.548 4 19582.887 106510.417 .000 
Part * Status 1680.510 2 840.255 4570.107 .000 
Part * Concentration 5103.321 4 1275.830 6939.182 .000 
Status * Concentration 1593.539 8 199.192 1083.398 .000 
Part * Status * 
Concentration 
2214.700 8 276.837 1505.706 .000 
Error 11.032 60 .184   
Total 379705.999 90    
Corrected Total 107453.799 89    
a.
 R Squared = 1.000 (Adjusted R Squared = 1.000) 
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APPENDIX - CHAPTER 5 
 
Table A.5.1: Percentage inhibition of protein extracts from chitin and chitosan samples to 
rabbit serum pAbαCR 
Concentration 
Protein extract 
0  
µg/mL 
0.01  
g/mL 
0.1  
µg/mL 
1  
µg/mL 
10  
µg/mL 
CTS1-Acetate 
0.0000 
± 0.0000 
38.6551 
± 1.1483 
41.2658 
± 1.3619 
47.1047 
± 0.9661 
66.6019 
± 0.7314 
CTS1-SDS-DTT 
0.0000 
± 0.0000 
33.4224 
± 2.1572 
36.7709 
± 1.6732 
38.5722 
± 1.4612 
44.6817 
± 1.0458 
CTS1-NaOH 
0.0000 
± 0.0000 
39.6983 
± 1.5575 
43.2487 
± 1.4704 
44.7898 
± 1.6340 
46.0113 
± 0.7264 
CTS1-Phosphate 
0.0000 
± 0.0000 
40.0788 
± 1.2885 
41.4976 
± 0.8870 
45.5760 
± 0.8410 
46.7418 
± 0.5571 
CTS2- Acetate 
0.0000 
± 0.0000 
37.8007 
± 2.5792 
39.5447 
± 1.1869 
60.0807 
± 1.2237 
69.6900 
± 1.6464 
CTS2-SDS-DTT 
0.0000 
± 0.0000 
35.1707 
± 2.4870 
41.1220 
± 1.3967 
41.8433 
± 3.1663 
47.0047 
± 3.7736 
CTS2-NaOH 
0.0000 
± 0.0000 
40.6863 
± 2.9213 
43.2103 
± 3.0213 
47.7007 
± 2.6944 
59.3970 
± 2.4577 
CTS2-Phosphate 
0.0000 
± 0.0000 
40.3614 
± 2.8108 
45.3411 
± 1.3545 
51.4519 
± 2.3556 
60.2050 
± 1.5162 
CT-Supernatant I 
0.0000 
± 0.0000 
41.6494 
± 1.7082 
43.4502 
± 0.9782 
46.0542 
± 0.9643 
48.5580 
± 1.0994 
CT-Supernatant II 
0.0000 
± 0.0000 
40.3337 
± 1.5897 
43.6099 
± 1.1956 
45.2073 
± 1.7617 
63.1045 
± 1.2187 
CT-Phosphoric 
0.0000 
± 0.0000 
41.6793 
± 0.1931 
43.4644 
± 0.1069 
46.1113 
± 1.7330 
69.7166 
± 0.1202 
TROP 
0.0000 
± 0.0000 
59.8351 
± 1.1216 
84.4939 
± 0.4346 
93.7848 
± 0.0970 
96.9942 
± 0.0322 
CRUS 
0.0000 
± 0.0000 
49.4999 
± 1.3756 
82.3815 
± 0.5477 
97.6154 
± 0.0607 
100.0197 
± 0.0466 
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Table A.5.2: Statistical analysis of the percentage inhibition of protein extracts from chitin 
and chitosan samples to rabbit serum pAbαCR 
Source 
Type III Sum 
of Squares df Mean Square F Sig. 
Corrected Model 66199.541
a
 54 1225.917 490.671 .000 
Intercept 224392.568 1 224392.568 89812.742 .000 
Preparation 1634.242 10 163.424 65.410 .000 
Concentration 61878.240 4 15469.560 6191.665 .000 
Preparation * 
Concentration 
2687.059 40 67.176 26.887 .000 
Error 274.829 110 2.498   
Total 290866.938 165    
Corrected Total 66474.371 164    
a. R Squared = .996 (Adjusted R Squared = .994) 
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Table A.5.3: Percentage inhibition of protein extracts from chitin and chitosan samples to 
rabbit serum pAbαTM 
Concentration 
Protein extract 
0 
µg/mL 
0.01 
µg/mL 
0.1  µg/mL 
1 
µg/mL 
10 
µg/mL 
CTS1-Acetate 
0.0000 
± 0.0000 
55.3314 
± 3.0174 
57.9086 
± 2.5726 
63.2828 
± 2.6968 
84.2494 
± 1.0406 
CTS1-SDS-DTT 
0.0000 
± 0.0000 
54.3759 
± 2.7005 
57.0022 
± 2.2230 
58.3662 
± 2.2697 
58.7536 
± 2.1467 
CTS1-NaOH 
0.0000 
± 0.0000 
56.5252 
± 3.6675 
60.3084 
± 2.6431 
61.1595 
± 2.4906 
67.5772 
± 2.0490 
CTS1-Phosphate 
0.0000 
± 0.0000 
56.8770 
± 2.8236 
59.0245 
± 2.5862 
61.1375 
± 2.5552 
72.3191 
± 1.8482 
CTS2- Acetate 
0.0000 
± 0.0000 
56.2395 
± 2.3678 
56.9502 
± 2.2287 
75.5447 
± 1.2209 
96.4231 
± 0.2024 
CTS2-SDS-DTT 
0.0000 
± 0.0000 
53.0140 
± 2.5914 
54.4964 
± 2.4670 
56.6806 
± 3.4169 
64.1391 
± 0.9640 
CTS2-NaOH 
0.0000 
± 0.0000 
57.9202 
± 1.7871 
60.1240 
± 2.5016 
62.3171 
± 2.3319 
71.9716 
± 1.5165 
CTS2-Phosphate 
0.0000 
± 0.0000 
57.5728 
± 2.7651 
59.1929 
± 2.9465 
61.1514 
± 2.4352 
64.6248 
± 1.5874 
CT-Supernatant I 
0.0000 
± 0.0000 
57.1367 
± 3.1882 
65.5325 
± 2.2291 
68.1793 
± 1.9992 
73.1259 
± 2.3585 
CT-Supernatant II 
0.0000 
± 0.0000 
58.7385 
± 2.5757 
60.5532 
± 2.4150 
65.6914 
± 2.1737 
99.3050 
± 0.0559 
CT-Phosphoric 
0.0000 
± 0.0000 
56.4411 
± 2.5873 
63.3985 
± 2.2861 
66.1491 
± 2.2210 
90.2027 
± 0.6362 
TROP 
0.0000 
± 0.0000 
95.0196 
± 0.2538 
99.0794 
± 0.0699 
99.8061 
± 0.0451 
99.7697 
± 0.0458 
CRUS 
0.0000 
± 0.0000 
83.3230 
± 0.8228 
93.4321 
± 0.3548 
97.8683 
± 0.1321 
99.2243 
± 0.0703 
 
  
 
 
249 
 
 
Table A.5.4: Statistical analysis of the percentage inhibition of protein extracts from chitin 
and chitosan samples to rabbit serum pAbαTM 
Source 
Type III Sum 
of Squares df Mean Square F Sig. 
Corrected Model 119434.570
a
 54 2211.751 68.036 .000 
Intercept 431890.398 1 431890.398 13285.395 .000 
Preparation 1605.323 10 160.532 4.938 .000 
Concentration 115574.821 4 28893.705 888.800 .000 
Preparation * 
Concentration 
2254.426 40 56.361 1.734 .013 
Error 3575.953 110 32.509   
Total 554900.921 165    
Corrected Total 123010.523 164    
a.
 R Squared = .971 (Adjusted R Squared = .957) 
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APPENDIX – CHAPTER 6 
 
 
A.6.1 Characterization of the properties of some commercial chitin/chitosan products 
 
Table A.6.1:  Moisture content of chitin and chitosan samples 
Sample Moisture content (%) Standard derivation 
Chitin 1 4.5885 0.1367 
Chitin 2 5.3973 0.0907 
Chitin 3 6.3663 0.2568 
Chitosan 1 6.0210 0.2392 
Chitosan 2 8.3412 0.1715 
Chitosan 3 10.9278 0.0766 
 
 
Table A.6.2: Statistical analysis of moisture content of chitin and chitosan samples 
Source Type III Sum of Squares df Mean Square F Sig. 
Corrected Model 80.847
a
 5 16.169 523.375 .000 
Intercept 867.034 1 867.034 28064.223 .000 
Type 80.847 5 16.169 523.375 .000 
Error .371 12 .031   
Total 948.252 18    
Corrected Total 81.218 17    
a
. R Squared = .995 (Adjusted R Squared = .994) 
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Table A.6.3:  Ash content of chitin and chitosan samples 
Sample Ash content (%) Standard derivation 
Chitin 1 0.1755 0.0312 
Chitin 2 0.3998 0.0543 
Chitin 3 0.0702 0.0127 
Chitosan 1 0.7333 0.0457 
Chitosan 2 5.8325 0.0464 
Chitosan 3 0.3619 0.0139 
 
 
Table A.6.4: Statistical analysis of ash content of chitin and chitosan samples 
Source Type III Sum of Squares df Mean Square F Sig. 
Corrected Model 75.970
a
 5 15.194 10697.626 .000 
Intercept 28.677 1 28.677 20190.342 .000 
Type 75.970 5 15.194 10697.626 .000 
Error .017 12 .001   
Total 104.664 18    
Corrected Total 75.987 17    
a
. R Squared = 1.000 (Adjusted R Squared = 1.000) 
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A.6.2 Characterization of the antimicrobial properties of normal chitosan  
A.6.2.1 Spectrophotometer method 
 
Table A.6.5: The optical density (OD) of bacteria over time in solutions of different chitosan 
concentration 
Bacteria 
Chitosan 
concentration 
0 hour 4 hours 24 hours 
Escherichia coli 
0% 
0.011  
± 0.003 
0.297  
± 0.062 
0.841  
± 0.167 
0.01% 
0.073  
± 0.004 
0.023  
± 0.010 
0.645 
± 0.061 
0.05% 
0.030  
± 0.027 
0.035  
± 0.034 
0.033  
± 0.030 
0.1% 
0.015  
± 0.008 
0.020  
± 0.008 
0.019  
± 0.011 
Staphylococcus 
aureus 
0% 
0.011 
± 0.001 
0.432  
± 0.104 
0.873 
± 0.037 
0.01% 
0.059  
± 0.021 
0.020  
± 0.001 
0.806  
± 0.017 
0.05% 
0.019  
± 0.008 
0.025  
± 0.003 
0.025  
± 0.006 
0.1% 
0.020  
± 0.015 
0.028  
± 0.008 
0.029  
± 0.011 
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Table A.6.6: Statistical analysis of Escherichia coli over time in solutions of different 
chitosan concentration  
Source Type III Sum of Squares df Mean Square F Sig. 
Corrected Model 2.621
a
 11 .238 74.323 .000 
Intercept 1.044 1 1.044 325.567 .000 
Concentration .839 3 .280 87.210 .000 
Incubation .849 2 .424 132.343 .000 
Concentration * 
Incubation 
.934 6 .156 48.540 .000 
Error .077 24 .003   
Total 3.742 36    
Corrected Total 2.698 35    
a
. R Squared = .971 (Adjusted R Squared = .958) 
 
 
Table A.6.7: Statistical analysis of Staphylococcus aureus over time in solutions of different 
chitosan concentration  
Source Type III Sum of Squares df Mean Square F Sig. 
Corrected Model 3.441
a
 11 .313 278.649 .000 
Intercept 1.377 1 1.377 1226.499 .000 
Concentration 1.147 3 .382 340.725 .000 
Incubation 1.075 2 .538 478.884 .000 
Concentration * 
Incubation 
1.218 6 .203 180.866 .000 
Error .027 24 .001   
Total 4.844 36    
Corrected Total 3.467 35    
a
. R Squared = .992 (Adjusted R Squared = .989) 
  
 
 
254 
 
A.6.2.2 Viable cell counts method 
 
Table A.6.8: The viable cell counts of bacteria (log10 CFU/mL) over time in solutions of 
different chitosan concentration  
Bacteria 
Chitosan 
concentration 
0 hour 4 hours 24 hours 
Escherichia coli 
 
0% 9.23 ± 0.03 11.37 ± 0.09 12.27 ± 0.04 
0.01% 9.24 ± 0.06 11.28 ± 0.02 12.20 ± 0.03 
0.05% 9.27 ± 0.06 4.19 ± 0.03 4.30 ± 0.10 
0.1% 9.24 ± 0.06 4.20 ± 0.03 4.20 ± 0.10 
Staphylococcus 
aureus 
 
0% 9.06 ± 0.06 10.21 ± 0.09 10.45 ± 0.02 
0.01% 9.13 ± 0.09 10.23 ± 0.07 10.34 ± 0.07 
0.05% 9.06 ± 0.08 2.40 ± 0.00 2.40 ± 0.00 
0.1% 9.06 ± 0.08 2.40 ± 0.00 2.81 ± 0.71 
 
 
 
Table A.6.9: Statistical analysis of viable cell counts of Escherichia coli (log10 CFU/mL) over 
time in solutions of different chitosan concentration 
Source 
Type III Sum of 
Squares df Mean Square F Sig. 
Corrected Model 1.460E25 11 1.328E24 439.716 .000 
Intercept 3.810E24 1 3.810E24 1261.722 .000 
Concentration 3.846E24 3 1.282E24 424.558 .000 
Incubation 5.342E24 2 2.671E24 884.650 .000 
Concentration * Incubation 5.417E24 6 9.028E23 298.984 .000 
Error 7.247E22 24 3.019E21   
Total 1.849E25 36    
Corrected Total 1.468E25 35    
a
. R Squared = .995 (Adjusted R Squared = .993) 
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Table A.6.10: Statistical analysis of viable cell counts of Staphylococcus aureus (log10 
CFU/mL) over time in solutions of different chitosan concentration 
Source 
Type III Sum of 
Squares df Mean Square F Sig. 
Corrected Model 3.545E21 11 3.222E20 118.870 .000 
Intercept 1.945E21 1 1.945E21 717.310 .000 
Concentration 1.758E21 3 5.860E20 216.158 .000 
Incubation 7.815E20 2 3.908E20 144.149 .000 
Concentration * Incubation 1.005E21 6 1.675E20 61.800 .000 
Error 6.506E19 24 2.711E18   
Total 5.554E21 36    
Corrected Total 3.610E21 35    
a
. R Squared = .982 (Adjusted R Squared = .974) 
 
 
 
A.6.3 Comparison the antimicrobial property between normal chitosan and purified 
chitosan 
 
Table A.6.11: Statistical analysis of MIC of chitosan samples 
Source 
Type III Sum of 
Squares df Mean Square F Sig. 
Corrected Model 21267.361
a
 5 4253.472 9.800 .001 
Intercept 55555.556 1 55555.556 128.000 .000 
Bacteria .000 1 .000 .000 1.000 
Type 21267.361 2 10633.681 24.500 .000 
Bacteria * Type .000 2 .000 .000 1.000 
Error 5208.333 12 434.028   
Total 82031.250 18    
Corrected Total 26475.694 17    
a
. R Squared = .803 (Adjusted R Squared = .721)  
 
 
256 
 
Table A.6.12: Statistical analysis of MBC of chitosan samples 
Source Type III Sum of Squares df Mean Square F Sig. 
Corrected Model 411729.601
a
 5 82345.920 10.765 .000 
Intercept 489637.587 1 489637.587 64.007 .000 
Bacteria 12207.031 1 12207.031 1.596 .230 
Type 397243.924 2 198621.962 25.965 .000 
Bacteria * Type 2278.646 2 1139.323 .149 .863 
Error 91796.875 12 7649.740   
Total 993164.063 18    
Corrected Total 503526.476 17    
a
. R Squared = .818 (Adjusted R Squared = .742)  
 
 
Table A.6.13: Statistical analysis of inhibition diameter of chitosan samples 
Source Type III Sum of Squares df Mean Square F Sig. 
Corrected Model 2595.675
a
 9 288.408 596.707 .000 
Intercept 6409.408 1 6409.408 13260.845 .000 
Bacteria 35.208 1 35.208 72.845 .000 
Type 2268.217 4 567.054 1173.216 .000 
Bacteria * Type 292.250 4 73.063 151.164 .000 
Error 9.667 20 .483   
Total 9014.750 30    
Corrected Total 2605.342 29    
a
. R Squared = .996 (Adjusted R Squared = .995)  
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A.6.4 Comparison of the antimicrobial activity of normal and purified chitosan in the 
preservation of raw shrimp tissue 
 
Table A.6.14: Weight loss of shrimp (%) during storage 
Treatments Day 5 Day 10 Day 15 
nCTS 2.36 ± 0.28 2.94 ± 0.15 3.53  ± 0.14 
pCTS 2.55 ± 0.07 3.28 ± 0.12 3.76 ± 0.19 
Acetic  2.79 ± 0.17 3.57 ± 0.19 4.07 ± 0.15 
Control 2.43 ± 0.19 3.24 ± 0.21 3.59 ± 0.18 
 
 
 
Table A.6.15: Statistical analysis of weight loss of shrimp (%) during storage  
Source 
Type III  
Sum of Squares df Mean Square F Sig. 
Corrected Model 10.273
a
 11 .934 29.892 .000 
Intercept 363.060 1 363.060 11620.600 .000 
Treatment 1.372 3 .457 14.640 .000 
Time 8.834 2 4.417 141.370 .000 
Treatment * Time .067 6 .011 .359 .898 
Error .750 24 .031   
Total 374.083 36    
Corrected Total 11.023 35    
a
. R Squared = .932 (Adjusted R Squared = .901) 
 
  
 
 
258 
 
Table A.6.16: Hardness of shrimp (force - N) during storage 
 
0 day 5 days 10 days 15 days 
nCTS 4.26 ± 0.21 4.28 ± 0.29 4.30 ± 0.29 3.96 ± 0.10 
pCTS 4.26 ± 0.21 4.08 ± 0.26 4.09 ± 0.16 3.71 ± 0.21 
Acetic 4.26 ± 0.21 3.93 ± 0.07 3.66 ± 0.20 3.59 ± 0.12 
Control 4.26 ± 0.21 3.51 ± 0.09 3.30 ± 0.20 3.30 ± 0.12 
 
 
 
Table A.6.17: Statistical analysis of the hardness of shrimp (%) during storage  
Source 
Type III  
Sum of Squares df Mean Square F Sig. 
Corrected Model 5.850
a
 15 .390 10.164 .000 
Intercept 737.822 1 737.822 19228.647 .000 
Treatment 2.425 3 .808 21.068 .000 
Time 2.433 3 .811 21.132 .000 
Treatment * Time .992 9 .110 2.874 .013 
Error 1.228 32 .038   
Total 744.900 48    
Corrected Total 7.078 47    
a
. R Squared = .827 (Adjusted R Squared = .745) 
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Table A.6.18: Total plate count (CFU/mL) of shrimp during storage 
 
 
Day 0 Day 5 Day 10 Day 15 
nCTS 
1.23E+07   
± 2.52E+06 
1.93E+08  
± 2.52E+07 
1.60E+09  
± 2.00E+08 
1.23E+09  
± 5.77E+07 
pCTS 
1.23E+07  
± 2.52E+06 
2.00E+08  
± 1.73E+07 
1.47E+09  
± 1.15E+08 
1.20E+09  
± 1.00E+08 
Acetic 
1.23E+07  
± 2.52E+06 
1.83E+08  
± 1.53E+07 
2.53E+09  
± 2.08E+08 
1.83E+09  
± 5.77E+07 
Control 
1.23E+07  
± 2.52E+06 
3.17E+08  
± 2.31E+07 
2.63E+09  
± 2.52E+08 
2.20E+09  
± 1.00E+08 
 
 
 
Table A.6.19: Total plate count (log10 CFU/mL) of shrimp during storage 
 
Day 0 Day 5 Day 10 Day 15 
nCTS 
7.09  
± 0.09 
8.28  
± 0.06 
9.20  
± 0.05 
9.09  
± 0.02 
pCTS 
7.09  
± 0.09 
8.30 
± 0.04 
9.17  
± 0.03 
9.08  
± 0.04 
Acetic 
7.09  
± 0.09 
8.26  
± 0.04 
9.40  
± 0.04 
9.26 
± 0.01 
Control 
7.09  
± 0.09 
8.50  
± 0.03 
9.42 
± 0.04 
9.34  
± 0.02 
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Table A.6.20: Statistical analysis of total plate count of shrimp during storage  
Source 
Type III  
Sum of Squares df Mean Square F Sig. 
Corrected Model 4.243E19
 a
 15 2.829E18 240.250 .000 
Intercept 4.588E19 1 4.588E19 3896.551 .000 
Treatment 2.862E18 3 9.539E17 81.011 .000 
Time 3.692E19 3 1.231E19 1045.326 .000 
Treatment * Time 2.646E18 9 2.940E17 24.971 .000 
Error 3.768E17 32 1.177E16   
Total 8.869E19 48    
Corrected Total 4.281E19 47    
a
. R Squared = .991 (Adjusted R Squared = .987) 
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APPENDIX – CHAPTER 7 
 
 
A.7.1 Film forming capacity of chitosan 
A.7.1.1 Effect of the neutralization to the solubility of chitosan films 
 
Table A.7.1:  The solubility (%) of neutralised and non-neutralised chitosan films  
Replication Non-neutralised film Neutralised film 
1 14.72 8.07 
2 15.03 8.33 
3 16.50 8.14 
Average 15.42 8.18 
STD 0.95 0.13 
 
 
Table A.7.2: Statistical analysis of the solubility of neutralised and non-neutralised chitosan 
films 
Source Type III Sum of Squares df Mean Square F Sig. 
Corrected Model 78.554
a
 1 78.554 170.338 .000 
Intercept 835.204 1 835.204 1811.068 .000 
Film 78.554 1 78.554 170.338 .000 
Error 1.845 4 .461   
Total 915.603 6    
Corrected Total 80.399 5    
a. R Squared = .977 (Adjusted R Squared = .971) 
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A.7.1.2 Effect of the degree of deacetylation of chitosan and the concentration of 
chitosan solution on the properties of chitosan film  
 
Table A.7.3:  The thickness (µm) of homogeneous chitosan films at different degree of 
deacetylation and concentrations 
Replication 
DD = 76 % DD = 94 % 
Chitosan concentration Chitosan concentration 
0.5 % 1 % 1.5 % 0.5 % 1 % 1.5 % 
Film A Film B Film C Film D Film E Film F 
1 8.75 17.60 25.45 9.50 18.00 23.33 
2 9.00 18.35 26.00 9.00 19.75 21.67 
3 9.25 16.8 26.05 9.50 19.00 24.25 
Average 9.00 17.58 25.83 9.33 18.92 23.08 
STD 0.25 0.78 0.33 0.29 0.88 1.31 
 
 
Table A.7.4: Statistical analysis of the thickness (µm) of homogeneous chitosan films at 
different degree of deacetylation and concentrations 
Source Type III Sum of Squares df Mean Square F Sig. 
Corrected Model 723.948
a
 5 144.790 260.252 .000 
Intercept 5382.031 1 5382.031 9673.919 .000 
DD .587 1 .587 1.055 .325 
Concentration 709.771 2 354.885 637.888 .000 
DD * Concentration 13.590 2 6.795 12.214 .001 
Error 6.676 12 .556   
Total 6112.655 18    
Corrected Total 730.624 17    
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Table A.7.5:  The solubility (%) of homogeneous chitosan films at different degree of 
deacetylation and concentrations 
Replication 
DD = 76 % DD = 94 % 
Chitosan concentration Chitosan concentration 
0.5 % 1 % 1.5 % 0.5 % 1 % 1.5 % 
Film A Film B Film C Film D Film E Film F 
1 10.46 10.58 10.00 16.86 14.67 14.95 
2 11.81 10.31 11.62 15.45 15.68 15.59 
3 10.35 10.04 10.05 15.24 15.87 15.59 
Average 10.87 10.31 10.56 15.85 15.41 15.38 
STD 0.81 0.27 0.92 0.88 0.65 0.37 
 
 
Table A.7.6: Statistical analysis of the solubility (%) of homogeneous chitosan films at 
different degree of deacetylation and concentrations 
Source Type III Sum of Squares df Mean Square F Sig. 
Corrected Model 111.806
a
 5 22.361 46.086 .000 
Intercept 3071.190 1 3071.190 6329.667 .000 
DD 110.906 1 110.906 228.575 .000 
Concentration .842 2 .421 .868 .445 
DD * Concentration .058 2 .029 .060 .943 
Error 5.822 12 .485   
Total 3188.818 18    
Corrected Total 117.628 17    
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Table A.7.7:  The mechanical properties of homogeneous chitosan films at different degree of 
deacetylation and concentrations 
Replication 
DD = 76 % DD = 94 % 
Chitosan concentration Chitosan concentration 
0.5 % 1 % 1.5 % 0.5 % 1 % 1.5 % 
Film A Film B Film C Film D Film E Film F 
Tensile strength (MPa) 
1 40.59 40.42 41.17 40.07 40.88 40.39 
2 40.42 40.54 40.58 40.27 40.16 40.56 
3 39.53 40.66 39.76 40.72 40.58 40.41 
Average 40.18 40.54 40.50 40.35 40.54 40.45 
STD 0.57 0.12 0.71 0.34 0.36 0.09 
Deformation (%) 
1 17.43 31.40 31.45 17.24 32.14 31.47 
2 18.00 31.18 32.09 17.55 31.34 30.12 
3 17.44 30.92 32.56 17.03 31.25 31.18 
Average 17.63 31.16 32.03 17.27 31.58 30.93 
STD 0.33 0.24 0.56 0.26 0.49 0.71 
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Table A.7.8: Statistical analysis of the mechanic properties of homogeneous chitosan films at 
different degree of deacetylation and concentrations 
Dependent Variable: Tensile strength 
Source 
Type III Sum of 
Squares df Mean Square F Sig. 
Corrected Model .295
a
 5 .059 .325 .888 
Intercept 29420.102 1 29420.102 161915.809 .000 
DD .008 1 .008 .042 .841 
Concentration .247 2 .123 .679 .526 
DD * Concentration .041 2 .021 .113 .894 
Error 2.180 12 .182   
Total 29422.578 18    
Corrected Total 2.476 17    
 
Dependent Variable: Deformation  
Source 
Type III Sum of 
Squares df Mean Square F Sig. 
Corrected Model 783.707
a
 5 156.741 730.105 .000 
Intercept 12895.645 1 12895.645 60068.215 .000 
DD .551 1 .551 2.568 .135 
Concentration 781.423 2 390.711 1819.943 .000 
DD * Concentration 1.733 2 .866 4.036 .046 
Error 2.576 12 .215   
Total 13681.928 18    
Corrected Total 786.283 17    
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A.7.2 Improvement of the solubility and seal-ability of chitosan films 
A.7.2.1 Film forming capacity of some biopolymers 
 
Table A.7.9:  The thickness (µm) of homogeneous edible films 
Biopolymer Code Average STD 
Chitosan 1 % CHI1 18.92 0.88 
Agar 1 % A1 33.85 0.48 
Agar 2 % A2 39.66 1.02 
Agar 3 % A3 51.57 0.35 
Carrageenan 2 % CAR2 30.38 1.01 
Carrageenan 3 % CAR3 41.33 0.49 
Carrageenan 4 % CAR4 44.33 0.74 
CMC 1 % CMC1 20.56 1.71 
CMC 1.5 % CMC1.5 26.42 0.88 
CMC 2 % CMC2 31.97 0.34 
Corn starch 1 % S1 24.71 0.73 
Corn starch 2 % S2 33.41 0.38 
Corn starch 3 % S3 52.85 1.12 
Gelatin 3 % G3 45.38 0.53 
Gelatin 4 % G4 53.24 0.75 
Gelatin 5 % G5 60.49 0.30 
Pectin 1 % P1 19.38 1.35 
Pectin 1.5 % P1.5 25.47 1.28 
Pectin 2 % P2 32.47 1.35 
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Table A.7.10: Statistical analysis of the thickness (µm) of homogeneous edible films 
 
Source 
Type III Sum of  
Squares df Mean Square F Sig. 
Corrected Model 8152.444
a
 18 452.914 542.616 .000 
Intercept 75181.674 1 75181.674 90071.808 .000 
Biomaterial 8152.444 18 452.914 542.616 .000 
Error 31.718 38 .835   
Total 83365.836 57    
Corrected Total 8184.162 56    
a. R Squared = .996 (Adjusted R Squared = .994) 
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Table A.7.11:  The solubility (%) of homogeneous edible films 
 
Biopolymer Code Average STD 
Agar 1 % A1 93.33 3.06 
Agar 2 % A2 84.00 4.00 
Agar 3 % A3 67.33 3.06 
Carrageenan 2 % CAR2 96.67 2.31 
Carrageenan 3 % CAR3 93.33 3.06 
Carrageenan 4 % CAR4 70.00 7.21 
CMC 1 % CMC1 96.67 2.31 
CMC 1.5 % CMC1.5 96.00 2.00 
CMC 2 % CMC2 92.00 6.00 
Corn starch 1 % S1 39.33 3.06 
Corn starch 2 % S2 30.67 1.15 
Corn starch 3 % S3 15.33 1.15 
Gelatin 3 % G3 98.67 1.15 
Gelatin 4 % G4 97.33 2.31 
Gelatin 5 % G5 90.67 1.15 
Pectin 1 % P1 92.67 3.06 
Pectin 1.5 % P1.5 92.00 6.00 
Pectin 2 % P2 90.67 6.11 
Chitosan 1 % CHI1 15.41 0.65 
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Table A.7.12: Statistical analysis of the solubility (%) of homogeneous edible films 
Source 
Type III Sum of 
Squares df Mean Square F Sig. 
Corrected Model 39976.702
a
 18 2220.928 168.342 .000 
Intercept 339957.965 1 339957.965 25768.090 .000 
Biomaterial 39976.702 18 2220.928 168.342 .000 
Error 501.333 38 13.193   
Total 380436.000 57    
Corrected Total 40478.035 56    
a. R Squared = .988 (Adjusted R Squared = .982) 
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Table A.7.13:  The mechanic properties of homogeneous edible films 
Biopolymer Tensile strength (MPa) Deformation (%) 
Agar 1 % 30.74 ± 1.95 3.27 ± 0.05 
Agar 2 % 34.83 ± 0.81 9.19 ± 0.91 
Agar 3 % 42.28 ± 1.60 11.81 ± 1.59 
Carrageenan 2 % 33.94 ± 0.23 13.81 ± 0.45 
Carrageenan 3 % 19.39 ± 0.55 24.70 ± 1.10 
Carrageenan 4 % 25.80 ± 1.19 29.77 ± 2.40 
CMC 1 % 32.03 ± 1.84 27.42 ± 1.46 
CMC 1.5 % 28.33 ± 0.51 13.96 ± 1.07 
CMC 2 % 31.96 ± 0.80 25.16 ± 1.61 
Corn starch 1 % 7.88 ± 0.49 1.64 ± 0.13 
Corn starch 2 % 20.66 ± 0.94 2.22 ± 0.14 
Corn starch 3 % 15.96 ± 0.67 2.33 ± 0.11 
Gelatin 3 % 15.25 ± 2.58 23.55 ± 0.29 
Gelatin 4 % 14.10 ± 1.48 26.87 ± 0.27 
Gelatin 5 % 13.37 ± 2.21 29.18 ± 1.42 
Pectin 1 % 21.39 ± 0.78 15.58 ± 1.81 
Pectin 1.5 % 29.99 ± 1.44 6.24 ± 0.60 
Pectin 2 % 32.00 ± 0.60 16.44 ± 0.72 
Chitosan 1 % 40.54 ± 0.36 31.58 ± 0.49 
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Table A.7.14: Statistical analysis of the mechanic properties of homogeneous edible films 
 
Dependent Variable:Tensile 
Source 
Type III Sum of 
Squares df Mean Square F Sig. 
Corrected Model 4548.130
a
 18 252.674 143.815 .000 
Intercept 34674.624 1 34674.624 19735.900 .000 
Biomaterial 4548.130 18 252.674 143.815 .000 
Error 66.763 38 1.757   
Total 39289.517 57    
Corrected Total 4614.893 56    
a. R Squared = .986 (Adjusted R Squared = .979) 
 
 
Dependent Variable:Deformation 
Source 
Type III Sum of 
Squares df Mean Square F Sig. 
Corrected Model 5241.396
a
 18 291.189 62.673 .000 
Intercept 13528.902 1 13528.902 2911.837 .000 
Biomaterial 5241.396 18 291.189 62.673 .000 
Error 176.555 38 4.646   
Total 18946.853 57    
Corrected Total 5417.951 56    
a. R Squared = .967 (Adjusted R Squared = .952) 
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Table A.7.15:  The water vapor permeation (WVP) (g.m
-1
. s
-1
.Pa
-1
) of homogeneous edible 
films 
Biopolymer Water vapor permeation (WVP) STD 
Agar 1 % 9.66E-11 2.01E-12 
Agar 2 % 2.82E-10 1.64E-11 
Agar 3 % 9.08E-11 3.78E-12 
Carrageenan 2 % 6.76E-11 6.61E-12 
Carrageenan 3 % 9.52E-11 7.25E-12 
Carrageenan 4 % 1.62E-10 2.31E-12 
Gelatin 3 % 5.62E-11 1.02E-11 
Gelatin 4 % 1.01E-10 5.86E-12 
Gelatin 5 % 1.47E-10 1.47E-11 
Corn starch 1 % 8.30E-11 7.06E-12 
Corn starch 2 % 5.35E-11 4.42E-12 
Corn starch 3 % 1.37E-10 3.12E-12 
CMC 1 % 5.98E-11 2.12E-12 
CMC 1.5 % 6.18E-11 6.40E-12 
CMC 2 % 6.88E-11 3.73E-12 
Pectin 1 % 5.87E-11 2.32E-13 
Pectin 1.5 % 5.73E-11 4.71E-12 
Pectin 2 % 7.16E-11 7.38E-12 
Chitosan 1 % 6.27E-11 1.53E-12 
LDPE 2.32E-12 3.81E-25 
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Table A.7.16: Statistical analysis of the water vapor permeation (WVP) of homogeneous 
edible films 
 
Source 
Type III Sum of 
Squares df Mean Square F Sig. 
Corrected Model 1.907E-19
a
 19 1.004E-20 193.200 .000 
Intercept .000 1 .000 .000 1.000 
Biomaterial .000 19 .000 .000 1.000 
Error 2.078E-21 40 5.195E-23   
Total 6.881E-19 60    
Corrected Total 1.928E-19 59    
a. R Squared = .989 (Adjusted R Squared = .984) 
 
 
Table A.7.17:  The mechanical properties of the seal of 5 % gelatine films 
Replication Tensile strength (MPa) Deformation (%) 
1 1.71 11.44 
2 1.41 10.82 
3 1.72 9.40 
Average 1.61 10.55 
STD 0.18 1.05 
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A.7.2.2 The effect of blending ratio to the forming film properties 
 
Table A.7.18:  The thickness (µm) of composite edible films 
 
% Gelatin % CTS Average STD 
Film 1 3 0.50 40.18 0.75 
Film 2 3 0.75 42.60 0.30 
Film 3 3 1.00 47.83 1.43 
Film 4 4 0.50 52.52 0.28 
Film 5 4 0.75 54.83 0.35 
Film 6 4 1.00 57.47 0.37 
Film 7 5 0.50 57.78 0.16 
Film 8 5 0.75 59.20 0.69 
Film 9 5 1.00 60.70 0.58 
 
Table A.7.19: Statistical analysis of the thickness of composite edible films 
Source Type III Sum of Squares df Mean Square F Sig. 
Corrected Model 125.624
a
 8 15.703 63.912 .000 
Intercept 1686.777 1 1686.777 6865.249 .000 
Gelatin 53.021 2 26.510 107.899 .000 
Chitosan 54.043 2 27.022 109.979 .000 
Gelatin * Chitosan 18.560 4 4.640 18.885 .000 
Error 4.423 18 .246   
Total 1816.824 27    
Corrected Total 130.047 26    
a. R Squared = .966 (Adjusted R Squared = .951) 
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Table A.7.20:  The solubility (%) of composite edible films 
 
% Gelatin % CTS Average STD 
Film 1 3 0.50 77.98 0.38 
Film 2 3 0.75 75.86 0.51 
Film 3 3 1.00 73.67 0.44 
Film 4 4 0.50 80.29 1.02 
Film 5 4 0.75 77.14 0.21 
Film 6 4 1.00 75.94 0.71 
Film 7 5 0.50 84.69 0.68 
Film 8 5 0.75 80.68 0.56 
Film 9 5 1.00 78.32 0.60 
 
 
Table A.7.21: Statistical analysis of the solubility (%) of composite edible films 
Source 
Type III Sum of 
Squares df Mean Square F Sig. 
Corrected Model 254.508
a
 8 31.813 86.571 .000 
Intercept 165472.962 1 165472.962 450284.714 .000 
Gelatin 134.035 2 67.017 182.368 .000 
Chitosan 115.113 2 57.556 156.622 .000 
Gelatin * Chitosan 5.360 4 1.340 3.646 .024 
Error 6.615 18 .367   
Total 165734.084 27    
Corrected Total 261.122 26    
a. R Squared = .975 (Adjusted R Squared = .963) 
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Table A.7.22:  The mechanical properties of composite edible films 
 
% Gelatin % CTS Tensile strength (MPa) Deformation (%) 
Film 1 3 0.50 26.78 ± 0.38 23.84 ± 0.21 
Film 2 3 0.75 28.11 ± 0.28 21.50 ± 0.73 
Film 3 3 1.00 29.88 ± 0.41 20.33 ± 0.42 
Film 4 4 0.50 24.05 ± 0.37 61.21 ± 0.57 
Film 5 4 0.75 25.53 ± 0.45 33.50 ± 0.54 
Film 6 4 1.00 26.70 ± 0.57 31.51 ± 0.17 
Film 7 5 0.50 23.03 ± 0.55 66.81 ± 0.95 
Film 8 5 0.75 23.65 ± 0.43 51.62 ± 0.83 
Film 9 5 1.00 24.90 ± 0.37 43.87 ± 0.68 
 
Table A.7.23: Statistical analysis of the mechanic properties of composite edible films 
Dependent Variable:Tensile 
Source 
Type III Sum of 
Squares df Mean Square F Sig. 
Corrected Model 119.665
a
 8 14.958 80.351 .000 
Intercept 18037.406 1 18037.406 96892.534 .000 
Gelatin 89.205 2 44.602 239.593 .000 
Chitosan 29.046 2 14.523 78.013 .000 
Gelatin * Chitosan 1.414 4 .354 1.899 .154 
Error 3.351 18 .186   
Total 18160.422 27    
Corrected Total 123.016 26    
a. R Squared = .973 (Adjusted R Squared = .961) 
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Dependent Variable:Deformation 
Source 
Type III Sum of 
Squares df Mean Square F Sig. 
Corrected Model 7259.397
a
 8 907.425 2380.552 .000 
Intercept 41813.310 1 41813.310 109693.704 .000 
Gelatin 4769.723 2 2384.861 6256.483 .000 
Chitosan 1772.677 2 886.338 2325.234 .000 
Gelatin * Chitosan 716.998 4 179.249 470.246 .000 
Error 6.861 18 .381   
Total 49079.569 27    
Corrected Total 7266.259 26    
a. R Squared = .999 (Adjusted R Squared = .999) 
 
Table A.7.24:  The water vapor permeation (WVP) (g.m
-1
. s
-1
.Pa
-1
) of composite edible films 
 
% Gelatin % CTS 
Water vapor permeation 
(10
-10
.g.m
-1
. s
-1
.Pa
-1
) 
STD 
(10
-10
.g.m
-1
. s
-1
.Pa
-1
) 
Film 1 3 0.50 1.5246 0.0060 
Film 2 3 0.75 1.4287 0.0069 
Film 3 3 1.00 0.8687 0.0006 
Film 4 4 0.50 1.8125 0.0068 
Film 5 4 0.75 1.6590 0.0050 
Film 6 4 1.00 1.4571 0.0092 
Film 7 5 0.50 1.9375 0.0502 
Film 8 5 0.75 1.6863 0.0084 
Film 9 5 1.00 1.5875 0.0073 
LDPE - - 0.0145 0.0090 
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Table A.7.25: Statistical analysis of the water vapor permeation (WVP) of composite edible 
films 
Source 
Type III Sum of 
Squares df Mean Square F Sig. 
Corrected Model 2.217
a
 8 .277 865.278 .000 
Intercept 64.979 1 64.979 202859.700 .000 
Gelatin 1.078 2 .539 1683.296 .000 
Chitosan .948 2 .474 1479.859 .000 
Gelatin * Chitosan .191 4 .048 148.980 .000 
Error .006 18 .000   
Total 67.202 27    
Corrected Total 2.223 26    
a. R Squared = .997 (Adjusted R Squared = .996) 
 
Table A.7.26:  The tensile strength (MPa) of the seal of composite edible films 
 
% Gelatin % Chitosan Tensile strength (MPa) STD 
Film 1 3 0.50 7.93 0.90 
Film 2 3 0.75 6.39 0.61 
Film 3 3 1.00 5.55 0.24 
Film 4 4 0.50 8.23 0.27 
Film 5 4 0.75 6.83 0.33 
Film 6 4 1.00 6.65 0.30 
Film 7 5 0.50 13.27 0.39 
Film 8 5 0.75 9.21 0.44 
Film 9 5 1.00 7.08 0.59 
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Table A.7.27: Statistical analysis of the mechanic properties of the seal of composite edible 
films 
 
Source 
Type III Sum of 
Squares df Mean Square F Sig. 
Corrected Model 125.624
a
 8 15.703 63.912 .000 
Intercept 1686.777 1 1686.777 6865.249 .000 
Gelatin 53.021 2 26.510 107.899 .000 
Chitosan 54.043 2 27.022 109.979 .000 
Gelatin * Chitosan 18.560 4 4.640 18.885 .000 
Error 4.423 18 .246   
Total 1816.824 27    
Corrected Total 130.047 26    
a. R Squared = .966 (Adjusted R Squared = .951) 
 
 
A.7.3 Application of composite edible films in spice casing for instant noodles 
Table A.7.28:  The weight loss (%) of the seasoning bags during 6 months of storage 
Sample 1 month 2 months 3 months 4 months 5 months 6 months 
A 
-0.0412  
± 0.0029 
0.4539  
± 0.1739 
-0.1160  
± 0.0113 
0.3756  
± 0.1063 
-0.6474  
± 0.0116 
-2.5660  
± 0.1908 
B 
-0.1109  
± 0.0419 
0.0235  
± 0.0117 
-0.0444  
± 0.0120 
0.0445  
± 0.0061 
-0.2327  
± 0.0028 
-0.1875  
± 0.0447 
C 
0.0290  
± 0.0111 
0.0482  
± 0.0095 
0.1786  
± 0.0717 
0.0542  
± 0.0107 
-0.0332  
± 0.0053 
0.0905  
± 0.0130 
D 
0.0261  
± 0.0094 
0.0390  
± 0.0095 
0.0536  
± 0.0110 
0.0305  
± 0.0078 
-0.1088  
± 0.0153 
0.0402  
± 0.0033 
 
Note:  A: Mixed bag - Ambient environment  C: Mixed bag - OPP wrapped 
B: PE bag - Ambient environment   D: PE bag - OPP wrapped  
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Table A.7.29: Statistical analysis of the weight loss (%) of the seasoning bags 
Source 
Type III Sum of 
Squares df Mean Square F Sig. 
Corrected Model 21.894
a
 27 .811 256.277 .000 
Intercept .723 1 .723 228.493 .000 
Sample 2.216 3 .739 233.496 .000 
Month 5.654 6 .942 297.832 .000 
Sample * Month 14.023 18 .779 246.223 .000 
Error .177 56 .003   
Total 22.794 84    
Corrected Total 22.071 83    
a. R Squared = .992 (Adjusted R Squared = .988) 
 
 
Table A.7.30:  The weight loss (%) of the oil bags during 6 months of storage 
Sample 1 month 2 months 3 months 4 months 5 months 6 months 
A 
0.6285 
± 0.0489 
1.0082 
± 0.1619 
2.1541 
± 0.1305 
2.2111 
± 0.1167 
2.3004 
± 0.0705 
2.4997 
± 0.0430 
B 
0.1628 
± 0.0097 
0.0877 
± 0.0046 
-0.3059 
± 0.0568 
-0.5732 
± 0.0515 
-0.6891 
± 0.0181 
-0.6850 
± 0.0149 
C 
0.2356 
± 0.0299 
0.3684 
± 0.0470 
0.6630 
± 0.0815 
0.7994 
± 0.0778 
0.8518 
± 0.0515 
0.8872 
± 0.0146 
D 
0.0992 
± 0.0261 
0.1169 
± 0.0371 
0.1907 
± 0.0329 
0.2278 
± 0.0272 
0.2488 
± 0.0157 
0.3179 
± 0.0233 
 
Note:  A: Mixed bag - Ambient environment  C: Mixed bag - OPP wrapped 
B: PE bag - Ambient environment   D: PE bag - OPP wrapped 
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Table A.7.31: Statistical analysis of the weight loss (%) of the oil bags 
Source 
Type III Sum of 
Squares df Mean Square F Sig. 
Corrected Model 60.394
a
 27 2.237 652.826 .000 
Intercept 20.422 1 20.422 5960.338 .000 
Sample 38.129 3 12.710 3709.372 .000 
Month 5.562 6 .927 270.527 .000 
Sample * Month 16.703 18 .928 270.834 .000 
Error .192 56 .003   
Total 81.008 84    
Corrected Total 60.586 83    
a. R Squared = .997 (Adjusted R Squared = .995) 
 
 
Table A.7.32:  The moisture content (%) of the seasoning during storage 
Sample 0 month 3 months 4 months 5 months 6 months 
A 
0.4644 
± 0.0841 
0.3927 
± 0.0585 
0.3476 
± 0.0700 
0.3517 
± 0.0160 
1.1204 
± 0.0418 
B 
0.4644 
± 0.0841 
0.2223 
± 0.0388 
0.1532 
± 0.0386 
-2.0293 
± 2.2340 
0.2404 
± 0.0288 
C 
0.4644 
± 0.0841 
0.3622 
± 0.0219 
0.1978 
± 0.0306 
-1.8354 
± 0.0601 
0.2585 
± 0.0239 
D 
0.4644 
± 0.0841 
0.2515 
± 0.0383 
0.0885 
± 0.0836 
-2.4161 
± 1.0644 
0.2894 
± 0.0257 
Note:  A: Mixed bag - Ambient environment  C: Mixed bag - OPP wrapped 
B: PE bag - Ambient environment   D: PE bag - OPP wrapped 
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Table A.7.33:  The moisture content (%) of the oil during storage 
Sample 0 month 3 months 4 months 5 months 6 months 
A 
0.9866 
± 0.1546 
5.6391 
± 1.0737 
0.0000 
± 0.0000 
-0.8848 
± 0.3427 
-0.3116 
± 0.1514 
B 
0.9866 
± 0.1546 
0.2055 
± 0.4294 
1.0278 
± 0.9749 
-5.1944 
± 6.2372 
-1.4716 
± 0.2925 
C 
0.9866 
± 0.1546 
-0.5144 
± 0.4279 
0.1684 
± 0.2917 
0.7384 
± 0.1286 
0.2623 
± 0.0911 
D 
0.9866 
± 0.1546 
0.0087 
± 0.3056 
0.2252 
± 0.1972 
0.4450 
± 0.0333 
0.3545 
± 0.2461 
Note:  A: Mixed bag - Ambient environment  C: Mixed bag - OPP wrapped 
B: PE bag - Ambient environment   D: PE bag - OPP wrapped 
 
 
 
 
 
 
 
 
